Investigation of substitutes for foetal calf serum in animal cell culture media by Murphy, Edel
Investigation of Substitutes for Foetal Calf Serum in 
Animal Cell Culture Media
by
Edel Murphy
Submitted to the National Council for Educational Awards for a
M.Sc. degree, September 1986
The experimental work described here was carried out in the 
Animal Cell Culture Laboratory,
National Institute for Higher Education, Dublin.
Research Supervisors Dr. Martin Clynes, Ph.D.
ABSTRACT
The purpose of this thesis was to develop a serum-free medium which would support 
the growth of a human tumour cell line, RPMI 2650. Serum is used almost 
universally as a medium supplement to support growth of cells in culture, but 
investigators in the field have long recognised the problems associated with the 
undefined, complex and variable composition of serum whereas serum-free media 
permit growth of cells in a precisely-defined environment.
In order to gain experience in the techniques used to grow cells in culture in 
the absence of serum, initial work was carried out on a canine kidney cell line 
(MDCK), for which a serum-free medium had already been developed. Growth of 
RPMI 2650 was initially examined in reduced serum conditions at clonal cell 
densities and the effect of various growth factors, hormones and other nutritional 
factors was examined. Significant growth stimulation was observed due to the 
addition of a number of factors (transferrin, insulin, EGF and selenium).
Growth occurred in dishes precoated with DEAE dextran in the absence of any 
serum supplement following addition of medium containing six components (transferrin, 
insulin, epidermal growth factor, selenium, ascorbic acid and a commercially- 
available amino acid mixture, MEM non-essential amino acids).
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1When attempts were first made to grow animal cells in culture, the media 
used were biological fluids. These included embryo extract, spinal or 
amniotic fluid (Barnes and Sato, 1980 a), lymph (Harrison, 1907) and 
plasma or serum (Brooks, 1975). It was thought that these materials
resembled the natural environment of the cells. In time, a basal nutrient 
mixture of salts, sugars, amino acids and vitamins was found to support 
the growth of almost all cell types, but only when supplemented by a 
poorly defined biological fluid, generally serum. Sera from a number of 
sources are used - horse, bovine, human - but the most widely used serum 
is foetal calf serum (FCS).
1.1 Role of FCS
FCS is a complex mixture of proteins, hormones and nutrients (as well as 
salts and various metabolites). It contains some factors which are 
essential for the survival and growth of cells in culture, but our 
knowledge of the nature and mode of action of these factors is still 
incomplete, in spite of considerable research in this field.
Identification and purification of the various components in serum has 
proven very difficult for several reasons, for example :
(1) Serum contains a complex and diverse mixture of active components, 
including proteins:
(2) Many of the active components (e.g. hormones) are present in 
minute and variable amounts and may also, in some cases, be bound 
to serum proteins:
(3) There may be synergistic action between factors in the serum, which 
may be diminished or lost during fractionation procedures.
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2A considerable amount of information is, nevertheless, available on the 
active components of serum. Identified components can be divided into 
four groups :
- proteins and peptides (non-hormonal)
- hormones
- metabolites and nutrients
- trace elements
One important rn vitro role for serum proteins is to act as carrier proteins 
for minerals, fatty acids and hormones. These proteins may stabilise and 
modulate the action of substances which they bind, or in some instances, 
they may detoxify the medium, as in the case of transferrin, which binds 
iron, thus rendering it less toxic but still available to the cells.
Serum contains a trypsin inhibitor; it has been suggested that the a2- 
macroglobulin molecule is responsible for this action (Freshney, 1983).
This, and possibly other protease inhibitors, play a very important role 
in protecting cells from proteases during passaging of cells in vitro.
Serum also supplies factors which are involved in attachment and spreading 
of cells to and on the substrate. These include the proteins fibronectin 
and fetuin and possibly a number of other components which combine to act 
in a similar manner to stromal influences in vivo.
Certain polypeptides seem to play a critical role in promoting growth. One 
major contributor, platlet-derived growth factor (PDGF), is released from 
the platlets during clotting. This is thought to be the major growth 
promoter in serum for some cell types e.g. mouse Balb/c-3T3 cells 
(Antoniades, 1975). There is much speculation regarding some other 
polypeptide growth factors e.g. epidermal growth factor (EGF), fibroblast 
growth factor (FGF), multiplication stimulating activator (MSA) - which 
have been detected in the medium. It is not totally clear whether or not 
these are always present in minute quantities in the serum. It is clear 
in some instances that they are secreted by the cells into the medium 
during growth (La Rocca & Rheinwald, 1985) and act as autostimulators.
The hormonal composition of foetal calf serum is poorly defined. Insulin 
is known to be present in serum; growth hormone and the somatomedins are 
also thought to be present and may function synergistically to have a 
mitogenic effect (Freshney, 1983).
3A number of nutrients such as glucose and amino acids are present in serum; 
these may be important when added to a simple basal medium, but cells 
growing in a complex basal medium have little need for these nutrients. 
However, serum vitamins may play a more critical role for some cell types 
e.g. bio tin is absent from many basal media. Different cell types have 
different nutritional requirements and serum may supply a low, but critical 
level of a vitamin or some other nutrient. This specific nutritional 
requirement must be identified and supplied when growth is taking place in 
a serum-free environment.
Trace elements including iron, copper, zinc and selenium may be supplied to 
the cells by serum. These and possibly traces of many other minerals, may 
be bound to serum proteins.
1.2 Reasons for development of serum-free media
Almost all cell types require serum for growth in culture but there are 
numerous disadvantages associated with its use and these have led to increased 
interest in the development of serum-free media in the past fifteen years.
Workers in cell culture have long realised problems associated with the 
undefined, complex and variable composition of serum and their aim is to 
develop precisely defined environments for growth of cells. The 
concentration of various components varies considerably from batch to 
batch and this batch variation causes four main problems :
(1) the actual growth of cells - i.e. number of population doublings 
and time taken for each doubling to occur - can vary dramatically. 
This renders study of growth or any growth-related parameter very 
difficult.
(2) Specific cell types can be affected differently by batch variation.
A batch of serum may preferentially support or inhibit growth of a 
specific cell type - thus, in a laboratory growing more than one 
cell type different batches of serum are required for optimum 
growth of different cell lines.
4(3) Continuous long-term studies are disrupted when a change over to 
a new batch of serum occurs. Much time can be spent trying to 
achieve standard growth conditions with each new batch - and the 
nature and extent of growth will never match exactly that in the 
previous batch.
(4) If hormonal or nutritional studies on a serum component are being 
carried out, the serum contribution of this component can vary 
significantly from batch to batch.
Serum is also an expensive componentj 100mls of FCS costing between 
£20 and £25 and a considerable portion of a cell culture laboratory's 
budget is spent on serum. The supply of FCS is also variable - in 1979 
a world-wide crisis occurred which forced many laboratories to seek 
alternatives to FCS to maintain their stocks. There can also be variations 
in the manner in which the serum is processed prior to sale, thus increasing 
the variation associated with its use.
There have been reports of the presence of antibodies, bacterial toxins 
and growth inhibitors in serum (Harrington and Godman, 1981). Antibodies 
which were produced by the animal prior to collection of the serum remain 
in the serum after processing and may interfere with growth, possibly by 
binding to cell surface antigens. There may be some bacterial lipopoly- 
saccharides in some serum batches which may also affect growth. Some cell 
types grow better in the absence of serum^which suggests the presence of 
an inhibitor in the serum (Wille e£ a_L, 1984). It is also possible that 
physiological growth inhibitors may be present in varying amounts in 
different batches of serum. (Steck et *L, 1979).
Cell culture concentrated initially on growth of fibroblasts and thus 
conditions were optimized for their growth. Serum stimulates fibroblast 
growth in culture but this is proving a major problem in primary culture 
work. Fibroblast overgrowth of other cell types is common and thus, a 
defined medium which would yield selective growth of different cell types 
would be a major step in the area of primary cultures.
5Thus, the attractions of working with a defined medium are clear and 
these have led to numerous attempts at the development of such conditions.
1.3 Approaches to the development of a serum-free medium
When serum is omitted from culture medium substitutes must be found for all 
of the critical roles which serum plays, as described above. Three main 
approaches have been taken in attempting to minimise or replace the use 
of serum in cell culture media :
(1) Adaptation of cell lines to continually decreasing levels of serum, 
generally accompanied by the introduction of some known growth 
stimulators : Gradual adaptation to low serum levels may lead to 
selection of a sub-population of cells which will survive under 
these conditions. This is not desirable for many applications
as the selected sub-population may vary significantly from the 
parent population in some important aspects. Thus, this method 
has proven generally unsatisfactory.
(2) Adjustment of basal medium components to provide cells with an 
optimal nutrient balance : All cells are cultured in a basal 
nutrient medium which consists of a balanced salt solution (which 
provides the correct ratio of various ions, an iso-osmotic 
environment for the cells and a buffering system), amino acids, 
vitamins and glucose or another carbon source. There are a number 
of commercially available basal media which are widely used in 
conjunction with serum for the growth of a variety of cell types.
The laboratory of R.G. Ham, in particular, made considerable 
progress in optimising concentrations of the individual components
of basal media. By sequentially optimising the precise concentration 
of each component in the basal medium, new media have been developed 
which support the growth of specific cell types in a totally 
defined medium. Peehl and Ham (1980) show that in two media 
developed in this manner from Ham's F12, human keratinocytes grow 
selectively in MCDB 151 medium and fibroblasts in MCDB 105.
6This approach has led to the formulation of many useful 
chemically-defined media, some of which are now becoming 
available commercially. These optimal basal media often require 
supplementation with a much lower serum concentration than do 
standard media and replacement of serum often proves easier in 
such circumstances.
(3) Replacement of growth stimulatory activities of serum by a 
combination of hormones at the correct concentrations :
Many laboratories have followed the lead of Barnes and Sato (1980a) 
along this line of research. The first step involves choosing 
a basal medium which is rich in low molecular weight factors (e.g. 
vitamins, amino acids, trace metals), since serum supplies such 
nutrients. Ham's F12 (Ham, 1965) is one of the most widely used 
media, as its relatively complex nature seems suitable for growth 
of many cell types. It is often used in conjunction with other 
simpler media - e.g. a Dulbecco's Modified Eagles medium (DMEM) :
Ham's F12 mixture forms the basis for a number of serum-free media 
(e.g. Taub, (1979) - canine kidney cells; Calvo et al.(1984) - 
human breast carcinoma cells; Morrison et al.(1981) - rat astrocytes). 
Dulbecco's medium contains high concentrations of many essential 
nutrients, whereas Ham's F12 contains a wider variety of nutrients 
at lower concentration.
A wide variety of hormones have been tested on a range of cell types. In 
general, workers have found that cells need factors other than hormones to 
grow in the absence of serum. Also, the combination of components for 
different cell and tissue types varies considerably. This is a fact, which, 
if exploited, could be of major significance in the area of primary culture 
work, where, as mentioned previously, fibroblast overgrowth proves a major 
obstacle to growth of epithelial cell cultures. A system allowing selective 
growth of epithelial cells over fibroblasts would be of considerable help.
Thus, developing a serum-free medium for a specific cell type involves 
investigating the effects of all available hormones, binding proteins and 
attachment factors on the cells in vitro. Table 1.1 lists some of the 
factors which have been used in serum-free formulations to date.
7TABLE 1.1 
Hormones and Growth Factors
Insulin
Epidermal Growth Factor (EGF) 
Fibroblast Growth Factor (FGF)
Plat let-derived growth factor (PDGF)
Nerve growth factor (NGF)
Hydrocortisone
Triiodothyronine
Progesterone
Glucagon
Growth hormone
Follicle stimulating hormone (FSH)
Luteinizing hormone
Thyrotropin releasing hormones
Parathyroid hormone
Somatomedin C
Estradio 1
Testosterone
Prostaglandin E^
Prostaglandin F2a
Prolactin
Glycyl-histidyl lysine 
Bombesin
Binding proteins
Transferrin
Bovine serum albumin
Attachment and Spreading Factors
Collagen
Poly-D-lysine
Gelatin
Fibronectin
Laminin
Fetuin
conc. used
0 .1 - 10jjg/ml
1 - lOOng/ml
1 - 100ng/ml
1 - 5ng/ml
1 - 10jjg/ml
1 - 10OnM
1 - 1OOpM
1 - lOOnM
0 .1 - 5pg/ml
50 - 500ng/ml
50 - 500ng/ml
0.5 - 2jjg/ml
1 - lOng/ml
1ng/ml 
1ng/ml 
1 - 1OnM 
1 - 1OnM 
1 - 100ng/ml 
1 - 100ng/ml 
5pg/ml 
1 - 2 0 0ng/ml 
1 - 200ng/ml
0.5 - 100jjg/ml 
0 .1 - 1Omg/ml
precoating 
precoating 
precoating
precoating/2- 1Opg/ml in medium
precoating
1 - 5pg/ml in medium
8TABLE 1..1 (cont'd)
Low-molecular weight nutrient factors/Trace elements
Selenium 10 - 100nM
Cadmium 0.1 - 1 jjM
Putrescine lOOpM
Ascorbic Acid lOjjg/ml
Trace Element mixtures
Ferrous sulphate 10 "*M
Table 1.1 : Serum-free media components
A list of some of the components used in serum-free media formulations.
Data compiled from Barnes and Sato (1980 a,b ), McKeehan (1984), 
and Bottenstein £t ¿1. (1979).
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9As the work carried out in our laboratory has followed the latter approach,
I will discuss the conventional pathway of investigation. In order to see 
some stimulation of growth when the various factors are added to the medium, 
the growth-promoting capacity of the serum supplement must be reduced in 
some way. However, total removal of serum initially is usually too 
dramatic a step as it may be difficult to see any growth at all with only 
a small number of randomly chosen factors - but a negative result at this 
stage does not necessarily mean that all the factors under study can be 
discarded as having no stimulatory ability. A vital factor may be missing, 
in the presence of which some or all of the original components may be 
growth stimulatory. In general, if a low level of serum is present, a 
growth stimulating component will be detected more readily by stimulating 
growth above the background level which the low serum concentration generates.
Thus, it is normal to first lower the serum concentration in the medium 
until growth, while still occurring, is significantly reduced. Then, under 
such suboptimal conditions, a wide range of factors can be tested individually 
and in combinations. As stimulatory factors are identified, the serum 
concentrations can be reduced and the optimal concentration of these factors 
worked out.
Table 1.1 lists many of the factors that have been used in serum-free media.
Of these, insulin, transferrin, epidermal growth factor (EGF) and selenium 
are possibly the most commonly used components. Insulin, which is 
normally used at concentrations which are much higher than physiological 
levels t and transferrin are found in almost all serum-free media. They 
have been found to stimulate a wide range of cell lines e.g. SV40 Balb/c 
3T3 (Rockwell 1984), human diploid fibroblasts (Kan and Yamane, 1982) and 
a human mammary tumour cell line MCF-7 (Barnes and Sato, 1979). Insulin 
and transferrin are also included in serum-free media used to establish 
some primary cultures e.g. human lung cancer cells(Carney et al., 1981) and 
canine kidney cells (Taub et aL, 1979).
Epidermal growth factor (EGF) was originally isolated from male mouse 
submaxillary glands (Cohen, 1962). It is now commercially available and 
although relatively expensive, has been used in many serum-free media e.g.human 
keratinocytes (Tsao et al,, 1982), rat hepatocytes (Enat et al, 1984) and 
Hela cells (Hutchings et al,, 1978). EGF is a 53 amino acid polypeptide, 
with a molecular weight of approximately 6,000 Daltons. Its contribution
I
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to growth in the absence of serum, varies between cell types; in some cases, 
EGF can replace another component e.g. in growing MDCK cells in culture, the 
PGF^ requirement can be removed by adding EGF (Taub et^  al, 1984) . In many 
serum-free media however, EGF seems to be required and cannot be replaced by 
other factors.
Selenium is a very interesting addition to serum-free media. It is added as 
a trace element in the form of sodium selenite or selenous acid and it has 
been shown to play a critical role in the growth of primary lung cultures 
(Carney et al., 1981), a lung cell line NC1-H69 (Carney jit al., 1984), 
canine kidney cells (Taub £t al«, 1979) and MCF-7, a human mammary tumour 
cell line (Barnes & Sato, 1979). Addition of selenium is considered more as 
a modification to the basal medium than as an addition of a growth factor as 
such. It has been suggested that the requirement for selenium becomes 
greater as the level of FCS decreases (Ham, 1 9 8 4 b )  which would support the 
idea that selenium is present as a trace element in FCS.
Other growth factors have been isolated and shown to stimulate growth of 
specific cell types. Platelet-derived growth factor (PDGF) is thought to be 
a major mitogen in serum for many cell lines, in particular those of 
mesenchymal origin. It has been used in serum-free media for Balb/c 3T3 
cell line (Dicker e^ t al, 1981) and has also been shown to be mitogenic for 
fibroblasts, smooth muscle cells and glial cells (Westermark et al^ , 1983).
In the past two years much interest has been shown in this factor and it 
may come to play a much more prominent role in serum-free media in the near 
future.
Fibroblast growth factor (FGF) is used in many serum-free formulations to 
stimulate cell growth. A number of extracts from bovine neural tissue have 
proven to contain growth factors for cultured fibroblasts and vascular 
endothelial cells (Gospodarowicz, 1984). There are thought to be several 
factors present which have been given the name FGF; they are all single­
chain proteins 14-18kDa in size(Goustin etal.,1986). Many fibroblastic 
lines have shown increased growth in the presence of FGF, e.g. Balb/c 3T3 
(McClure, 1983), Swiss 3T3 cells (Shipley & Ham, 1983) and BHK kidney cells 
(Maciag et al., 1980) but other cell types also respond to FGF - e.g. a rat 
glioblastoma cell line, C6 (Bottenstein e£ aL, 1979). Commercially 
available, FGF is generally isolated from bovine pituitary glands, as first 
described by Gospodarowicz (1975).
li
Glucocorticoids have been tested by various workers for growth- 
promoting ability. Hydrocortisone and its synthetic analogue, 
dexamethasone, are the two most commonly used. The former stimulates 
canine kidney cells (Taub et al., 1979), lung carcinoma cell lines 
(Carney et_ a L , 1981) and human bronchial epithelial cells (Lechner et aL, 
1982), while dexamethasone is included in media for the growth of WI-38 
fibroblasts (Allegra and Lippman, 1978) and a rat myoblast cell line, L6 
(Florini et_ aL, 1979).
Table 1.1 shows a wide range of other hormones that have been tested in 
serum-free media formulations. Some of these occur frequently in media 
for a range of cell types e.g. triiodothyronine, but some other hormones 
are less frequently used. An important factor to be noted is that specific 
cell types have very specific requirements and addition of a more unusual 
hormone, at what may appear to be a very low concentration, can prove to 
be the most crucial component in a serum-free medium. This hormone/growth 
factor may have no effect on a wide range of cell types but a given cell 
type may depend on its presence for survival in a serum-free environment.
A typical example of this is the addition of a prostaglandin, PGE^, to 
five other components, by Taub (1979) in developing a serum-free medium 
for MDCK cells. Growth is doubled on addition of PGE^, at a concentration 
of 25ng/ml, yielding a level of growth comparable to that in 5% FCS.
A number of attachment factors are listed in Table 1.1. For many cell types 
attachment to the substratum is vital for growth and replication, but in 
the absence of serum fibronectin - thought to be the main serum component 
involved in attachment, many cells are unable to attach to the usual plastic 
tissue culture surfaces. Many, but not all, serum-free formulations 
involve precoating of dishes with one of a variety of factors. Collagen 
gels are often used to improve cell growth. Both native and denatured 
collagen have enhanced growth in different cell types - for example, in 
fibroblasts (Grinnell et aL, 1978) and epithelial cells (Wicha e^ aL, 1979). 
Many reports also show that interactions between collagen and other factors 
- fibronectin, laminin, chondronectin - enhance growth, where collagen on 
its own has no effect (Kleinman et aL, 1981).
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The natural factor that has so far been shown to have an effect with the 
widest range of cell types is fibronectin. This high-molecular weight 
plasma glycoprotein, which is commercially available, has been shown to 
enhance attachment in a wide variety of cells, e.g. fibroblasts, 
hepatocytes, epithelial cells (Grinnell, 1983). Precoating of dishes 
with collagen, fibronectin or some other factor prior to the introduction 
of cells and media, has proven a successful method of enhancing 
attachment in the absence of serum.
Interestingly, some adhesion factors work indirectly i.e. by incorporation 
into the growth medium and not by precoating. Examples °f this is 
chondronectin with chondrocytes and epibolin with epidermal cells (Hewitt, 
1980; Stenn^1980) where precoating of the surfaces has no effect on 
cell growth but inclusion of the two factors in the media has significant 
stimulatory effects.
1.4 Miscellaneous considerations in using serum-free media
Apart from selection of the correct combination of components to replace 
the mitogenic action of serum, there are many other factors which have 
to be taken into account in the development of a serum-free medium.
The whole growth system is much more sensitive in the absence of serum 
than in its presence and; thus, all aspects of culturing cells must be 
considered carefully.
In general, the shelf-life of powdered medium is longer than that of 
basal liquid media and for serum-free work it is advisable to use powdered 
medium, as any slight change in the medium composition due to instability 
of some factors may have much greater effect than in the presence of serum. 
This demands facilities for sterilising large volumes of medium, a 
facility that all laboratories may not have.
Many of the components used in serum-free media remain stable for a 
short period of time only. Stability at 4°C may be measured in hours for 
some components and^ thus, medium has to be made up freshly from frozen
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concentrated stock solutions immediately prior to use. Some of the 
components remain stable for a reasonable length of time only if they 
are in a lyophilised form, so even the stock solutions need to be replaced 
regularly. Some of the components used are very expensive, e.g. fibronectin, 
EGF, FGF and inclusion of these in serum-free media increases the cost 
of routine growth of cells in such media.
Another major problem is subculturing of cells. Serum contains a trypsin 
inhibitor which stops trypsin action once the cells have become detached 
and prevents damage of the cells. Soybean trypsin inhibitor is commonly 
used in serum-free work but some problems still exist, with cells 
suffering considerable damage. Low temperature trypsinization is a 
common method employed, while in some cases other proteases are used in 
an attempt to minimize cell damage.
1.5 Other biological supplements
Some work has been carried out on alternative biological supplements 
which would provide the same growth and attachment factors as serum.
Bovine and human milk have been studied in the laboratories of Klagsbrun, 
Fassolitis and Baserga and some reports published on growth stimulatory 
activity. Klagsbrun reported that normal fibroblastic cell lines grew 
in the presence of bovine milk and fibronectin (Steimer and Klagsbrun,
1981), while Sereni and Baserga (1981) reported that a number of cell 
lines, including 3T3, grew in medium supplemented with milk and 0.5% FCS. 
Fassolitis (1981) discovered that when medium was supplemented with a 
non-fat dried milk supplement it supported the growth of a number of 
epithelial cell lines but not of two fibroblast lines.
Quite a number of workers have isolated growth factors from human milk 
(Zwiebel et aL, 1986, Carpenter, 1980) and the mitogenic effect of these 
cells in culture has been recorded. Carpenter suggests that the growth 
factor involved is EGF, while Zweibel states that a transforming growth 
factor can be isolated from milk.
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There have also been reports of growth stimulation due to bovine colostrum. 
Klagsbrun ( 1 9 3 0 )  reports that this supports the growth and proliferation 
of epithelial cells but not of fibroblasts, but that milk taken from the 
same animal after eight days fails to influence either cell type.
1 .6  Commercially available serum substitutes
A considerable amount of interest has been shown by the commercial sector 
in the developments in the area of serum-free media. Some companies have 
carried out their own research and a number of new products have come on 
the market in the past few years. The claims made by the manufacturers 
range from a cautious approach, suggesting that a product reduces the 
serum level required, to a bolder claim of totally removing any serum 
requirement.
Table 1.2 lists a number of commercial serum substitutes. A number 
of similar claims are made by the manufacturers, e.g.:
- guaranteed lot-to-lot uniformity - constant composition relative 
to FCS.
- eliminates pretesting time on a range of FCS batches (and the need 
to buy a large amount of serum at the one time to be assured of 
uniformity).
ofrees valuable freezer space (most products are stored at 4 C 
and in more concentrated forms).
- low protein levels makes purification of cell derived products 
easier.
low protein levels decreases non-specific interference in 
monoclonal antibody screening.
Some information is available on the composition of the medium supplements. 
The exact components in "SerXtend" are listed (Table 1.2) but the exact 
concentrations of the polypeptide growth factors are not included. In most 
cases a minimum of information is given, e.g. UltraSerG.
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The cell lines on which the serum substitutes have been tested quite 
extensive in some cases, e.g. Nu-serum, but some other supplements are 
optimized specifically for a smaller range of cell types. The Nutricyte 
products fall into the latter category; these are a series of biochemically 
defined supplements formulated to replace FCS in hybridoma or lymphocyte 
cultures. The original Nutricyte supplement is for general use in cultures 
of human, mouse or rat myelomas, hybridomas or lymphocytes where strict 
immunocompatibility is not an issue, Nutricyte H is for use in the 
in vitro immunization of human lymphocytes and for human monoclonal antibody 
production, while Nutricyte BHK is designed specifically for suspension 
cultures of BHK and Vero cells.
Much of the literature which accompanies the serum substitutes gives details 
on growth of cells for one passage only - many do not give evidence for 
continuous culture in the absence of serum. In other cases, claims are 
made that continuous culturing with a given medium supplement is possible - 
but only if a low level of FCS - 0.5 - 2% generally - is added. Some 
references are also made to changes in morphology, growth rate or 
production of cellular products, e.g. UltroSerG supports the growth of GH3 
rat prolactin-producing cells but continuous growth requires the addition 
of "some hormones" (unspecified) and under these conditions prolactin 
production ceases.
Many of the manufacturers recommended a gradual adaptation of the cells 
away from serum-supplemented medium to medium supplemented with their 
products. The disadvantages of this procedure have already been 
discussed (See Sec.,13), but almost all the literature recommends it as a 
standard technique which will yield better results with the serum 
substitutes.
Thus, while many serum substitutes are commercially available, their 
applications are somewhat more limited than their promotional literature 
suggests. At the present time some of the products are of considerable 
use in short-term work, but much more progress is necessary before the 
term serum-substitute can be accurately applied.
Name of 
Product
Data Available 
on Composition
Range of Cell 
Types Tested
Data Given 
On Subculturing
Adaptation
Recommended
Protein 
Cone.
Comments
No FCS 
Required
UltroSerG Growth factors, 
Adhesion factors, 
Mineral "trace" 
elements, 
Hormones,
Binding proteins, 
Vitamins,
Trypsin inhibitor
Hela,
Vero,
Chondrocytes, 
GH^ rat,
Human fetal 
cells from 
amniotic 
fluid
Rabbit 
chondrocytes 
3 subcultures
Recommended 
in some 
instances
1.5 mg/ml Used in micro­
carrier 
cultures also
Nu-Serum EGF, ECGS, Insulin, 
Transferrin, T^, 
Progesterone, 
Estradiol, 
Testosterone, HC, 
Selenium, 
Phosphoryl- 
ethanol amine, 
Glucose, Amino 
acids, Vitamins, 
Serum,
Cell nutrients
Normal and neo­
plastic human 
lines,
Transformed and 
untransformed 
cell lines, 
Hybridomas, 
(e.g. Wl-38, 
FS-1230, MRC-5, 
Hela,
BHK-21,
Vero)
Data given for 
up to 8 
passages - no 
FCS controls
50% of 
that in 
FCS
Much emphasis 
on uniformity 
of batches
TABLE 1.2 Details on a range of commercially-available serum substitutes. Data compiled from 
promotional literature.
Name of 
Product
Data Available 
on Composition
Range of Cell 
Types Tested
Data Given 
On Subculturing
Adaptation
Recommended
Protein 
Cone.
Comments
Nutricyte BSA, Insulin, 
Transferrin
Human, mouse or 
rat myleomas, 
Hybridomas, 
Lymphocytes, 
e.g. Sp 2/0-AG- 
14,
Sp 2 derived 
hybrid
None Very strongly 
recommended - 
vital
40 pg/ml Suggests FCS 
additions are 
necessary in 
many cases 
and emphasise 
use of correct 
basal medium
Nutricyte H HSA, Insulin, 
Transferrin
Immunization of 
human lympho­
cytes ,
Production of 
monoclonals, 
Production of 
proteins 
secreted by 
human lymphoid 
cells.
None Very strongly 
recommended -
40 *Jg/ml Suggests FCS 
additions if 
cells are not 
growing well.
Nutricyte
NS
BSA, Insulin, 
Transferrin
NS1, Ag8.653 and 
P3 x 63 derived 
hybridomas
None 75 Mg/ml
TABLE 1.2 (continued) Details on a range of commercially-available serum substitutes.
Name of 
Product
Data Available 
on Composition
Range of Cell 
Types Tested
Data Given 
On Subculturing
Adaptation
Recommended
Protein 
Cone.
Comments
Nutricyte
BHM
Albumin 
Insulin, Fn, 
Transferrin, 
Peptide and 
non-peptide 
hormones, 
Vitamins, 
Amino acids, 
Non-peptide 
substances
BHK cells and 
variants of 
this line, 
Vero
Suggests it can 
occur
Not necessary 20 jjg/ml
HB 101 None given Sp2/0-Ag-14 
P3x63-Ag8.653 
Mouse myeloma 
& hybridoma 
cell lines 
4 human 
myeloma lines
Suggests sub­
culturing can 
be carried out
Recommended 
as an
alternative
Seems very 
specific for 
cell lines 
mentioned.
Some more grow 
with low FCS 
levels
HB 103 RPM1 1640 basal 
medium,
HSA,
Transferrin
Human mono­
nuclear cells
700 jJg/ml
HB 10 4 HSA,
Insulin
Human-human
hybridomas
Specifically 
for production 
of human mono- 
clonals
TABLE 1.2 (continued) Details on a range of commercially-available serum substitutes
Name of 
Product
Data Available 
on Composition
Range of Cell 
Types Tested
Data Given 
On Subculturing
Adaptation
Recommended
Protein 
Cone.
Comments
FCS/
Supplement
SerXtend MSA(800u/ml), 
FGF(800u/ml), 
EGF(80CWml) , 
Insulin(3ng/ml), 
BSA(40ng/jjl), 
Ethanolamine 
(240ng/ml),
T (3ng/ml), 
Se(120ng/ml), 
Trans (lng/ml), 
HC(1.8 g/ml), 
Protein Stab­
ilisers 
(2 .8ng/ml)
MCR-5, 
MDCK, 
Vero 
3T3
Use in 50:50 
mixture with FCS
ITS Insulin 5 pg/ml 
Transferrin 
5 p g/ml 
Selenium 
5 M-g/ml
BHK-21
Vero
Heia
MDCK
10 pg/ml Use in addition 
to FCS
TABLE 1.2 (continued) Details on a range of commercially-available serum substitutes
MSA multiplication stimulating activator, T^ - Triiodothyronine, Se - Selenium, USA - Human serum albumin
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1.7 Conclusion
There are still many limitations in the progress achieved in the development 
of serum-free media. A considerable amount of the work has been carried out 
only on cells at relatively high densities and in open petri dishes in 5% 
CO2 , rather than in closed flasks. In many cases continuous culture of 
cells has not yet been achieved in what are loosely called "serum-free 
media". The requirements for growth of some cell types over a single assay 
period, e.g. 7 days, may be insufficient to maintain growth over an 
extended period with many subculturings of cells.
Other supposedly serum-free media include a low level of FCS (1-10% of the 
normal FCS level), which is necessary for attachment and growth of cells, 
while many serum-free formulations include foetal bovine serum protein 
(FBSP), i.e. a protein fraction isolated from foetal calf serum.
Thus, although much progress has been made in the area of serum-free media 
and some cell lines are continuously cultured in a totally serum-free 
environment, there is still a lot of work to be done.
The principal objectives of this work were:
(a) To investigate some of the limitations listed above.
(b) To repeat, if possible, the results referred to in section 1.5 
on substitution of milk for serum.
(c) The principal objective was to develop a serum-free medium for 
a specific cell line, RPMI 2650 (Moorehead, 1965).
This epithelial cell line is quasi-diploid, has a low colony-forming 
efficiency (CFE) and is available at fairly low passage numbers and 
therefore may be more representative of primary human tumours than many of 
the lines (e.g. Hela), for which serum-free media are available. Develop­
ment of a serum-free medium for RPMI 2650 may eventually contribute to the 
development of improved serum-free media for primary human tumour 
epithelial cells.
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2. MATERIALS AND METHODS
2.1 Glassware
A good general principle to follow is that all glassware used in tissue 
culture should be reserved for that purpose alone. Traces of heavy 
metals or other toxic substances may adhere to the inside of glassware 
and can be difficult to detect, but will eventually lead to deterioration 
in cell quality. It is also recommended that separate washing of tissue 
culture glassware should occur.
The washing requirements for tissue culture are more stringent than for 
general glassware. Glassware was soaked for 1-2 hours in hot water in a 
special detergent RBS-25. The glassware was scrubbed and the detergent 
rinsed out. All glassware was then given three washes in reverse osmosis 
water and a final wash in water from a Millipore Milli-Q llltrapure water 
system. The glassware was then dried in an oven.
The metal lids of bottles were treated in a similar manner, but were kept 
separate from the glassware during washing.
2.2 Water
High purity water is critical in cell culture work. The water used for 
preparation of all media and reagents passed through a Millipore Milli-Q 
Ultrapure water system. This system consisted of a reverse osmosis 
system which, with two prefilters removed ionic and non-ionic solutes 
and a further purification stage consisting of two ion-exchange filters, 
a carbon filter and a 0.22 jjm cellulose acetate filter. The resulting 
water was of reagent grade and was regularly monitored by an on-line 
conductivity metre (10-18 megohms/cm was the acceptable resistivity).
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2.3 Incubation
Cells were cultured in sealed flasks or in petri dishes which allowed pH 
equilibration to take place with the external environment. Incubators 
were maintained at 37°C. Where gaseous exchange with the external 
atmosphere occurred incubators were filled with 5% CC^ (balance air) 
and a high humidity level was maintained by placing trays of sterile 
water on the base of the incubator. These incubators were cleaned 
regularly, as the high temperature and moist atmosphere caused increased 
risk of contamination.
2.4 Sterility
2.4.1. Contamination by microorganisms remains a major problem in tissue 
culture, in spite of the introduction of antibiotics. Bacteria, 
yeast and fungal spores may be introduced via the operator, the 
atmosphere, work surfaces, solutions and equipment. Many pre­
cautions were taken to minimize contamination.
All work with cells or reagents was carried out in a laminar flow 
cabinet with a vertical air-flow. All surfaces were swabbed with 
alcohol prior to use and all bottles, pipettes, flasks, etc., 
swabbed before being placed in the laminar flow. Operations were 
performed using the usual aseptic techniques.
Bottles were sterilised, with loosened lids, by autoclaving for 
20 minutes at 15 p.s.i., using autoclave tape as an indicator.
All plasticware used was purchased in a sterile condition. All 
waste was autoclaved prior to disposal to prevent contamination 
of either work or the worker. Water was autoclaved prior to use 
in making up media.
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2.4.2. Sterile filtration
A number of different methods were used to sterilise solutions.
The most successful method involved passing a solution through a 
Millipore Millex-GV 0.22 pm filter, using a syringe. These low- 
protein binding filters had a limited capacity - at times as 
little as 2 mis of a concentrated liquid could be forced through, 
Millex 0 . 2 2  pm filters were also used, but controlled experiments 
(Margaret Dooley, unpublished) showed that these bound more 
protein.
Sterifil-D units, another Millipore product, were used to sterilise 
larger volumes under water vacuum. Here, solutions were sucked 
from a non-sterile upper chamber into a sterile lower chamber via 
a 0.22 pm membrane. Sterivex filters were another Millipore 
product used, again with a 0.22 Mm membrane. Here the actual 
filter was enclosed in a sterile plastic case and the end protected 
by a bell-shaped shield, which increased sterility. The Sterivex 
filters were used to sterilise large volumes of powdered medium; 
a peristaltic pump pumped the medium across the membrane, the area 
of which was four times that of the Millex-GV filters.
Some sterilization of milk was performed under pressure. A 
sterilization unit consisted of a clear plastic (polycarbonate) 
cylinder which could hold up to 600 ml It had an inlet tubing 
adapter which could be connected up to a nitrogen cylinder and an 
outlet control valve at the other end, to which a swinnex adaptor 
was attached. A membrane (0.22 pm pore size) or a stack of 
membranes of decreasing pore size from 1 . 2 pm to 0 . 2 2  pm were 
placed in the swinnex and autoclaved prior to use. The swinnex was 
then attached to the polycarbonate cylinder under sterile conditions. 
The filtration unit was then connected to a nitrogen cylinder and 
filtration occurred under a pressure of 15 p.s.i. A Millex-GV filter 
(0.22 Jim) was attached to the swinnex adaptor when it was discovered 
that this was necessary to ensure sterility. The integrity of the
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membrane/membrane stack was tested by the bubble-point test. This 
test is based on detection of the minimum pressure required to 
force air through a wet membrane of a specific pore size. Bubble 
points, i.e. the minimum pressure have been calculated for all 
the filters used and details were available in commercial 
catalogues (Millipore).
Routine sterility checking of media and other solutions was 
carried out using the spread-plate technique on nutrient agar.
This showed up bacterial and fungal contamination after 
incubation at 37° C for 24 hrs. Sometimes a very low-level 
contamination, often yeast or fungal in nature, did not appear 
visible to the eye until 5 mis of the solution had been incubated 
in a universal container at 37°C for 48-96 hours.
2.4.3. Mycoplasma detection
Mycoplasma infections cannot be detected by the naked eye, other 
than by signs of gradual deterioration in the culture. Mycoplasma 
can be slow-growing and may interfere with the host cell 
metabolism prior to any obvious deterioration in the appearance 
of the culture. Hence, routine periodic testing of all cell 
cultures for the presence of mycoplasma is very important.
The test used here involved fluorescent staining of DNA by 
Hoechst 33258 stain (Chen, 1977). Hoechst (2-[2-(4-hydroxyphenyl)- 
6 - benzimidazolyl] - 6 - (1 - methyl - 4 piperazyl ) ~ 
benzimidazol - trihydrochloride) 33258 binds to DNA and) since 
mycoplasma contain DNA, they can be detected by observation of 
extra-nuclear fluorescence.
The method used, developed in this laboratory, was based on the 
assumption that if mycoplasmas were present in a culture they 
would be found, not only within the infected cells, but also in 
any medium which had been in contact with the cells. A normal 
rat kidney cell line (NRK) was used as the indicator cell line.
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NRK cells were set up on sterile coverslips or multiwell slides, 
at a concentration of 1 x 10^ - 1 x 10^ cells/ml. These were 
incubated for 24-48 hours at 37°C and 5% CO^. Medium was 
removed from cultures of all the cell lines to be tested . and 
medium which had not come in contact with any cells was used as 
a control. A small volume (500 jjl - 1000 pi) of the medium was 
added to the NRK cells and these were incubated for a further 
2-3 days.
The coverslips/slides were removed from the dishes, excess
medium poured off and the cells fixed in pre-cooled methanol for
o
8 minutes and acetone for 2 minutes at 20 C. A number of other 
fixation methods were tested unsuccessfully (Sec. 3.1). The 
slides were then rinsed for 5 minutes in PBS and 2 minutes in
distilled water.
The Hoechst stain was diluted in a balanced salt solution to a 
concentration of 0.05 jjg/ml. A few drops of this was added to 
the cells and incubated for 10 minutes in the dark. The cells 
were washed three times in distilled water and mounted in 
Mcllvaines Buffer, pH 5.5. The cells were then examined for 
fluorescent staining of DNA, using a Nikon Optiphot Fluorescent 
microscope, with a wavelength of 405 nm. Observation under oil 
immersion was required to detect low level mycoplasma infection.
2.5 Preparation of Culture Media
2.5.1. Liquid Media
Liquid media were prepared from concentrated stock solutions(lOx) 
of basal medium. 450mls of Milli- ) ultra-pure water were auto- 
claved and 50 mis of the lOx concentrate added aseptically.
1.7 g/1 Sodium Bicarbonate, acting as the main buffer, 2 mM 
L-glutaraine, an amino acid with a relatively short half-life in 
solution and 0.2 M 4 - (2 - hydroxy-ethyl) - 1 - piperazine -
2b
ethane sulfonic acid (Hepes) were all added to the medium. Some 
other additions were made to specific media (see Table 2.1).
The pH was adjusted to 7.4 - 7.6 with NaOH.
2.5.2. Powdered Media
Powdered medium made from a lyophilized basal medium is a better 
and more consistent quality medium, as the stability of some 
components is much greater when lyophilized than when stored in a 
liquid form. The lyophilized medium consists of a powdery mixture 
of all basal components - hence the title "powdered medium". 
Powdered Ham's F12 was made by dissolving one package of Gibco's 
powdered medium in 985 mis of Milli-Q water. 1.176 g/1 sodium 
bicarbonate was added and the pH adjusted to 7.4 - 7.6.
The medium was passed through a Millipore Sterivex unit,
(see section 2.4.2). The medium was collected in sterile glass 
bottles and stored for up to 4 weeks at 4°C.
TABLE 2.1 Media used to grow different cell types.
Medium Cell types grown Normal % FCS Specific addition
Modified Eagles RPMI 2650 5% MEM non-essential
(MEM) MDCK 5% amino acids
HEP-2
Dulbecco's Modified 3T3 5%
Eagles Medium A4 31 5%
(DMEM)
McCoy's 5A A549 10% Hydrocortisone
(0.4 /ig/ml
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2 .6 Cell Lines
A number of cell lines were used in this work. The three main lines were
RPMI 2650, 3T3 and MDCK. The RPMI 2650 cell line was established in 1962
from the pleural effusion of a patient with an extensive malignant tumour
of the nasal septum. The 3T3 Swiss albino cell line is a mouse embryo 
fibroblast cell line, isolated initially from a mouse embryo, Todaro &
Green (1963). The MDCK cell line was derived from a kidney of an apparently 
normal female Cocker Spaniel in 1958 and consists mainly of epithelial- 
like cells (Leighton et al., 1969).
Four other cell lines were also used to a lesser extent. A549 cell line 
was derived from a culture of a lung carcinomatous tissue of a Caucasian 
male patient, (Giard, 1973). HEP-2 cell line was produced from tumours 
that had formed in rats after injection with epidermoid carcinoma tissue
from the larynx of a Caucasian male, (Moore, et al.. 1955). It may have been
contaminated with Hela cells. The SCC-9 line originated from a squamous 
cell carcinoma of the tongue (Rheinwald & Beckett 1981). The A431 cell line 
is another human cell line, having been derived from a human epidermoid 
carcinoma (Fabricant et al., 1977).
2.7 Maintenance of cells in culture
2Cells were cultured routinely in 25 cm flasks, growing attached to the 
flask surface. Cell lines were cultured in different basal media (see 
Table 2.1 - Sec. 2.5), supplemented with FCS, generally at a concentration 
of 5% v/v.
Cells were subcultured every 3-6 days, depending on the cell type. Sub- 
culturing was carried out by a trypsinization procedure. A 0.2% trypsin 
solution was made up in sterile PBS and EDTA added to give a final working
concentration of 0.02% (known as Trypsin Versene, TV). This was incubated
oat 37 C for 20 minutes. Medium was removed from the cells and the 
residual medium in the flask washed out with 0.5 mis of TV - this removes 
remaining FCS which, with its trypsin inhibitor, may interfere with enzyme
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action. 2 mis of TV were then added to a 25cm flask and the flask
oincubated at 37 C for 5-10 minutes until all the cells had detached. 3 mis 
of medium plus FCS was added to the flask and the contents then spun at 
1,000 rpm for 5 minutes. The supernatant was discarded and the cells 
resuspended in 5 mis of medium.
Cell numbers were estimated using a haemocytometer. Stock flasks were then 
set up at the required concentration - this varied from 1x 10^ cells/flask 
for HEP-2 cells to 5 x 10^/1 x 10^ cells/flask for RPM1 2650.
A viability test was sometimes carried out on the cells using Trypan Blue (0.4%) 
dye. 250 pi of cell suspension was added to 50 pi of Trypan Blue, mixed 
well and allowed stand for 4-12 minutes. The cells were then counted on the 
haemocytometer - dead cells would have absorbed the blue dye - and hence 
percentage viability could be calculated.
2.8 Cell Freezing and Long-term Storage
2.8.1. Freezing Cells
Cells were trypsinized in mid to late exponential phase, before 
they had entered stationary phase, for successful freezing. A 
cell count of 2 x 10^ cells/ml was required for freezing. A 10%(v/v) 
DMS0 (dimethyl sulphoxide, a cryoprotective agent) solution was 
prepared in the growth medium of the cells. An equal volume of 
10% DMS0 was added dropwise to the high-density cell suspension.
The addition of the DMS0 was crucial, with very gradual addition 
and careful mixing of the cell suspension after the addition of 
each drop, to ensure correct freezing conditions were achieved.
The DMSO/cell suspension mixture was then dispensed into sterile 
cryotubes, 1.5 mis per cryotube. The cryotubes were placed in a 
neck plug which fitted into the top of a liquid-nitrogen-filled 
cryofreezer. The cryotubes were allowed stand in the liquid 
nitrogen vapour for 2^-3 hours. After this, they were placed into 
the liquid nitrogen proper. Long-term storage in liquid nitrogen 
proved successful for all cell lines used.
2
29
2.8.2. Thawing Cells
It was important to check stocks 24-48 hours after freezing to
ensure that the freezing was successful. A cryotube was removed
from the cryofreezer and the contents thawed in a waterbath or
incubator at 37°C as quickly as possible. The contents of the
cryotube was then emptied into a universal containing 5 mis of
medium and spun at 1,000 rpm for 5 minutes to remove the DMSO.
The supernatant was discarded and the cells resuspended in 5 mis
2of medium and transferred to a 25 cm flask. 24h later 
this medium, containing any unattached cells was poured off and the 
flasks refed with 10 mis of medium. The flasks were examined at 48 h 
for cell attachment and growth.
2 .9 Preparation of Growth Factors
Polypeptide growth factors, hormones, proteins and other components tested 
for growth promoting ability were carefully dissolved in a solute which 
allowed complete dissolution in a minimum length of time. Table 2.2 
describes in detail the solvents used for different components.
Compounds were dissolved initially in water, PBS A or absolute alcohol and 
filter sterilised using 0.22 /im Millex-GV filter (see sec. 2.4.2.).
Subsequent dilutions were made, if necessary, to bring the concentration of 
each component to 1 , 0 0 0 times the concentration required for use in an assay. 
Solutions were dispensed into 500 pi volumes and stored at - 20°C for up to
3 months.
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Solvent used Compound Storage Cone. Comments
Absolute
Alcohol Hydrocortisone
Estradiol
Progesterone 
Retinoic Acid
PGE
PGF-2a
1x 10_5M
lxlO~Sl 
1x10 ¡¡M 
1x10 M
2.5 pg/ml 
20 pg/ml
Diluted in PBS after 
initial dissolving. 
Higher conc. did not 
freeze at -20°C
Very acidic - came out 
of soln. in medium at 
high conc.
PBS A Transferrin 
Selenium(Sodium 
Selenite) 
Bombesin
Glycyl-hystidyl- 
lysine 
Ascorbic acid
Bovine. Serum 
Albumin 
Glucagon 
PDGF 
EGF
X3
Vitrogen
(Collagen)
5 mg/ml
lxlO_^M 
1x10 M
1 mg/ml 
1 mg/ml
500 mg/ml 
0 . 1  mg/ml 
1 unit/ml 
10 pg/ml 
1x10~5M
1 mg/ml
Very short shelf life 
in soln. - not stored 
at -20°C.
100 pi/5 mis of NaOH 
required for dissolving
Commercial collagen in
liquid gel at 3 mg/ml conc.
Dist.H20 Phosphoethalo- 
1amine 
Poly-l-lysine 
Fe2S04 .7H20 
Dextran Sulphate 
DEAE dextran 
Methyl cellulose 
Gelatin 
L-lysine 
PVP
1x10~2M 
1 mg/ml 
1 x 10 M 
1 mg/ml ) 
1 mg/ml ) 
1 mg/ml ) 
1 mg/ml ) 
1 mg/ml ) 
1 mg/ml )
All of these are attachment 
factors and after sterili­
zation were stored at 4°C.
HC1 Insulin 
Collagen
5 mg/ml 
1 mg/ml
Difficult to dissolve - 
leave stand at room temp. 
Dissolved at 37°C.
TABLE 2.2 Preparation of growth and attachment factors. This table 
indicates the solvents used to make dilutions of the range 
of growth and attachment factors used.
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2.10 Ultrafiltration
2.10.1 Tangential Flow Ultrafiltration of Milk
Milk from commercial dairies, was purchased in local retailers
and ultrafiltered on the day of purchase. This process consisted 
of passing 2 1 of milk through a Pellicon filtration unit 
across a 1 x 10  ^molecular weight membrane, which was contained 
in a stainless steel cassette. A peristaltic pump was used to 
pump milk into the cassette and, as it was a tangential flow
system, a filtrate tube removed the filtrate and a retentate
tube returned the retentate into the original container for 
recirculation. The unfiltered milk and the straw-coloured 
filtrate were kept on ice during the ultrafiltration procedure.
2 1 of milk was reduced to 600-800 mis Of retentate which became 
increasingly thick and creamy during the process. The filtrate 
was either filter sterilised immediately (see sec. 2.4.2.) or 
else ultrafiltered on an Amicon ultrafiltration unit (see sec. 
2.10.2.).
2 .10 . 2 . Ultrafiltration on an Amicon ultrafiltration unit
Two ultrafiltration membranes were used, a 10,000 and a 5,000 
molecular weight membrane. One of these was placed in an Amicon 
ultrafiltration unit and milk filtrate collected from the Pellicon 
ultrafiltration cassette (see sec. 2 .1 0 .1 .) was poured into this 
unit. A magnetic stirrer was assembled to prevent clogging of 
the membranes. This filtration took place under Nj pressure 
(60 p.s.i.) and the original volume reduced down to 10%. The 
filtrate was collected on ice and both it and the retentate 
were filter-sterilised immediately.
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2.11 Freeze Drying
Preparations of growth factors in medium (see sec. 2.9) were freeze-dried 
before storing at - 20°C. The samples were dispensed into 2.5 ml volumes 
and frozen to - 20°C initially. Then they were immersed in liquid nitrogen 
for a short period of time (1 - 2 min.) before being transferred to the 
freeze dryer.
An Edwards Modulyo freeze dryer was used. Samples were placed in it and 
freeze drying took place overnight. The dessicated pellets were stored at 
- 20°C and reconstituted when required by addition of 2.5 ml of ultrapure 
water.
2.12 Preparation of Colostrum
Colostrum was collected from a cow within 4 hours of birth of a calf and 
was frozen at - 20°C immediately. Upon thawing, the colostrum was centri­
fuged in a RC-5 Sorvall centrifuge at 12,000g for 30 minutes. The fat 
floating on top of the centrifuge tube was discarded, as was cellular debris 
and other sediment that had pelleted at the bottom of the tube. The 
supernatant was prefiltered, using an AP25 prefilter (see sec. 2.4.2.) to 
remove any large pieces of debris, before passing it through the Pellicon 
ultrafiltration unit (see sec. 2.10.1). The clear, straw-coloured filtrate 
was sterilised by passing it through a 0.22 pm Millex-GV filter and stored 
at - 20°C until used.
2.13 Preparation of Dried Milk
A normal household brand of dried milk was used. A solution of 100 g/1 was 
made up and dissolved using a magnetic stirrer. This was then passed through 
the Pellicon ultrafiltration unit and the filtrate sterilised using a 
Millex-GV filter. Baby food was made up and treated in an identical manner.
i
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2.14 Isoenzyme Analysis
It is necessary in cell culture work to check routinely that no cross 
contamination between cell lines has taken place. An electrophoretic 
technique was used to characterize the different cell lines in use in the 
laboratory.
2Cells were grown in 25 cm flasks and trysinized (see sec. 2 . 1 ) .  A cell£
suspension of at least 3 x 10 cells was then centrifuged and washed twice
in PBS. On the final centrifugation, the cells were resuspended in 500 ¿il
oof PBS and freeze thawed three times m  liquid nitrogen at 37 C.
Centrifugation followed at 5,000 r.p.m. for 5 minutes and the supernatant was
opoured into a cryotube and stored at - 20 C until used.
The isoenzyme detected was lactate dehydrogenase (LDH) which is present 
in serum and can be separated into five isoenzymes by the technique used. A 
sample of FCS was used as a control. The isoenzymes were separated by 
ulactrophoresis in a barbitol buffer (0.05M with 0.035^ EDTA) at pH 8 .6 . 
Following separation, the isoenzymes were detected by supplying lactate as 
a substrate. LDH catalyses the oxidation of lactic acid to pyruvate and 
the NADH produced was used to reduce a tétrazolium salt to its corresponding 
formazan, which is coloured. Thus, the two reactions which occur are:
T T\1J
L - Lactate + NAD - > Pyruvate + NADH
and NADH + INT1 ---- > NAD + INF2
A commercial kit from Corning Electrophoresis was used. 1 Ml of sample was 
applied to each well of the agarose gel and electrophoresis was carried out 
for 35 minutes. Incubation with the lactate substrate was carried out at 
37°C for 20 minutes in a moist environment. The agarose film was washed and 
dried at 37°C for 20 minutes.
^INT - iodonitrotetrazolium chloride 
2INF - lodonitroformazan
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2.15 RPM1 2650 Monolayer Assay System
2.15.1. Setting up the assay
This assay was developed specifically to test the effect of 
various components on the growth of RPM1 cells at clonal densities, 
in the presence of a low level of FCS. Much work was carried out 
to identify the most suitable background FCS level (see sec. 3.2).
A background level was used in all experiments to investigate the 
effect of different factors.
The assay was carried out in 35 mm dishes placed on trays in 5% 
CO^ incubators at 37°C. A DME: Ham's F12(l:l) mixture was the 
basal medium used on a routine basis. Dishes were set up in four 
replicates, with a final volume of 2 mis of medium per dish. The 
method used involved adding 1 ml of cell suspension in DME-FCS 
(unsupplemented DME) and 1 ml of Ham'S F12, which contained twice 
the required concentration of growth factors and/or FCS, to each 
dish.
Media for any four replicates was prepared in a universal.
Growth factor stocks were diluted in medium to 100 times the 
final concentration required. Small additions were made to the 
Ham's F12 to achieve the required concentrations. This method 
reduced the quantity of solvent (e.g. absolute alcohol) which 
actually came in contact with the cells. FCS was also added to 
the Ham's F12 as required. The Ham's F12 medium was dispensed
into the 35 mm dishes and allowed equilibrate in the 5% C0£
incubator for 30 minutes.
During this period cells, which had been growing for 2-3 days
ft 2at 1 x 10 cells/ml in 25 cm flasks with 5% FCS were trypsinized
(see sec. 2.7). When all the cells had detached an equal volume
of sterile soybean trypsin inhibitor (1 iqg/ml) was added and 
the cells centrifuged at 1,000 rpm for 5 minutes. The super­
natant was discarded and the cells resuspended in DME-FCS and
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and centrifuged again to remove any traces of FCS, trypsin
or trypsin inhibitor. Cells were resuspended in DME-FCS and
4counted. A suspension of 1 x 10 cells/ml was made.
The dishes were removed after equilibration and 1 ml of cell
suspension was added to each dish. The trays on which the 35 mm
dishes were placed were covered with aluminium foil to reduce
the risk of contamination and were placed in a 5% C0„ incubator 
oat 37 C.
2.15.2. Collection of Data
The growth period was generally 7 days. The trays were then 
removed from the incubator and medium discarded from the dishes.
The cells were then rinsed with PBS and 1.5 mis of Leishmann's 
stain (0.3g/100 mis of methanol) added to each dish for 10 minutes.
1.5 mis of distilled water was then added for 10 minutes. This 
mixture was then poured off and the dishes rinsed twice in 
distilled water and inverted to dry. All cells, now growing in 
colonies, stained up a dark blue.
Counting of colonies was done using an AMS 40—10 Image Analyser. 
This consists of a camera lens, which observes the image of the 
darkly-stained colonies against a bright back-ground supplied 
by a light-box. This image is transferred to a television 
screen which is linked to a computer memory. The computer has 
the ability to count the number of colonies and to calculate the 
total colony area. Data from the assays was collected consistently 
using this image analyser.
2.16 Precoating of Dishes
Some of the experiments involved precoating of dishes with various substrates. 
The substrates were made up at the specified concentrations and were 
sterilised, generally by passing through a 0.22 pm Millex-GV filter (gelatin 
was an exception, it was autoclaved). 1.5 mis of the substrate was added
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to each 35 ram dish. Precoating conditions varied - for 30 minutes, 4 hourso
or overnight, at 37 C, 4°C or room temperature.
The precoating materials were removed from the dishes and the dishes washed 
first with PBS and then with medium. Great care was required to avoid 
contamination. The assay was then set up in the normal manner in the 
precoated dishes. (See sec. 2.15.1).
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3. RESULTS
3.1.1. Development of a cell fixation method for testing for 
mycoplasma contamination
The mycoplasma detection method described in Section 2.4.3. using the Hoechst 
stain required the development of a suitable cell fixation method. After 
fixation, the cells must remain intact and the membrane must be permeable to 
the Hoechst stain.
Numerous fixation methods were tested (Table 3.1). Dislodging cells by 
trypsinization and adding fixative to the cell pellet which forms after 
centrifugation proved very unsatisfactory. The cells, when fixed, were 
dropped onto a prewashed slide using a Pasteur pipette but this method 
resulted in total destruction of the cell membrane, regardless of the 
fixatives used, (Methods 1, 2 and 4, Table 3.1).
Attempts were then made to fix cells growing attached to a glass coverslip 
or a 35 mm dish. KC1: ethanol, methanol: acetic acid and formaldehyde: 
methanol fixatives all proved unsatisfactory (see Table 3.1, for details). 
Swelling of cells prior to fixation in ice-cold KC1 or PBS A was found to 
have no effect on fixation.
The method which finally proved successful involved fixation in precooled 
methanol and acetone (Method 8). Cell morphology and number were of a 
consistently high standard to allow detection of mycoplasma, using an 
immunofluorescent technique (Sec. 2.4.3.).
Method
Number Fixation Method
Swelling 
of cells Condition of cells during fixation
Treatment
after
Fixation
Results and Comments
1. Ethanol 
Room Temp. 
30 mins.
Ice-cold 
KC1 
(10 mins)
Cells trypsinized and centrifuged. 
Washed PBS x 3
Dropped 
onto slide. 
Stained 
with Giemsa
Cells totally broken open- 
no intact cytoplasms or nuclei. 
Low cell density.
2 . KC1: Ethanol 
Gradual fixation - 
initally 2 :1  
mixture, then 50:50 
then 0:100 (KC1: 
Ethanol)
Ice-cold 
KC1 
(10 mins)
Cells trypsinized and centrifuged 
Washed in PBS x 3
Dropped 
onto slide. 
Stained 
with Giemsa
Some cells intact but majority 
broken open. Low cell number 
visible.
Tried using a larger cell 
pellet - no effect.
3. As in 2. Ice-cold
KC1
(10 mins)
Cells grown in 35 mm petri dishes - 
washed in PBS x 3. Fixative added 
to cells in situ.
Air dried Cells rounded up or split open - 
better than previous results 
but cytoplasm and nucleus not 
discernable.
High cell density.
4. Methanol:Acetic 
Acid (311)
Added dropwise to
pellet
2 x 10 mins
PBS A 
(10 mins)
Cells trypsinized and centrifuged 
Washed in PBS x 3.
Dropped 
onto slide-
& air dried
Fixative changed after 10 mins. 
by centrifugation. Very few 
cells formed pellet in methanol: 
acetic acid - hence very low 
cell number and very poor 
quality.
5. As in 4. PBS A 
(10 mins)
Cells grown in 35 mm petri dishes 
Washed in PBS x 3
Air dried Quality and number of cells 
improved but cells split open 
during air drying.
TABLE 3.1 Fixation methods tested for suitability for use with NRK cells in detection of mycoplasmas
Method
Number Fixation Method
Swelling 
of cells Condition of cells during fixation
Treatment 
af ter 
Fixation
Results and Comments
6 . Methods 2 and 4 
both used
Varied Cells grown in 35 mm petri dishes 
Washed in PBS x 3
Air dried Varied swelling times - 0,5, 
10 mins. in PBS and in KC1. 
No significant improvement 
in cell quality.
7. Formaldehyde 10 min. 
Methanol 10 mins. 
at - 20°C
None Cells grown in 35 mm petri dishes 
Washed in PBS x 3
Air dried Very poor quality. All cells 
burst open.
8 . Methanol 8 mins. 
Acetone 2 mins. at 
- 20°C
None Cells grown in 35 mm petri dishes 
Washed in PBS x 3
Air dried Very good cell quality. 
Morphology well preserved, 
nucleus and cytoplasm intact.
TART.F 3.1 (cont'd) Fixation methods tested for suitability for use with NRK cells in detection of mycoplasmas.
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3.1.2. Isoenzyme analysis of RPMI 2650 and MDCK cells
Lactate dehydrogenase (LDH) enzymes were detected in RPMI 2650 and MDCK 
cell lines, by the electrophoretic technique described in Section 2.14. 
Foetal calf serum was used as a standard. The LDH of FCS can be separated 
into five isoenzymes, each one being a tetramer composed of a combination 
of H and M subunits.
Fig. 3.2 shows the electrophoretic mobilities of the LDH isoenzymes in FCS, 
RPMI 2650 and MDCK. Five isoenzymes are present in FCS, four in RPMI 2650 
and three in MDCK. The differences in the number of isoenzymes and in 
their electrophoretic mobilities between RPMI 2650 and MDCK indicate 
clearly the presence of two distinct cell lines.
Fig. 3.2. Electrophoretic mobilities of the Lactate dehydrogenase 
isoenzymes in RPMI 2650 and MDCK.
2650
Cell Lines
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3.2 Growth of MDCK cells in serum-free medium
The MDCK cell ine is grown routinely in MEM + 5% FCS. Taub et_ al_ (1979) 
reported the development of a serum-free medium which supports the growth 
of MDCK cells. The basal medium is a DME: Ham's F12 (1:1) mixture and 
this is supplemented with transferrin, hydrocortisone, insulin, triiodothy­
ronine (T^) , selenium and prostaglandin E-^  (PGE^);(called THITS (PGE^)).
Experiments were set up to repeat the findings of this group in an attempt
to establish the basic methods. MDCK cells were set up over a concentration 
3 Arange of 1x10 to 5x10 cells/35mm dish. The assays were set up in a 
similar manner to those described for RPMI 2650 (see Sec. 2.15.1). Growth 
occurred after 4-6 days in 5% FCS and in THITS (PGE^). Some signs of 
attachment and a little growth were evident in unsupplemented medium.
Results were collected either by trypsinization followed by a cell count 
(Table 3.2) or by staining with Leishmann's stain (see Sec. 2.15.2) and 
counting colony formation on an image analyser. (Table 3.3).
The growth achieved in THITS (PGE^) medium varies from 37% to 63% of that 
achieved in 5% FCS. Cell morphology is similar in both media.
2Many attempts were made to grow MDCK cells in 25 cm flasks, but no growth
at all was achieved in THITS (PGE ). The THITS (PGE1) medium turns very
2 7basic in sealed 25 cm flasks during an assay period, but the use of control 
flasks fed with DME: F12 + 5% FCS supports normal MDCK growth, with the 
medium turning acidic as cell number increases.
4 4Cells were set up over a range of concentrations; at 1x10 - 5x10 cells/
225 cm flask(growth in 5% FCS was normal but no growth occurred m  THITS
(PGE^). Flasks were gassed with 5% CO^ prior to sealing the caps, in an
attempt to maintain a suitable pH for growth. Flasks were also placed in
5% CO^ incubator with loosened lids to allow gaseous exchange which would
maintain a suitable medium pH. Neither method helped growth in THITS (PGE^),
while growth in 5% FCS continued normally (Table 3.4). Controls set up in
335 mm dishes simultaneously (at 1x10 cells/dish) always showed growth in 
THITS (PGE1).
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TABLE 3.2 Growth of MDCK in THITS (PGE^
Initial cell density: 1.5xl04 Cells/ 3x10^ Cells/ 7.5xl03 Cells/
35mm dish 35mm dish 35mm dish
Medium Cell No.xlO5 Cell No.xlO5 Cell No.xlO5
5% FCS 14.0 - 0.37 32.2 - 0.5 13.0 - 0.1
- FCS 0 0 0.08 - 0 . 0 1
THITS (PGE1) 6.3 -  1.2 17.0 - 1 5.56 -  0.2
% Growth in THITS(PGE1)* 45% 53% 43%
Note: T= Trans (5pg/ml), H= Hydrocortisone (50nM) , 1= Insulin (5Mg/ml),
second T= T^(5pM), S= Selenium (50nM) ; PGE^ (25ng/ml) used.
* Growth expressed as a percentage of growth in 5% FCS 
Results expressed as average - S.E.M. (n=3)
TABLE 3.3 Growth of MDCK at clonal concentrations in THITS (PGE1)
Initial cell conc: 31x10 cells/35mm dish 2x1 0  ^ cells/dish
Colonies/dish Colonies/dish
5% FCS 135 - 25 400 - 25
- FCS 0 0
THITS(PGE1) 85 -  5 170 - 21
% Growth in THITSCPGE^ 63% 43%
Note: Concentration as in Table 3.2. Colonies counted on image analyser.
*Growth expressed as a percentage of growth in 5% FCS 
Results expressed as average - S.E.M. (n=3)
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TABLE 3.4 Summary of attempts to grow MDCK in THITS(PGE..) in
225cm flasks
Treatments: Medium Results
Cells set up in sealed flasks 
at 37°C
5% FCS 
- FCS
THITS(PGE1)
Normal Growth
No Growth
Some single cell 
attachment, no 
growth
5% CO2 bubbled through medium 5Z FCS Normal Growth
prior to sealing flasks - FCS
THITS(PGE1)
No Growth 
No Growth
Loosened caps in 5% CO^ 
incubator
5% FCS 
- FCS
THITS(PGE1)
Good Growth 
No Growth 
No Growth
Note: Cells set up over a range of concentrations from 1x10 to 5x10
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3.3 Development of a serum-free medium for RPMI 2650
3.3.1. Choosing a suitable FCS batch
Batch to batch variation in FCS has always been highlighted as a major 
disadvantage in working with a serum-supplemented system. Hence it was 
necessary to screen a number of different batches of FCS to identify a 
batch which would consistently support growth of RPMI 2650 at a concentration 
of 1.0 x 10^ cells/35 mm dish for continual use in an assay (see Sec. 2.15).
Five different batches of FCS were screened and growth in medium supplemented 
with 5% FCS examined. Fig. 3.2 indicates the range of variability that is 
found, both within a FCS batch and between batches. This diagram shows the 
average colony numbers per 35 mm dish. Batch number 30 Q is obviously 
consistently yielding higher colony numbers, while batch number 20 F appears 
to be very unsuitable for growth of RPMI 2650 cells. Very little growth 
occurs in many experiments using this batch of FCS.
Hence, 30 Q FCS is the best batch screened for supporting growth of RPMI 2650. 
But even with this batch there can still be large variations in the number 
of colonies that form from an initial innoculum of 1 x 10  ^ cells/dish.
In some experiments two sets of replicates were independently set up at 
1 x 10^ cells/dish to examine the variance within a FCS batch. In Fig. 3.2., 
experiment number 8 shows that, using batch number 10 Q, the average number 
of colonies in identical sets of replicates can differ significantly.
However, the variation within an experiment, using batch number 30 Q 
(Experiment 10, Fig. 3.2.), is reduced to a much more acceptable level.
Colony
Number
I
800 -!II
per dish j 20F 10Q 30Q
Experiment Number
FIGURE 3.2: Growth of RPMI 2650 in three different batches of FCS.
Growth is in medium supplemented with 5% FCS.
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3.3.2. Détection of a minimum FCS level
To investigate the effects of various compounds on the growth of RPMI 2650 
cells, a minimum level of FCS was required which would allow limited growth 
(see Sec. 1.3). Growth was examined initially using MEM as the basal medium 
and different batches of FCS. Growth was consistently observed in 3% FCS 
with batch number 30 Q and this seemed to be a suitable background FCS level 
to work with.
But developments in choosing a basal medium resulted in a lowering of the 
FCS level (see Sec. 3.3.3). Using DME:F12 (1:1) mixture, growth occurred in 
1% FCS (Table 3.5). After 7 days growth, clonal growth was sufficient to 
allow staining with Leishmann’s stain and the colonies could be counted using 
the image analyser (see Sec. 2.15.2).
When consistent growth was occurring at the 1% FCS level, using this batch 
of FCS, examinations were made into growth in 0.5% FCS and 0.25% FCS. At a 
concentration of 1 x 10^ cells/dish growth occurs at both concentrations 
(Table 3.6). Either concentration is suitable for use as a minimum level of 
FCS which could be used to observe the response of RPMI 2650 to a variety of 
factors.
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TABLE 3.5 Lowering FCS level for growth of RPMI 2650
%
Colony
No.*
%
Colony
Area*
Colony No.
Total 
Colony Area
Csa. mm')
5% FCS 100 100 525 - 22 27.3 - 1.1
3% FCS 65 61 343 + 21 16.6 - 0.7
2% FCS 60 55 315 ± 22 15.1 - 1.5
1% FCS 24 16 128 - 9 4.4 - 0.2
Note: DME:F12 basal medium used
*Growth expressed as a percentage of growth of 5% FCS controls
TABLE 3.6 Growth of RPMI 2650 in low FCS concentrations
%
Colony
No.*
%
Colony
Area*
Colony No.
Total 
Colony Area 
(sq. mm)
5% FCS 
0.5% FCS
0.25% FCS
100
31
8
100
16
5
494 - 28
153 - 20 
41 - 7
47.8 - 3.4
7.8 - 1.2
2.2 - 0.5
*Growth expressed as a percentage of growth of 5% FCS controls
In these and in all succeeding tables of this format (unless specified), 
results are expressed as average - S.E.M. (n=4).
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3.3.3. Choosing a basal medium
RPMI 2650 cells are grown routinely in Eagle's Minimal Essential Medium (MEM)
+ 5% FCS. Initial investigations into growth in reduced FCS concentrations 
were carried out using MEM. Having observed growth in 3% FCS, and having 
observed some stimulation due to ITS (see Sec. 3.3.4) at this FCS level 
investigations into different basal media were carried out to see if any 
other basal media would support growth to a greater extent in reduced FCS 
conditions.
Ham's F12 (Ham, 1965) is the basal medium most commonly used in serum-free 
media. Comparisons were made between growth in MEM and MEM:F12 mixtures.
Table 3.7 shows that in the presence of Ham's F12, RPMI 2650 grow better 
than in MEM. At a 6:1 ratio with MEM, growth in 5% FCS is unchanged, but 
growth at 3% FCS shows a five-fold increase in colony number and a doubling 
in colony area. In a MEM:F12 (3:1) mixture, growth in both 5% FCS and 3%
FCS is significantly better; the CFE and colony area are both increased 
significantly at the two FCS concentrations.
Thus Ham's F12 was seen to be contributing significantly to growth of RPMI 265(
particularly in reduced FCS conditions. A MEM:FI2 (1:1) mixture was then 
examined and growth in this mixture supplemented with 2% FCS was equal to the 
growth observed with MEM alone, supplemented with 3% FCS. Table 3.8 shows 
that colony number and colony area are equal in MEM:F12 + 2% FCS and MEM +
3% FCS.
Thus it seems that Ham's F12 is markedly influencing growth. Yet RPMI 2650 
failed to grow in F12 + 0.5% FCS (Table 3.10). The recommended combination 
is DME:F12 (1:1) mixture - this is the most widely used in serum-free work. 
RPMI 2650 responded well to this mixture and growth was recorded consistently 
in 1% FCS (Table 3.9 and 3.5).
Investigations were then made into lowering the FCS concentration further 
(Sec. 3.3.2). Using 0.5% FCS a number of combinations of basal media were 
tested but, while some yielded equal growth to DME:F12 (1:1) yielded better
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growth (Table 3.10). The basal media tested included one called Special 
Liquid Medium (SLM). This differs from the other basal media by having 
sodium pyruvate as the main energy source, where most basal media have 
glucose. SLM on its own in the presence of 5% FCS resulted in the same 
growth as DME:F12, yet a SLM:F12 mixture tested showed no great change in 
growth levels.
Thus DME:F12 was chosen as being the best basal medium for supporting 
growth of RPMI 2650. The mixture of these two media (not F12 on its own) 
seem to supply the optimum combination of nutrients for this cell line.
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TABLE 3.7 Growth of RPMI 2650in MEM:FI2 v MEM
FCS % % Total
Medium Cone Colony Colony Colony No. Colony Area
No.* Area* (sq. mm)
MEM1 5% 100 100 206 J 48 11.25 -  2.75
3% 8 9 16 - 6 1.0 - 0.5
MEM:F12L (6:1) 5% 102 70 210 - 20 7.9 j 1.5
3% 44 20 91 - 9 2 . 2  - 0 . 1
MEM:F12 (3:1) 5% 224 242 462 ; 2 27.2 Ì 2.4
3% 143 108 294 - 60 12.2 - 3.0
Note: Growth in MEM:F12 (3:1) is significantly greater (p<0.01) at
5% and 3% FCS than in MEM alone.
^MEM- Eagles Minimal Essential Medium; F12 - Ham's F12
*Growth expressed as a percentage of growth in 5% FCS
TABLE 3.8 Growth of RPMI 2650 in MEM:F12 v MEM
FCS % % Total
Medium Cone Colony Colony Colony No. Colony Area
No.* Area* (sq. mm)
MEM 5% 100 100 1000 i  8 151.5 j 14.5
3% 92 63 919 - 16 95.5 - 3.9
MEM:F12 (1:1) 5% 103 107 1034 -  5 162.7 j 4.4
3% 97 86 965 J 35 130.4 - 17.0
2% 92 64 915 - 30 97.5 - 5.3
* Growth expressed as a percentage of growth in 5% FCS and MEM
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TABLE 3.9 Growth of RPMI 2650 in DME:F12 (1:1) basal medium
%
Colony
No.*
%
Colony
Area*
Colony No.
Total 
Colony Area
(sq. mm)
5% FCS 100 100 717 -  6.5 67.7 -  4.2
3% FCS 101 104 726 -  6 70.7 - 1.0
2% FCS 80 53 573 -  40 36.1 -  5.0
1% FCS 56 31 405 - 10 21.2 -  0.7
* Growth expressed as a percentage of growth in 5% FCS
TABLE 3.10 Growth of RPMI 2650 in a variety of basal media
Basal medium
%
Colony
No.*
%
Colony
Area*
Colony No.
Total 
Colony Area
(sq. mm)
DME:F12 + 5% FCS 100 100 919 - 32 204.2 - 6.7
DME:F12 + 0.5% FCS 35 15 326 - 12 29.7 - 1.1
F12 + 5% FCS 26 7 239 - 30 14.4 - 2.1
FI2 + 0.5% FCS 0 0 0 0
SLM + 5% FCS 97 97 888 - 91 198.8 -  15.4
SLM +0.5% FCS 33 8 309 - 50 17.1 -  4.5
SLM:FI2 + 5% FCS 91 78 839 - 84 160.0 - 36.8
SLM:F12 + 0.5% FCS 33 14 306 - 60 30.3 - 6.5
SLM:DME + 5% FCS 115 92 1053 - 70 187.0 - 14.9
SLM:DME +0.5% FCS 21 4 193 - 31 7.3 - 2.1
* Growth expressed as a percentage of growth in 5% FCS
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3.3.4 First observations of growth stimulation due to Insulin,
Transferrin and Selenium
First investigations into the response of RPMI 2650 to insulin, transferrin
and selenium were carried out using a FCS concentration of 3%j this was using
MEM as a basal medium, prior to selection of the optimum basal medium. Assays
4were set up as described in section 2.15, at a concentration of 1x10 cells/
35mm dish. A mixture of insulin (5jug/ml) , transferrin (5>ug/ml) and selenium 
_8
(1x10 M) (ITS) was found to stimulate growth, leading to a three-fold
increase in colony number and a seven-fold increase in total colony area
™8(Table 3.11). Two other compounds, hydrocortisone (1x10 M) and 
triiodothyronine (T^)> when added together to 3% FCS + ITS - supplemented 
medium, led to a decrease in cell growth, relative to that observed in the 
3% + ITS supplemented dishes. In the absence of FCS, the ITS-mixture failed 
to support any growth at all.
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TABLE 3.11 Growth stimulation of RPMI 2650 due to the addition 
of Insulin, transferrin and selenium (ITS)
%
Colony
No.*
%
Colony
Area*
Colony No.
Total 
Colony Area 
(sq. mm)
5% FCS 100 100 688 - 38 72.8 -  5.4
3% FCS 29 13 200 -  57 9.7 -  3.8
3% FCS + ITS 98 87 677 - 40 63.0 - 8.9
FCS + TKIT S 52 21 355 - 67 15.1 - 3.8
- FCS + ITS 0 0 0 0
Note: There is a significant difference in both colony number and area
(p<0.01) between 3% FCS and 3% FCS + ITS; this was using MEM as a 
basal medium prior to selection of an optimum basal medium.
*Growth expressed as a percentage of growth in 5% FCS
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3.3.5 Initial investigations into the action of transferrin, insulin, 
epidermal growth factor and selenium
Having established a background FCS level (see Sec. 3.3.2) and having 
observed some growth stimulation with higher FCS levels (see Sec. 3.3.4) 
due to the addition of ITS, we then attempted to identify compounds which 
consistently stimulated growth of RPMI 2650. The four compounds tested in 
detail initially were transferrin, insulin and selenium, (the most commonly 
used components in serum-free media) and epidermal growth factor (EGF).
Tables 3.12 and 3.13 show the contribution made by these factors. Table
3.12 shows that transferrin on its own contributes significantly to growth, 
increasing the colony forming efficiency almost eight-fold and the total 
colony area is six times greater than in the 0.5% FCS control. In combina­
tion with insulin, transferrin is even more effective. Data presented in 
Table 3.13 confirms the critical role played by transferrin. There is a 
significant increase in the colony number and colony area (p< 0.05) when 
transferrin alone is added to 0.5% FCS. In conjunction with selenium or 
with both EGF and selenium growth is significantly improved at this FCS 
background level also.
The increase in growth in the presence of insulin is less marked than that 
with transferrin, but when added at a concentration of 5 pg/ml to 5% FCS 
the colony number and colony area values are twice those with 0.5% FCS 
alone (Table 3.12). The exact extent to which insulin stimulated growth 
in RPMI 2650 merited considerable attention. Numerous sets of data 
initially showed insulin, in combination with transferrin, stimulating 
growth at 1 - 3% FCS concentrations (Tables 3.11 and 3.13). At lower FCS 
concentrations insulin is also shown to stimulate growth of RPMI 2650 
(Tables 3.12 and 3.14).
Insulin is dissolved in 1M HC1 (see Sec. 2.9) and can be difficult to 
dissolve. The first batch of insulin used for this work dissolved 
readily in a 1:5 mixture of 1M HC1 and PBS A. The second batch used 
required the addition of some concentrated HC1 to dissolve at the same 
concentration (5 mg/ml). Thus, even after diluting 1:1000 for addition to
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the culture medium, it was considerably more acidic than the first batch used. 
The effect of increased acidity on cell growth is not clear.
The data presented in Table 3.15 shows that in three out of four instances 
insulin acted to stimulate growth of RPMI 2650 in the presence of transferrin,
EGF and selenium. These sets of experiments were set up using the second 
batch of insulin. It appears that, in general, insulin stimulates growth of 
RPMI 2650, but its use should be approached with caution.
EGF (10 ng/ml) when added to transferrin and insulin, leads to a very 
significant increase in the colony number and colony area (p^O.OOl) with a 
FCS background of 0.5% (Table 3.12). This marked effect of EGF is confirmed 
by results presented in Table 3.13, especially at the lower FCS concentration. 
However, there is no detectable increase in cell growth when EGF is added on 
its own to FCS (Table 3.13). It appears to interact with other compounds 
(e.g. transferrin, selenium) in influencing growth of RPMI 2650 cells. Table
3.13 shows that, with a 0.5% FCS level, neither EGF nor selenium cause any 
increased growth when added on their own, yet when the two are added together 
there is a significant increase (p<0.05) over the 0.5% FCS control.
The exact contribution made by selenium is difficult to determine.
Preliminary work at higher FCS background levels reveal no growth-stimulatory 
effects due to addition of selenium (Tables 3.13 and 3.16). At 2% and 3%
FCS there is no increased growth on addition of selenium, while there is a 
very slight increase at a 1% FCS concentration (Table 3.13). But when the 
FCS level is lowered to 0.5% FCS and 0.25% FCS some effects of selenium 
become evident.
In most cases, there is a slight increase in the CFE and colony area when 
selenium is added in conjunction with another compound but no stimulation is 
evident when it is added on its own. Table 3.12 shows a significant increase 
in the colony number (p<0.01) when selenium is added to 0.5% FCS + TIE while the 
results in Table 3.13 also show an increase in the CFE (p<0.05). There is no 
significant increase in the colony area in either case. Thus, selenium 
appears to be influencing growth in some way which leads to an increase in 
colony number but not in colony area. The continual appearance of this 
effect by selenium on RPMI 2650 growth justifies including it as one of the 
components in the development of a serum-free medium formulation.
JU
Thus, these four compounds - transferrin, insulin, EGF and selenium 
(referred to as TIES) are the basis of a serum-free medium formulation for 
growth of RPMI 2650 * The results presented here show that in the presence
of 0 . 5 4  FCS + TIES clonal growth of RPMI 2650 is maintained to some extent 
relative to growth in 5% FCS.
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TABLE 3.12 Effects of transferrin
RPMI 2650 cells
, insulin, EGF and Selenium on
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq. mm)
5% FCS 100 100 534 - 53 154 - 204
0.5% FCS 0.7 0 . 2 4 - 0.5 0.3 - 0.06
0.5% FCS + I (5pg/ml) 1 . 6 0.4 9 - 0.5 0 . 6  - 0.3
0.5% FCS + T (5>jg/ml) 5.5 1 .2 2 9 - 7 1.9 - 0.8
0.5% FCS + TI 9.7 2 .2 52 -  8 3.4 -  0.9
0.5% FCS + TI E (lOng/ml) 30.5 13.2 163 - 17 20.4 - 0.7
0.5% FCS + TIE S (lOnM)33.3
1
14.2 178 -  30 21.9 -  4.0
Concentrations tested: Transferrin (T) - 5pg/ml, Insulin (I) - 5pg/ml,
EGF (E) - lOng/ml, Selenium (S) - lOnM
*Growth expressed as a percentage of growth in 5% FCS
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TABLE 3.13 Response of RPMI 2650 to transferrin, insulin, 
selenium with varying FCS backgrounds
EGF and
% % Total
Colony Colony Colony No. Colony Area
No. * Area * (sq. mm)
5% FCS 100 100 718 -  6.5 67.7 - 5.0
2% FCS 80 53 573 -  41 36.1 - 5.0
2% FCS + IT 109 97 783 -  30 65.9 -  8.3
2% FCS + ITS 106 87 762 - 31 59.0 - 8.0
2% FCS + TIES 121 134 867 - 42 90.6 -  5.0
1% FCS 56 31 405 -  11 2 1 .2 -  1 . 2
1% FCS + IT 74 45 529 - 27 30.4 - 3.8
1% FCS + ITS 77 53 554 - 33 35.5 - 0.9
1% FCS + TIES •79 62 569 - 35 42.0 - 1.2
5% FCS 100 100 695 -  13 46.3 -  2 . 9
0.5% FCS 31 20 216 -  15 9.2 + 0.7
0.5% FCS + T 44 32 303 - 13 14.8 -  2.8
0.5% FCS + EGF 22 24 156 - 20 11.3 - 2.1
0.5% FCS + S 35 22 241 -  25 10.3 - 0.5
0.5% FCS + TS 49 35 343 - 32 16.0 -  2 .8
0.5% FCS + ES 52 40 366 - 14 18.5 - 2.0
0.5% FCS + TES 63 49 441 -  47 2 2 .8 - 1 . 8
* Growth e x p r e s s e d  as  a p e r c e n t a g e  o f  growth  in  5% FCS
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TABLE 3.14 Growth of RPMI 2650 in the presence of insulin
%
Colony 
No. *
%
Colony
Area*
Colony No.
Total 
Colony Area 
(sq. mm)
5% FCS 100 100 1153 - 24 192.7 - 10.9
0.5% FCS 61 22 705 - 76 43.0 - 6.9
0.5% FCS + I 80 41 926 - 49 79.0 - 9.9
0.5% FCS + T 96 64 1104 - 62 124.0 - 9.0
Insulin (Spg'ml) and Transferrin (5pg/ml) both show significant increases 
(p<0.05) over 0.5% FCS control
* Growth expressed as a percentage of growth in 5% FCS
TABLE 3.15 Growth of RPMI 2650 in TIES v TES
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq. mm)
5% FCS 100 100 953 j 48 180.0 ^ 1 1 .0
0.5% FCS 40 16 385 - 30 28.3 - 2.1
0.5% FCS + TES 54 28 516 - 54 50.1 - 4.4
0.5% FCS + TIES 75 34 718 - 47 60.3 - 9.1
5% FCS 100 100 871 I  67 135.8 - 13.0
0.25% FCS 3 0.5 25 - 12 0.75 j 0.4
0.25% FCS + TES 29 9 248 - 37 11.6 - 1.7
0.25% FCS + TIES 45 17 395 - 34 21.75 - 2.2
5% FCS 100 100 1060 - 125 180.8 ~ 62.3
0.25% FCS 19 4 197 ; 24 7.7 - 1.7
0.25% FCS + TES 33 10 346 - 4 18.3 - 0.6
0.25% FCS + TIES 54 25 575 - 48 44.5 - 4.2
5% FCS 100 100 410 ~ 29 35.5 j 2.6
0.5% FCS 11 9 45 - 9 3.3 - 1.8
0.5% FCS + TES 65 45 268 - 17 15.9 - 2.6
0.5% FCS + TIES 60 47 246 - 23 16.7 - 3.2
* Growth expressed as a percentage of growth in 5% FCS
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TABLE 3.16 Response of RPMI 2650 to selenium in the presence of 
3% and 2% FCS
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq. mm)
5% FCS 100 100 525 - 22 27.3 - 0.8
3% FCS 65 61 344 -  21 16.6 - 0.7
3% FCS + IT 105 96 551 - 20 26.2 -  1 . 0
3% FCS + ITS 106 122 556 -  18 33.3 - 1.5
2% FCS 60 55 314 - 30 15.1 -  1.5
2% FCS + IT 86 89 453 -  20 24.4 -  1.4
2% FCS + ITS 83 90 436 - 31 24.7 - 0.3
*Growth expressed as a percentage of growth in 5% FCS
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3.3.6 Varying concentrations of the main components
Experiments were set up to investigate the optimum range of the four 
components found to consistently produce the greatest stimulation to growth 
of RPMI 2650 in a low FCS background level, i.e. Transferrin, Insulin, EGF 
and Selenium.
Table 3.17 shows the effect of varying the concentration of insulin. A 
concentration range of 5 Mg/ml - 10 Mg/ml resulted in no obvious change in 
either the CFE or colony area, while insulin at a lower concentration range - 
1 - 2.5 Mg/ml was shown to be less effective. Hence, a concentration of 
5 jjg/ml was chosen for routine use as the lowest concentration of insulin 
which gave maximal effect.
Table 3.17 also shows the effect of varying EGF concentrations from lng/ml 
to lOOng/ml. Between lng/ml and 50ng/ml there is no significant difference
in either the colony area or the colony number. At a higher concentration
of lOOng/ml, EGF is less effective,’ there is a significant decrease in both 
the CFE and the colony area (p<0.02).
Table 3.18 shows growth of RPMI 2650 under varying transferrin and selenium 
concentrations. Transferrin was tested over a range from 1 pg/ml to 
10 pg/ml but growth was almost the same under all conditions. A value in 
the middle of the range, 5 jjg/ml, was chosen for routine use.
Selenium is present in most serum-free formulations as a trace element.
-9 - 8Hence, a range from 5 x 10 M to 5 x 10 M was examined. Greatest growth
was observed in the middle region of the range (1 x 10 M - 2 x 10 M);
__8therefore a concentration of 1 x 10 M was used on a routine basis.
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TABLE 3.17 Varying concentrations of Insulin and EGF
% % Total
Colony Colony Colony No. Colony Area
No. * Area* (sq. mm)
5% FCS 100 100 208 - 18 1 0 . 2  -  2 .1
0.5% FCS 6 3 13 - 1 0.3 -  0.02
0.5% FCS + TES +:
Ins (1 pg/ml) 25 23 6 4 - 6 2.4 -  0.4
Ins (2.5 pg/ml) 30 29 6 3 - 5 3.0 -  0.4
Ins (5 jjg/ml) 62 55 128 - 16 5.6 - 0.9
Ins (7.5 pg/ml) 55 41 115 - 9 4.2 - 0.7
Ins (10 jjg/ml) 64 56 133 - 14 5.7 -  1.0
5% FCS 100 100 489 - 26 43.2 -  2.7
0.5% FCS 25 12 124 -  21 5.5 -  3.5
0.5% FCS + TIS +:
EGF (lng/ml) 69 47 337 - 27 20.1 - 2.4
EGF (lOng/ml) 82 68 399 ~ 5 29.4 -  0.4
EGF (20ng/ml) 66 61 324 - 37 26.4 -  3.8
EGF (50ng/ml) 79 66 388 -  15 28.6 - 4.0
EGF (lOOng/ml) 55 31 271 - 26 13.2 -  2 . 1
Concentrations of Trans (5 pg/ml), Selenium (lOnM) and either insulin (5 pg/ml) 
or EGF (lOng/ml) were kept constant to observe the effect of changing insulin 
or EGF concentrations.
* Growth expressed as a percentage of growth in 5% FCS
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TABLE 3.18 Varying concentrations of Transferrin and Selenium
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq. mm)
5% FCS 100 100 501 + 52 31.8 - 6.9
0.5% FCS 16 10 ' 77 + 25 3.2 -  1 . 8
0.5% FCS + TIE +:
S (5x10_9M) 76 61 382 + 52 19.4 -  3.8
S (1x10_8M) 72 59 363 + 48 18.9 -  5.3
S (2x10_8M) 80 67 405 + 42 21.3 - 4.4
S (5x10_8M) 58 49 289 + 84 15.5 Î 4.2
0.5% FCS + IES+:
T (1 pg/ml) 71 50 354 + 42 16.0 - 3.0
T (2.5 pg/ml) 58 44 289 + 44 14.0 - 2 .6
T (5 pg/ml) 72 59 363 + 48 18.9 -  5.3
T (10 pg/ml) 77 62 385 + 30 19.7 - 2 .0
Concentrations of insulin (5 pg/ml), EGF (10 ng/ml) and either transferrin 
(5 pg/ml) or selenium (lOnM) were kept constant to observe the effect of 
varying transferrin and selenium concentrations.
* Growth expressed at a percentage of growth in 5% FCS
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3.3.7 Examination of the effects of a range of compounds on growth 
of RPMI 2650 cells
Experiments were set up to investigate the activity of a large number of 
compounds, in the presence of a background level of FCS, on the growth of 
RPMI 2650. The background level of FCS varied from 0.25% FCS to 0.5% FCS. 
Compounds were tested over a range of concentrations and usually on their 
own and in conjunction with transferrin (5 pg/ml), insulin (5 pg/ml),
EGF (lOng/ml) and selenium (10nM)(TIES). In some cases, experiments were 
carried out without insulin (TES), as investigations were being carried 
out simultaneously into the exact role of insulin (see Sec. 3.3.5). Growth 
was measured in terms of both the colony number and the colony area. (The 
colony number is a reflection of the colony forming efficiency (CFE) and at 
times is referred to as such). The colony area is given in square millimetres 
(mm^) .
3.3.7.1 Hydrocortisone
A number of experiments were set up to test the effect of hydrocortisone (HC). 
In early developmental work with higher background FCS levels, HC seemed to 
be stimulating growth when added with some other factors (Table 3.19). But 
this stimulation, while observed on occasions with lower FCS background 
levels, was not evident consistently and hence it was concluded that HC did 
not play a critical part in supporting RPMI growth in the absence of FCS 
(Table 3.20).
I
65
TABLE 3.19 Hydrocortisone (H) as a 
RPMI 2650 with 3% FCS
medium component. Effect on
% % Total
Colony Colony Colony No. Colony Area
N o . * Area * (sq. mm)
5% FCS 100 1 0 0 410 -  22 89.4 ~ 2.1
3% FCS 33 20 135 - 15 17.9 - 1.8
3% FCS + TIES 64 45++ 262 - 4 40.4 - 2.5
3% FCS + THIES 70 54++ 287 - 10 48.3 - 2.7
++ Differences in CFE and area are significant at 5% level (p<0.05) 
* Growth expressed as a percentage of growth in 5% FCS
TABLE 3.20 Effect of Hydrocortisone (HC) on 
(0.5% FCS level)
growth of RPMI 2650
% % Total
Colony Colony Colony No. Colony Area
No . * Area * (sq. mm)
5% FCS 100 100 501 - 52 31.8 - 6.9
0.5% FCS 16 10 77 -  25 3.2 - 1.8
0.5% FCS + TIES 72 59 363 -  48 18.9 - 3.8
0.5% FCS + TIES:
HC (5x10 -8M) 45 27 227 - 74 8.7 - 4.0
- 8 , +HC (2.5x10 M) 71 59 355 - 27 18.7 - 3.8
HC (1x10~8M) 73 58 365 * 44 18.6 - 3.6
HC (5xlO_9M) 58 39 293 - 57 12.4 - 3.3
HC (1x10_9M) 56 44 283 - 64 14.0 - 2.0
* Growth expressed as a percentage of growth in 5% FCS
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3.3.7.2 Triiodothyronine and the Prostaglandins
Triiodothyronine (T^) and PGE^ are present in the serum-free medium which 
supports the growth of MDCK (see Sec. 3.2). Hence, experiments were 
carried out to examine the effects of these compounds on growth of RPMI 
2650. Another prostaglandin, PGF2a> was also tested. All three were 
tested individually in the presence of 0.5% FCS or 0.25% FCS + TIES. T^ and 
PGE^ were tested in combination with each other and with hydrocortisone 
(HC) .
Table 3.21 shows that at two different concentrations, T^ has no effect on 
the growth of RPMI 2650, in the presence of 0.5% FCS + TIES, while Table 
3.22 shows that T^ (2x10 ^M) and HC(5xl0 ^M) when combined in the 
presence of 0.5% FCS + TIES make no major impact on growth of RPMI 2650. 
However, when T^ and PGE^ are combined there is a significant decrease in the 
CFE (p<0.001) and the combination of HC, T^ and PGE^ inhibits growth to 
almost one third that obtained in the 0.5% + TIES control.
PGE^ (25 ng/ml) when added to 0.5% FCS + TIES, seems to cause some reduction 
in growth (Tables 3.21 and 3.22), but when PGE and either T^ or HC are added 
to 0.5% + TIES more significant growth inhibition occurs. Both the CFE and 
colony areas are affected and when all three are supplied to the medium 
together, the growth inhibition is greatest. This pattern was detected on 
other occasions, with PGE^ inhibition being more pronounced at times 
(results not given).
PGF„ was added at a range of concentrations to 0.5% + TIES. It has no
d* 0£>
effect on either the CFE or the colony area (Table 3.23).
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TABLE 3.21 Effect of Triiodothyronine (T^) on growth of RPMI 2650
% % Total
Colony Colony Colony No. Colony Area
No. * Area* (sq. mm)
5% FCS 100 100 647 - 60 70.7 - 13.3
0.5% FCS 33 20 213 - 4 14.0 - 0.7
0.5% FCS + TIES 58 40 374 - 50 28.6 - 2.9
-a0.5% FCS + TIES T3 (1x10 M) 56 37 363 - 21 26.4 - 3.8
0.5% FCS + TIES T (2xlO_ 12M) 55 37 358 - 66 26.0 - 5.7
0.5% FCS + TIES PGE1 A3 35 281 - 41 24.7 - 3.5
0.5% FCS + TIES HC T3 PGE x 32 18 205 - 19 12.9 - 1.7
“ 8PGE (25 ng/ml) and HC (5x10 M) were used in this experiment. 
*Growth expressed as a percentage of growth in 5% FCS
TABLE 3.22 Response of 
and T3
RPMI 2650 to additions of PGE^, hydrocortisone
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq. mm)
5% FCS 100 100 534 - 53 154.0 -  20.4
0.5% FCS 0.7 0 . 2 4 - 0.5 0.3 - 0.06
0.5% FCS + TIES 33 14 178 - 31 21.9 - 2.4
0.5% FCS + TIES T 33 17 179 - 21 26.5 -  3.7J + +0.5% FCS + TIES (PGE ^ ) 29 14 155 - 16 22.1 - 4.25
0.5% FCS + TIES HC 35 16 190 - 7.4 24.9 -  2.1
0.5% FCS + TIES HC T„ 31 14 165 - 12 21.6 -  5.1
+ +0.5% FCS + TIES HC (PGE-^ 16 7 85 - 13 1 0 .0 - 4.0
0.5% FCS + TIES T3 (PGE1) 22 12 116 - 3 17.9 - 2.3
0.5% FCS + TIES HC T3 (PGE]) 13 
... .....
6 72 - 14 9.0 -  1.4
Concentrations used: HC(50nM), T3 (2pM), PGE-^(25ng/ml)
* Growth expressed as a percentage of growth in 5 % FCS
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TABLE 3.23 Growth of RPMI 2650 in the presence of PGF2a
% % Total
Colony Colony Colony No. Colony Area
No. * Area* (sq. mm)
5% FCS 100 100 799 - 10 172.0 - 4.6
0.5% FCS 81 27 653 - 10 45.7 - 1.7
0.5% FCS + TIES 89 34 712 - 54 58.4 - 7.9
0.5% FCS + TIES +:
PGF2a 2ng/ml 88 32 705 - 30 55.0 - 2.5
PGF2a 20ng/ml 82 29 653 - 31 50.1 -  2.0
PGF lOOng/ml or. 29 705 - 49 50.3 - 5.7
*Growth expressed as a percentage of growth in 5% FCS
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3.3.7.3 Ascorbic Acid
Addition of freshly-dissolved ascorbic acid to medium supplemented with 
0.25% + TES increases growth of RPMI 2650. Table 3.24 shows the effect of 
adding ascorbic acid over a concentration range from 1 pg/ml to 100 pg/ml.
At concentrations of 1 pg/ml and 10 pg/ml of ascorbic acid both the CFE and 
the colony area are significantly increased (p<0.05). Over twice the number 
of colonies form and over three times the colony area is recorded, compared 
to the 0.25% FCS + TES controls. At the higher concentration of 100 jjg/ml 
there is no significant increase in growth.
3.3.7.4 Bombesin
“ 6 —8Bombesin was tested over a range from 1x10 M to 1x10 M, both with 0.5%
FCS only and with 0.5% FCS + TIES or TES. This compound seems to influence 
growth of RPMI 2650 to some extent, but consistent growth stimulation was 
not recorded with bombesin. Table 3.25 shows the results of five experiments 
carried out to examine the effect of bombesin on growth. In medium supple­
mented with 0.5% FCS only, bombesin stimulated RPMI 2650 growth significantly 
—7 -8(p<0.05) at 10 M and 10 M, in experiment (1) but in experiment (3) 
stimulation is seen at 10 Si.
In medium supplemented with TIES or TES, with both 0.25% FCS and 0.5% FCS 
backgrounds, stimulation by bombesin is recorded, but under similar conditions, 
experiments (4) and (5) show no significant increase in RPMI 2650 growth 
due to bombesin.
These results are difficult to interpret. There is too much evidence for 
stimulation to suggest that its appearance is due to experimental error, yet 
it does not appear consistently. It seems that there is some inherent 
variation in the role of bombesin as a medium supplement which cannot be 
detected within this assay system.
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TABLE 3-24 Growth of RPMI 2650 in the presence of Ascorbic acid
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq. mm)
5% FCS 100 100 731 - 129 296.0 - 11.3
0.25% FCS 17 2 123 - 70 7.1 ^ 3.4
0.25% FCS + TES 26 6 193 - 10 16.6 - 1 . 2
0.25% FCS + TES +:
Ascorbic Acid 1 jjg/ml 62 13 456 - 29 38.0 - 4.6
Ascorbic Acid lOpg/ml 69 21 505 - 104 63.4 -  18.9
Ascorbic Acid 100 pg/ml 32 5 236 - 57 15.5 -  6 . 8
This experiment was carried out using TES (no insulin) 
*Growth expressed as a percentage of growth in 5% FCS
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TABLE 3.25 Growth of RPMI 2650 in the presence of bombesin
% % Total
Colony Colony Colony No. Colony Area
No. * Area* (sq. mm)
(1)
5% FCS 100 100 953 - 48 180.0 - 1 1 .0
0.5% FCS 40 16 385 - 30 28.3 - 2.1
0.5% FCS + B(10”6M) 47 15 448 - 53 27.3 - 2.9
0.5% FCS + B(10-7M) 52 + 16 498 -  54 29.5 -  7.3
0.5% FCS + B(10"8M) 58 + 19 + 549 -  37 33.8 - 4.1
0.5% FCS + TES 54 28 516 -  54 50.1 - 4.4
0.5% FCS + TES B(10_6M) 62 30 587 - 28 54.8 - 4.8
0.5% FCS + TES B(10"7M) 86 + 49 + 818 i 30 88.3 - 11.0
0.5% FCS + TES B(10~8M) 95 + 54 + 901 -  2 97.3 - 8 .6
(2)
5% FCS 100 100 883 - 33 237.5 - 16.7
0.25% FCS 14 9 123 - 12 20.2 - 1.4
0.25% FCS + TIES 33 14 287 -  76 33.2 - 4.9
0.25% FCS + TIES +:
b(io”6m) 55 + 21 + 489 -  47 49.1 - 6.2
b(io-7m) 43 + 17 377 -  25 41.1 - 3.2
B(10_8M) 47 + 19 + 415 - 54 45.3 -  6.4
(3)
5% FCS 100 100 705 - 67 155.4 - 18.4
0.5% FCS 22 13 156 i 76 19.5 - 8 .0
0.5% FCS + B(10~6M) 43 + 20 + 305 - 65 30.8 -  5.9
0.5% FCS + B(10_7M) 23 12 163 -  65 19.2 -  11.4
0.5% FCS + B(10"8M) 30 14 208 -  60 21.4 - 4.0
0.5% + TIES 77 48 544 - 38 75.0 -  15.1
0.5% + TIES +
B(10_6M) 90 + 64 + 635 - 41 99.6 - 19.2
b(io"7m) 86 + 56 + 605 - 21 8 6 .8 - 17.0
b(io~8m) 93 + 61 + 657 - 70 94.5 - 22.5
+ This indicates a significant increase (p<0.05) in either colony number or 
colony area.
* Growth expressed as a percentage of growth in 5% FCS
p.t.o.
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TABLE 3.25 (cont'd) Growth of RPMI 2650 in the presence of bombesin
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq. mm)
(4)
5% FCS 100 100 871 - 67 135.8 - 13.0
0.25% FCS 3 0.5 25 - 12 0.75 - 0.4
0.25% FCS + TIES 45 16 395 - 34 21.75 - 2.2
0.25% FCS + TIES +:
B(10-6M) 34 9 297 - 32 12.9 -  2.0
b(io-7m) 32 9 285 - 7 12.6 - 1.3
b(io_8m) 33 10 288 - 32 13.1 -  2.4
(5)
5% FCS 100 100 911 - 37 1 0 1 .0 - 8 .6
0.5% FCS 21 7 191 - 25 7.4 - 0 . 8
0.5% FCS + TES 53 29 479 - 23 28.8 - 3.3
0.5% FCS + TES B(10_6M) 37 17 333 - 31 17.2 - 2.1
0.25% FCS 1 0.3 9 - 2 0.3 - 0.15
0.25% FCS + TES 20 6 185 - 32 6.3 - 0.5
0.25% FCS + TES B(10_6M) 23 8 211 - 16 8.3 - 0 . 6
Three experiments included insulin, two excluded insulin.
* Growth expressed as a percentage of growth in 5% FCS
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3.3.7.5 Glycyl-hystidy1-lysine (GHL)
Glycyl-hystidyl-lysine is a polymer that has been used in some serum-free 
formulations. Experiments were set up to examine its effect on growth of 
RPMI 2650. GHL was tested over a range of concentrations (lOng/ml - 
200ng/ml) in the presence of 0.5% FCS + TIES. Under these conditions, no 
stimulation due to GHL was recorded (Table 3.26).
3.3.7.6 MEM non-essential amino acids and sodium pyruvate
MEM non-essential amino acids is a commercially available mixture of amino 
acids which are added to the basal MEM medium, at a 1:100 dilution, in which
RPMI 2650 cells are grown routinely (for composition, see Table 3.27).
Experiments were set up to investigate the effect of adding this amino acid 
mixture to the DME:F12 basal medium, supplemented with 0.5% + TES. The non- 
essential amino acids were diluted 1 :1 0 0 in the medium.
Table 3.28 shows that the amino acid mixture enhances growth of RPMI 2650. 
There is a significant increase in both co-lony area and colony number (p<0.05) 
with the greatest increase being in colony number. Thus it would appear that 
there are some amino acids in this mixture which either are not present, or 
are not at a sufficiently high concentration in the DME:F12 basal medium, 
supplemented with 0.5% FCS + TES.
Sodium pyruvate is an alternative carbon source found in some basal media. 
Experiments were set up to see if its inclusion in medium, in conjunction 
with the normal carbon source glucose, would have any effect on cell growth. 
Sodium pyruvate was added at a concentration of l.lmM. These showed 
that it had no significant effect on growth of RPMI 2650 in the presence of 
0.5% FCS + TES, (data not presented).
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TABLE 3.26 Growth of RPMI 2650 in medium supplemented with 
glycyl-hystidy1-lysine (GHL)
% % Total
Colony Colony Colony No. Colony Area
No. * Area* (sq.mm)
5% FCS 100 100 806 - 9 154.8 -  7.5
0.5% FCS 34 17 275 - 52 26.6 - 4.3
0.5% FCS + TIES 53 25 429 - 28 38.1 - 6.2
0.5% FCS + TIES +
GHL(10ng/ml) 47 20 379 - 28 31.6 - 4.3
GHL(50ng/ml) 49 23 394 - 28 35.4 -  2.1
GHL(100ng/ml) 40 18 325 - 29 28.5 - 4.7
GHL(150ng/ml) 50 25 406 - 22 38.7 -  5.4
GHL(200ng/ml) 53 22 427 -  37 34.6 - 8.7
* Growth expressed as a percentage of growth in 5% FCS
TABLE 3.27 Composition of HEM non-essential amino acids
Ingredient mg/1
L-alanine 8.90
L-asparagine . 1^0 15.00
L-aspartic acid 13.30
Glycine 7.50
L-glutamic acid 14.70
L-proline 11.50
L-serine 10.50
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TABLE 3.28 Growth of RPMI 2650 in medium supplemented with MEM non- 
essential amino acids (NEAA)
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq.mm)
5% FCS 100 100 953 - 48 180.0 - 1 1 .2
0.5% FCS 40 16 385 - 30 28.3 - 2.1
0.5% FCS + TES 54 28 516 -  54 50.7 - 4.4
0.5% FCS + TES NEAA 88 42 840 -  77 75.8 - 10.2
0.5% FCS + TES 72 31 689 -  57 55.3 -  4.5
* Growth expressed as a percentage of growth in 5% FCS
TABLE 3.29 Growth of RPMI 2650 in medium supplemented with PDGF 
and Retinoic acid (RA)
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq.mm)
5% FCS 100 100 920 - 49 165.7 - 16.7
0.5% FCS 48 22 442 - 120 36.9 ~ 17.6
- FCS 0 0 0 0
0.5% + TIES 74 44 683 - 30 73.7 - 3.4
- FCS + TIES 0 0 0 0
0.5% + TIES(PDGF) 72 45 661 - 96 74.5 -  10.7
0.5% + TIES +
RA 10“9M 74 40 680 -  48 65.9 - 10.5
-8 +RA 10 M 68 35 622 - 78 57.7 - 10.0
-7 + +RA 10 M 35 x 16 x 323 - 37 27.0 - 4.8
RA 10"6M 46 x 22 x 419 - 37 37.0 ~ 6.7
-5RA 10 M 0 x 0 x 0 0
RA 10-4M 0 x 0 x 0 0
x Decrease in growth significant at p<0.01 
* Growth expressed as a percentage of growth in 5% FCS
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3.3.7.7. Other factors tested 
Platelet derived growth factor (PDGF)
This polypeptide growth factor was available only in a very small quantity. 
Thus it was possible to test it at one concentration only. The PDGF came 
from Bioprocessing Ltd. and a concentration of 1 unit/ml was recommended.
No details were supplied on the protein concentration present at 1 unit/ml. 
At this concentration, this preparation of PDGF showed no effect on growth 
of RPMI 2650 (Table 3.29). The growth in PDGF-supplemented medium is 
identical to that in the 0.5% FCS + TIES control.
Retinoic Acid
Retinoic acid (vitamin A) was tested over a wide concentration range. At
— 8 “ 9lower concentrations (10 - 10 M) retinoic acid has no significant effect
on RPMI 2650 growth (Table 3.29). At concentrations of 10 ^M and 10 ^M 
growth inhibition has begun. There is a significant reduction in cell
number and colony area and when the concentration is further increased to
-5 -4 .10 - 10 M, no viable colonies remained after 7 days.
Progesterone
Experiments were set up to test the effect of progesterone over a range of
concentrations. With a background FCS level of 0.25%, progesterone on its
—7 -8own has no stimulatory effect and at higher concentrations (10 - 10 M)
growth is inhibited. In medium supplemented with 0.25% FCS + TIES,
-7 -9progesterone, over a concentration range of 10 M to 10 M has no effect at 
all on either colony number or colony area (Table 3.30).
Phosphoethanolamine
Phosphoethanolamine (PEtn) was added to the culture medium at concentrations 
of 10 5M - 10 ^M. In the presence of 0.5% + TIES, PEtn addition at all 
three concentrations tested, leads to a reduction in growth (Table 3.31). 
Both the CFE and the total colony area are reduced in the presence of PEtn.
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Ferrous sulphate
Ferrous sulphate is an iron source which cells can sometimes utilise in
place of the more conventional iron supply routes. Initial tests at a
-5concentration of 10 M  suggested that FeSO^ was inhibitory to cell growth 
(see Table 3.31). Growth was markedly reduced when FeSO^ was added to 
medium with a 0.5% FCS background,
-5 -9FeSO^ was tested over a range of concentrations, 10 M to 10 M, in the 
presence of transferrin. When medium was supplemented with 0.5% FCS + TIES, 
addition of ferrous sulphate at a concentration of 10 5M inhibits growth 
severely while lower concentrations have no effect (Table 3.31).
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TABLE 3.30 Growth of RPMI 2650 in the presence of Progesterone (P)
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq .ram)
5% FCS 100 100 731 - 129 229.5 - 94.5
0.25% FCS 17 3 122 - 70 7.1 - 3.4
0.25% + TIES 26 7 193 - 10 16.6 -  1 . 2
0.25% +
P (10"9M) 21 5 157 - 32 12.0 - 3.4
P (10_8M) 6 1 42 -  13 , 2.8 - 0.5
P (10~7M) 5 1 38 - 4 1.4 - 0.2
0.25% + TIES +
p (io“9m) 27 7 199 - 10 15.5 - 2.1
P (10~SM) 29 6 211 -  17 13.9 - 1.7
P (io“7m) 26 7 192 - 75 17.25 + 5.6
* Growth expressed as a percentage of growth in 5% FCS
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TABLE 3.31 Effect of Ph 
on growth of
osphoethanolamine and 
RPMI 2650 cells
Ferrous Sulphate (FeSO^)
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq.mm)
5% FCS 100 100 410 - 29 35.5 - 2.6
0.5% FCS 11 9 4 5 - 9 3.3 - 1.8
0.5% FCS + TIES 60 47 246 - 23 16.7 - 3.2
0.5% FCS + TIES +
-5 + +PEtn 10 M 32 21 130 - 13 7.4 - 1.3
- 6 + +PEtn 10 M 36 22 147 - 18 8 . 1  - 0 . 1
-7 + +PEtn 10 M 30 17 122 - 17 5.9 - 0 . 6
5% FCS 100 100 508 - 36 86.2 - 10.9
0.5% FCS 62 32 313 - 25 27.9 - 3.2
-5 + 4-0.5% + FeSO.(10 M) 3 1 1 4 - 4 0.9 - 0 . 6
H
0.5% + Trans (5 pg/ml) 67 39 342 - 42 33.5 -  6 .8
0.5% + TIES 79 61 402 -  10 52.4 -  4.7
5% FCS 100 100 799 - 10 172.0 - 4.6
0.5% FCS 81 27 653 - 10 45.7 -  1.7
0.5% FCS + TIES
i
89 37 712 - 54 63.2 -  7.9
0.5% FCS + TIES +
-5 + +FeSO. (10 M) 2 0.5 1 7 - 3 0 . 6  - 0 . 2
^ -7 v + +FeSO. (10 M) 78 29 624 - 37 50.1 - 1
-9 + +FeS04 (10 M) 85 28 681 - 61 47.3 - 8
*Growth expressed as a percentage of growth in 5% FCS.
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3.3.7.8  Inclusion of attachment factors as media components
Some compounds can stimulate growth of different cell types either through 
precoating of dishes or by adding the compounds into the medium. Thus, 
three of the compounds that were used for precoating (see Sec. 3.3.8.) - 
bovine serum albumin (BSA), collagen and fibronectin (Fn) were also added 
to the cells as medium supplements.
When Fn is added to medium containing 0.25% FCS + TIES at a concentration of 
10 jjg/ml, there is a significant increase in the colony number (p<0 .0 1) but 
the change in colony area is not significant. An identical pattern is 
observed, at 0.5% FCS background, the CFE value increasing (p 0.02) but with 
no significant increase in colony area.
Collagen at a concentration of 10 pg/ml influences growth positively, with 
the CFE value almost doubling and an increase is also recorded in the colony 
area. The results at a concentration of 1 pg/ml are most likely due to 
experimental error (Table 3.32).
Bovine serum albumin was added to 0.25% FCS + TES and its influence tested on 
growth of RPMI 2650. Over a concentration range from 0.5 mg/ml to 5 mg/ml 
there was no significant difference in growth, assuming that the low 
readings at the intermediate concentrations of 1 mg/ml are due to 
experimental error. Thus, it appears that the inclusion of BSA in the 
medium has no influence on growth of RPMI 2650.
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TABLE 3.32 Addition of collagen, fibronectin and BSA to medium
% % Total
Colony Colony Colony No. Colony Area
No.* ' Area* (sq.mm)
5% FCS 100 100 635 -  65 73.8 - 14.0
0.5% FCS 14 6 91 - 19 4.3 -  1.5
0.5% FCS + TIES 28 11 177 - 38 8 . 1  - 2 .2
0.5% FCS + TIES +:
Collagen 10pg/ml 49 18 312 - 34 13.0 - 2.6
Collagen lpg/ml 2 0.5 12 - 4 0.3 - 0.1
5% FCS 100 100 736 - 13 184.2 - 7.7
0.5% FCS 33 7 242 - 4 12.3 - 0.8
0.5% FCS + TIES 72 23 529 - 52 42.9 -  5.0
0.5% FCS + TIES (Fn) 90 29 662 - 48 54.3 - 10.4
0.25% FCS 35 12 261 - 39 22.3 - 5.2
0.25% FCS + TIES 54 17 398 - 16 32.2 -  3.2
0.25% FCS + TIES (Fn) 68 20 502 - 45 37.2 - 6 . 6
* + +5% FCS 100 100 731 - 129 296.0 - 11.3
0.25% FCS 17 2 122 -  70 7.1 - 3.4
0.25% + TES 26 6 193 - 10 16.6 - 1 . 2
0.25% + TES +:
BSA 500mg/ml 21 5 154 - 33 13.75 - 2.8
BSA 1mg/ml 5 1 39 -  14 2.2 - 0.3
BSA 5mg/ml 29 7 213 -  55 20.3 - 9.2
* Growth is expressed as a percentage of growth in 5% FCS
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3.3.8 Testing attachment factors
Various factors were examined to see their effect on cellular attachment. 
Experiments were carried out as described in Section 2.16.
3.3.8.1 Collagen
Collagen Type III (acid soluble) was tested initially at two concentrations - 
1 mg/ml and 100 jjg/ml. Table 3.33 shows the growth recorded in collagen- 
coated dishes. At a concentration of 100jjg/ml, collagen precoating 
occurred overnight (16 hrs) at 37°C or at room temperature. At the higher 
concentration, (1 mg/ml) growth was reduced relative to the 0.25% FCS + TIES 
control. The collagen was dissolved at 1 mg/ml in 1M HC1 and diluted to 
100 pg/ml in PBS A. It is possible that the precoating at 1 mg/ml 
concentration created an acidic surface which was unsuitable for growth.
Further tests were carried out at 100 jjg/ml concentration. The length of 
time for precoating was varied and the temperature at which the dishes were 
left during precoating was also varied. Table 3.34 shows that precoating 
under any conditions enhances cell attachment and clonal growth. Precoating 
at room temperature for 16 hrs. or at 37°C for 4 hrs. increases both the 
CFE and the colony area to the greatest extent. There is almost a four­
fold increase in the area covered by colonies and the number of colonies 
which form is more than doubled. Precoating at 37°C for longer - 16 hours - 
or shorter - 30 minutes - periods also leads to considerably more growth 
while precoating at 4°C or at room temperature also enhances colony 
formation and growth to varying degrees.
3.3.8 .2 Vitrogen
A commercially-available solution of collagen, Vitrogen, was also used to 
precoat dishes. A range of concentrations was used, 0.1 mg/ml -
3 mg/ml at 37°C, room temperature and 4°C. Table 3.35 shows that at 
the highest concentration, 3 mg/ml, at 37°C for 16 hrs., there is a 
significant increase in both colony number and area (p<0.05) and an 
increase in growth is also evident at a concentration of 100 jjg/ml at room 
temperature. Precoating at other temperatures at varying concentrations
had little effect on cell growth.
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TABLE 3.33 Growth of RPMI 2650 in dishes which had been precoated 
with collagen
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq.mm)
Controls - no precoating
5% FCS 100 100 548 -  27 170.1 - 28.1
0.25% FCS 10 2 56 - 23 4.0 - 2.1
0.25% FCS + TIES 26 8 144 -  29 14.0 -  5.3
Collagen 100 pg/ml
16 hrs. 37°C 58 29 319 - 25 49.8 - 5.0
16 hrs. Room Temp. 46 26 250 - 10 44.0 - 12.8
16 hrs. 4°C 11 4 59 - 2.6 7.0 - 1.4
Collagen 1 mg/ml
16 hrs. 37°C 13 2 73 - 30 3.6 - 1.6• + _ +16 hrs. Room Temp. 15 3 8 0 - 7 4.8 - 0.2
16 hrs. 4°C 10 3 55 - 19 4.8 - o.2
Details of precoating given in key. Controls were not precoated.
Cells are growing in 0.25% PCS + TIES in dishes precoated with collagen. 
* Growth expressed as a percentage of growth in 5% FCS
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TABLE 3.34 Growth of RPMI 2650 in collagen-coated dishes
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq.mm)
Controls - no precoating
5% FCS 100 100 635 - 65 73.8 - 14.0
0.5% FCS 14 6 92 - 20 4.3 - 1.5
0.5% FCS + TIES 28 11 177 - 38 8 . 1  - 2 . 2
- FCS - TIES 0 0 0 0
- FCS + TIES 0 0 0 0
Collagen 100 jyg/ml
16 hrs. 37°C 58 27 369 - 95 19.7 - 7.3
16 hrs. Room temp. 67 42 426 - 39 31.0 -  9.0
16 hrs. 4°C 38 15 242 - 80 11.2 - 5.2
4 hrs. 37°C 67 41 425 - 56 30.6 - 14.8
4 hrs. Room temp. 48 30 307 -  13 2 2 .2 -  1 . 2
4 hrs. 4°C 38 20 239 - 34 15.0 - 5.2
30 mins. 37°C 73 34 464 - 45 25.1 - 1.3
30 mins. Room temp. 31 25 196 - 49 18.4 - 1.4
30 mins. 4°C 54 38 346 - 57 28.2 - 2.4
Cells are growing in 0.25% FCS + TIES in dishes precoated with collagen. 
* Growth expressed as a percentage of growth in 5% FCS
I
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TABLE 3.35 Growth of RPMI 2650 in Vitrogen-treated dishes
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq .mm)
Controls - no precoating
5% FCS 100 100 548 - 27 170.0 - 28.1
0.25% FCS 10 2 56 -  23 4.0 - 2.1
0.25% FCS + TIES 26 8 144 - 29 14.0 - 5.3
Vitrogen - 37 °C
3 mg/ml 37 18 203 -  20 30.0 -  3.6
1 mg/ml 29 9 159 - 66 15.5 - 8.5
100 pg/ml 14 4 75 - 26 6.7 - 0.7
Vitrogen - Room Temp.
3 mg/ml 16 6 89 - 8.5 9.6 - 2.6
1 mg/ml 17 5 9 4 - 6 8.4 - 0.7
100 Mg/ml 36 16 195 - 58 27.1 - 4.4
Vitrogen 4°C
3 mg/ml 14 7 78 - 14 1 1 . 6  -  2 . 2
1 mg/ml 21 7 113 - 29 12.2 - 1.9
100 Mg/ml 12 8 6 6 - 6 13.6 - 1.1
Cells are grow ing in 0.25% FCS + TIES in dishes precoated with Vitrogen. 
* Growth expressed as a percentage of growth in 5% FCS
86
3.3.8.3 DEAE Dextran
DEAE dextran is a basic polymer, of approximately 500,000 molecular weight. 
Initial precoating at 1 mg/ml and 100 pg/ml showed some stimulation at the 
latter concentration, but total inhibition of growth at the higher 
concentration (Table 3.36). Further work was carried out at 100 pg/ml, 
using an FCS background level of 0.5% FCS. Results from precoating at 
room temperature or 37°C (Table 3.36) show high levels of growth in both 
instances - the colony area was greater than that in 5% FCS while the 
colony number was also significantly increased.
Further investigations with DEAE dextran precoating were carried out, with 
the level of FCS being reduced to 0.25% FCS and also removed completely. 
Table 3.37 shows that at an FCS level of 0.25% FCS, precoating at room 
temperature resulted in over a three-fold increase in CFE and a ten-fold 
increase in colony area. Precoating at 37°C, while less dramatic also 
led to significant increases in cell growth, as measured by both of these 
parameters.
Growth in TIES - supplemented medium in the absence of FCS was also achieved 
when dishes were precoated with DEAE dextran, for 4 or 16 hours. Although 
growth levels were low compared to 5% FCS, no growth at all is recorded in 
uncoated dishes in the absence of FCS.
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TABLE 3.36 Growth in dishes precoated with DEAE dextran 
for 16 hours
%
Colony
No.*
%
Colony
Area*
Colony No.
Total 
Colony Area 
(sq. mm)
Controls - no precoating
5% FCS 100 100 755 -  74 119.8 - 12.1
0.5% FCS 23 9 176 - 18 11.0 - 2.7
0.5% + TIES 53 25 398 - 74 30.0 - 9.7
Precoating (100pg/ml)
37°C 100 184 760 - 19+ 2 2 0 .0 - 2 1.6+
Room temperature 78 103 588 - 54+ 124.0 - 17.5+
Precoating (lmg/ml)
37°C 0 0 0 0
Room temperature 0 0 0 0
+ Growth stimulation significant at p<0.05. Cells growing in 0.5% FCS + TIES. 
* Growth expressed as a percentage of growth in 5% FCS.
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TABLE 3.37 Growth of RPMI 2650 in dishes precoated with DEAE dextran
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq. mm)
Controls - No precoating
5% FCS 100 100 1325 - 114 273.5 - 28.9
0.25% FCS 7 1 94 - 23 2 . 8  - 0 . 8
0.25% FCS + TIES 22 6 289 + 109 16.1 - 7.0
- FCS + TIES 0 0 0 0
Cells in 0.25% FCS + TIES:
*
37°C, 16 hours 44 23 580 - 105 63.2 - 20.6
37°C, 4 hours 33 15 443 - 50 41.9 - 5.0
Room Temp. 16 hours 67 64 891 - 82 173.9 - 40.5
Room Temp. 4 hour s 69 72 914 - 93 196.9 - 35.5
Cells in - FCS + TIES:
37°C, 16 hours 6 ■ 2 83 - 10 4.9 - 1.0
37°C, 4 hours 23 4 305 - 48 16.1 - 3.0
Room Temp. 16 hours 11 2 . 2 146 -  29 10.7 - 2.4
Room Temp. 4 hours 12 1.4 161 - 18 11.7 -  1.4
Precoating conditions varied - details in table. After precoating, cells 
were set up either in medium + 0.25% FCS + TIES jor in medium uusupplemented 
with TIES only (no FCS).
* Growth expressed as a percentage of growth in 5% FCS.
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3.3.8 .4 Dextran Sulphate, Gelatin and other polymers
Dishes were precoated with dextran sulphate at concentrations of 1 mg/ml 
and 100 pg/ml. At the former concentration, almost total inhibition of 
growth occurs after precoating at room temperature and 37°C. At the 
lower concentration, some attachment occurs but growth is considerably 
less than in controls (Table 3.38). These results are from cells set up 
in 0.25% FCS + TIES. Dishes precoated with 100 ug/ml dextran sulphate and 
in which cells were set up in - FCS + TIES showed absolutely no growth 
(data not presented).
Gelatin is another factor used widely for precoating dishes. At a 
concentration of 1 mg/ml, there was no significant inhibition or stimulation 
of growth when precoating was carried out at 4°C, room temperature or 37°C 
for 4 or 16 hours (Table 3.39). These results are confirmed by those 
presented in Table 3.40, where gelatin precoating is for 16 hours at room 
temperature and 37°C only.
Table 3.40 shows the effect of precoating dishes with a variety of basic 
polymers at room temperature and 37°C for 16 hours. Methyl cellulose 
precoating makes no major impact on cell growth. Polyvinylpyrolidone (PVP) 
and bovine serum albumin (BSA) have an inhibitory effect on cell growth* 
precoating at 37°C results in no growth at all with either compound, while 
precoating at room temperature supports a low level of growth, but both 
colony number and colony area are significantly smaller than the controls.
Poly-D-lysine is one of the most effective precoating polymers in widespread 
use. In the absence of poly-D-lysine, precoating with poly-L-lysine and 
L-lysine were carried out. Both result in marked reduction in growth 
(Tables 3.40 and 3.41). At two different concentrations, (20pg/ml and 
200pg/ml) and both at room temperature and 37°C, poly-L-lysine precoating 
leads to a significant decrease in both colony number and colony area. 
L-lysine similarily inhibits growth at room temperature and 37°C.
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3.3.8 .5 Fibronectin precoating
Fibronectin precoating has proved to be very successful in promoting
growth of some cell types in the absence of se,rum. In the present work 
Fibronectin (Fn) was tested at a concentration of 10yt|g/ml. Precoating 
with Fn alone and with a Fn:Collagen (100>Jg/ml) (1:1) mixture were both 
examined for their contribution to growth of RPMI 2650 in the presence of 
both 0.25% FCS + TIES and 0.5% FCS + TIES. Table 3.42 shows that Fn on its 
own has no significant effect but a combination of Fn and Collagen does 
enhance growth at both FCS levels. It is not clear what contribution Fn 
makes here, as Collagen, at twice the concentration present here, has been 
shown to increase both the CFE and colony area considerably (see Sec.
3.3.8.I.). Fn was also tested as a medium supplement (see Sec.3.3.7.8 .)..
3.3.8 . 6  FCS precoating
Precoating of dishes with FCS is a common treatment employed to allow cells 
to grow in a serum-free environment while still supplying some of the 
attachment factors supplied by the FCS. It is thought that some of these 
attachment factors bind to the dishes and ‘are not removed through the PBS 
washes. Thus, binding sites are available to the cells when they are 
added to the dishes in serum-free media.
Dishes were precoated with undiluted FCS for 4 hours at 37°C and room 
temperature. After washing the precoated dishes, cells were added in medium 
supplemented with 0.25% FCS + TIES. Precoated controls were fed with 
unsupplemented medium (-FCS-TIES) to investigate the growth stimulatory 
effects of any residual FCS in the dishes.
Table 3.43 shows that precoating with FCS greatly enhances growth, both in
o ,terms of CFE and colony area, at 37 C and room temperature. Dishes were
also precoated with FCS and subsequently fed with unsupplemented medium
(-FCS-TIES). This was to investigate the effect of any residual FCS which
remained in the dishes after the normal washing procedure had taken place.
In these dishes, relatively high levels of growth were recorded. This suggests
that residual FCS contributes significantly to the growth recorded in dishes
supplemented with 0.25% FCS + TIES. Thus the level of FCS in these dishes is
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undefined and if precoating with FCS is to be used to allow growth in 
serum-free conditions, even a very strict washing regime may not be 
sufficient to remove all residual FCS.
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TABLE 3.38 Precoating with Dextran Sulphate
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (Sq. mm)
Controls - no precoating
5% FCS 100 100 905 -  34 303.0 - 24.9
0.25% FCS 17 2 154 - 18 5.3 - 0.2
0.25% FCS + TIES 41 6 371 - 18 18.2 - 0.3
- FCS + TIES 0 0 0 0
- FCS - TIES 0 0 0 0
Precoating, lmg/ml
Room Temp 4 2.5 36 - 11 7.76 - 2.4
37°C 0 0 0 0
Controls - no precoating
5% FCS 100 100 1325 -  114 273.5 - 28.9
0.25% FCS 7 1 94 - 23 2 . 8 - 0 . 8
0.25% FCS + TIES 22 6 289 - 109 16.1 - 7.0
Precoating 100 pg/ml
37°C, 16 hours 4 0 . 6 56 -  15 1.7 - 0.7
Room Temp. 16 hours 19 3 256 - 88 9.0 - 1.5
37°C, 4 hours 0 0 0 0
Room Temp. 4 hours 9 2.5 123 - 46 6 . 8  - 3.2
Cells are growing in 0.25% FCS + TIES.
*Growth expressed as a percentage of growth in 5% FCS
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TABLE 3.39 Growth of RPMI 2650 in dishes precoated with gelatin.
% % Total
Colony Colony Colony No. Colony Area
No.* Area * (sq. mm)
Controls - no precoating
+ 4*5% FCS 100 100 922 - 50 288.0 - 24.7
0.5% FCS 82 54 754 - 12 156.0 - 7.9
0.5% FCS + TIES 92 84 850 - 33 242.0 - 22.6
Precoating conditions
16 hours Room Temp. 83 93 766 - 56 268.0 - 26.0
16 hours 37°C 97 63 893 - 109 181.0 - 24.0
16 hours 4°C 81 36 745 - 39 102.3 - 12.2
4 hours Room Temp. 77 106 710 - 39 304.4 - 31.7
4 hours 37°C 97 60 898 - 21 172.0 - 11.0
4 hours 4°C 98 49 899 -  76 140.4 - 23.1
Cells are growing in 0.5% FCS + TIES in dishes precoated with gelatin. 
*Growth expressed as a percentage of growth in 5% FCS.
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TABLE 3.40 Precoating with a range of polymers
% % Total
Colony Colony Colony No. Colony Area
No.* Area * (sq. mm)
Controls - no precoating
5% FCS 100 100 755 -  74 119.8 - 12.1
0.5% FCS 23 9 176 - 18 11.0 - 2.7
0.5% FCS + TIES 53 25 398 - 74 30.0 - 9.71
Precoating at Room Temp.
BSA lmg/ml 14 5 109 -  6 6 . 1 - 0 . 6
Methyl Cellulose lmg/ml 47 25 357 - 41 30.8 - 2.1
Gelatin lmg/ml 17 90 134 -  34 11.5 - 0.5
PVP lmg/ml 10 4 72 - 8 . 6 4.7 - 1.1
L-Lysine lmg/ml 38 16 285 -  86 18.3 - 1.9
Precoating at 37°C
BSA lmg/ml 0 0 0 0
Methyl Cellulose 1 mg/ml 36 11 276 -  1 13.3 - 0.4
Gelatin lmg/ml 44 20 330 - 77 24.0 -  5.9
PVP lmg/ml 0 0 0 0
L-Lysine lmg/ml 0 0 0 0
PVP = Polyvinylpyrrolidone
Cells are growing in 0.5% FCS + TIES in all precoated dishes 
* Growth expressed as a percentage of growth in 5% FCS
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TABLE 3.41 Growth of RPMI in poly-L-lysine-coated dishes
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq. mm)
Controls - no precoating
5% FCS 100 100 799 - 10 172.0 -  4.6
0.5% FCS 81 27 653 -  10 45.7 - 1.7
0.5% FCS + TIES 89 37 712 - 54 63.2 - 7.9
Precoating
16 hours Room Temp.
20 jjg/ml 11 3 88 - 21 4.3 - 0.9
100 Mg/ml 39 7 310 - 48 11.65 - 4
16 hours 37°C
20 jjg/ml 27 7 218 - 29 1 2 .0 -  2 .2
100 jjg/ml 28 8 226 -  40 13.6 - 3.3
Cells growing in 0.5% FCS + TIES in dishes precoated with poly-L-lysine 
*Growth expressed as a percentage of growth in 5% FCS
TABLE 3.42 Precoating with Fibronectin
% % Total
Colony Colony Colony No. Colony Area
No* Area* (sq. mm)
5% FCS 100 100 736 -  13 184.3 - 7.7
0.5% FCS 33 7 242 - 3.5 12.3 - 0.8
0.25% FCS 35 12 261 - 39 22.3 - 5.2
0.5% + TIES 72 23 529 -  52 42.9 -  5.0
0.25% + TIES 54 17 398 - 16 32.2 - 3.2
Fn -> 0.25% + TIES 58 15 426 -  57 28.2 -  6.5
Fn -> 0.5% + TIES 69 27 509 - 52 48.9 -  5.8
Fn: Coll ->0.25% + TIES 65 23 476 -  28 41.65 - 1.7
Fn: Coll ->0.5% + TIES 82 28 607 -  16 50.7 - 4.3
*Growth expressed as a percentage of growth in 5% FCS.
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TABLE 3.43 Growth of RPMI 2650 in dishes precoated with FCS
% % Total
Colony Colony Colony No, Colony Area
No.* Area* (sq. mm)
5% FCS 100 100 905 - 34 303 - 24.9
0.25% FCS 1 2 153 - 22 5.1 - 0.32
0.25% + TIES 41 6 373 -  20 19.5 -  2.4
- FCS + TIES 0 0 0 0
- FCS - TIES 0 0 0 0
Precoating with FCS, 37°C
0.25% FCS + TIES 96 42 868 - 90 127.7 - 11.3
- FCS - TIES 39 10 353 - 25 29.9 - 4.5
Precoating with FCS,
Room Temp.
0.25% FCS + TIES 104 45 942 - 89 135.0 - 31.9
- FCS - TIES 47 9 425 i 42 27.9 - 3.3
*Growth expressed as a percentage of growth in 5% FCS
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3.3.9. Testing stimulation by TIES over a range of cell concentrations
4Cells are normally set up at a concentration of 1x10 cells/35mm dish and 
clonal growth is measured after 7 days. Investigations into growth at 
lower cell concentrations show that stimulation due to TIES is visible at 
any concentration at which cells form colonies. These assays were counted
4after 12 days. Over a range of concentrations from 1x10 cells/dish to
2 .5x10 cells/dish, greater growth is recorded in medium supplemented with
0.5% FCS + TIES than with 0.5% FCS alone (Table 3.44).
3 . 2At 1x10 cells/dish and 5x10 cells/dish almost equal levels of growth are
observed in 0.5% FCS + TIES, where colony number is approx. 60% of the 5%
FCS control and colony area is slightly over one-third that in the 5% FCS
control. At higher cell concentrations, the relative growth in 0.5% FCS +
TIES is greater than at the lower concentrations, but this is due to the
fact that, after 12 days the colonies have grown so big that a monolayer
4has almost formed. Thus, growth at 1x10 cells/dish is being limited by the
2dish size, in 5% FCS and 0.5% FCS + TIES. At 1x10 cells/dish no colonies 
formed at all.
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TABLE 3.44 Varying concentration of cells
% % Total
Colony Colony Colony No. Colony Area
No .* Area* (sq. mm)
1x10^ cells/dish
5% FCS 100 100 983 - 59 234.0 - 53
0.5% FCS 93 28 919 - 10 65.0 - 2.7
0.5% FCS + TIES 104 97 1627 - 38.7 227.2 - 32
5x10^ cells/dish
5% FCS 100 100 755 - 31 277.4 - 7.3
0.5% FCS 36 9 275 - 38 24.7 -  2.5
0.5% FCS + TIES 90 64 678 - 14 178.5 -  1.5
1x10  ^ cells/dish
5% FCS 100 100 324 -  17 99.6 - 8.5
0.5% FCS 9 2 3 0 - 6 2.0 - 0.5
0.5% FCS + TIES 62 35 200 - 10 35.3 - 5.5
5x10^ cells/dish
5% FCS 100 100 182 -  18 46.0 - 8.5
0.5% FCS 8 2.5 1 5 - 4 1 . 2  - .1
0.5% FCS + TIES 60 39 109 - 15 17.8 - 2.1
1x1 0^ cells/dish
5% FCS )
0.5% FCS ) No countable colonies
0.5% FCS + TIES )
This assay was left for 12 days (instead of 7) to allow colonies grow large 
enough to be counted.
*Growth expressed as a percentage of 5% FCS
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3.3.10 Growth of RPMI 2650 in reduced serum in flasks
2Many attempts were made to grow RPMI 2650 m  25 cm tissue culture flasks
in medium with a low FCS level, supplemented with TIES. The surface area 
2(25 cm ) is approximately three times that in the 35mm dishes. Clonal
4growth occurred consistently at 1x10 cells/dish in the 35 mm dishes, hence
. . . 4 2cells were set up initially at 3x10 cells/25 cm flask. But growth in 5%
FCS was very poor at this concentration.
Therefore, growth at higher concentrations was examined. Cells were set up
at 5x10^ cells/flask in medium supplemented with 0.5% FCS + TIES. No growth
at all was recorded on two occasions at this concentration in either the
0.5% FCS control or the medium supplemented with 0.5% FCS + TIES. When the£
cell concentration was increased to 1x10 cells/flask, growth in 0.5% FCS
alone was very extensive - a complete monolayer formed and on trypsinization,
relatively little change in cell number was visible in 0.5% FCS + TIES 
(see Table 3.45), part (3) ).
£
With 0.25% FCS concentration and cells seeded at 1x10 cells/flask, no
growth occurred in 0.25% FCS or 0.25% FCS + TIES. The 5% FCS control grew
normally. On any occasion when no growth occurred in reduced serum
conditions, the medium appeared very basic. Hence, it was hypothesized
2that there might be a pH/buffering problem in the 25 cm flasks. Ham's F12 
does not contain any Hepes buffer, so the buffering capacity of the DME:F12 
mixture is less than that of MEM, the basal medium in which RPMI 2650 cells 
are usually grown.
£
Cells were then set up at 1x10 cells/ml, with 0.25% FCS background, in 
225 cm flasks and the flasks were partially sealed and placed in a 5% CO2 
atmosphere. This allowed gaseous exchange with the external (5% CO2) 
atmosphere. After 6 days colonies were stained and counted (Table 3.45, 
part (3) ). A significant difference (p<0.05) in growth was observed 
between the 0.25% FCS controls and 0.25% FCS + TIES. There was a doubling 
in colony number but a four-fold increase in total colony area when TIES 
was added to the medium. The medium changed to a slightly acidic colour, 
which is to be expected where growth is occurring.
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This experiment was repeated, at a concentration of 5x10^ cells/flask, with 
a 0.25% FCS level. Some flasks were sealed totally while replicates were 
partially sealed. Growth occurred in the 5% FCS controls in sealed and 
unsealed flasks in a 5% CO2 incubator. No growth occurred in any flasks 
in medium supplemented with 0.25% FCS. In partially-sealed flasks 
supplemented with 0.25% FCS + TIES many colonies formed (Table 3.45, part 
(6) ), but no growth at all occurred in sealed flasks supplemented with 
0.25% FCS + TIES.
Thus, the need for interaction with the external CO2 - rich atmosphere for
growth of RPMI 2650 cells in flasks with 0.25% FCS + TIES was confirmed. It
appears that the buffering capacity of the DME:F12 medium is insufficient to
support growth of the cells in reduced serum concentrations, even at high 
2density, m  25 cm flasks which are totally sealed. Further work is required 
at low cell densities to investigate growth patterns in flasks.
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TABLE 3.45 Growth of RPMI 2650 2cells in reduced serum m  25cm flasks
(1) Initial cell concentration:
43x10 cells/flask - sealed flasks
5% FCS Very few colonies after 7 days - 
none greater than 8 cells
0.5% FCS No growth
0.5% FCS + TIES No growth
(2) Initial cell concentration: 5x10^ cells/flask - sealed flasks
5% FCS 2.4x10^ cells/flask
0.5% FCS No growth
0.5% FCS + TIES No growth
(3) Initial cell concentration: 1x 1 0  ^ cells/flask - sealed flasks
5% FCS 3.4x10^ cells/flask
0.5% FCS 1.5x10^ cells/flask
0.5 FCS + TIES 1.65x10^ cells/flask
(4) Initial cell concentration:
£
1x10 cells/flask - sealed flasks
5% FCS 3.0x10^ cells/flask
0.25% FCS No growth
0.25% FCS + TIES No growth
(5) Initial cell concentration:
g
1x10 cells/flask - partially-sealed flasks 
Colony No. Total Colony Area
5% FCS 1749 - 394 408.9 - 107
0.25% FCS 889 - 258 46.2 - 11.3
0.25% FCS + TIES 1895 - 105 156.5 - 29.5
(6) Initial cell concentration: 5xl05 cells/flask
Sealed flasks Colony No. Total Colonv Area
5% FCS 1045 - 94 267.0 - 52.1
0.25% FCS 0 0
0.25% FCS + TIES 
Partially-sealed flasks
0 0
5% FCS 1175 - 54 212.8 - 8.7
0.25% FCS 0 0
0.25% FCS + TIES 2 3 8 - 2 0  24.8 - 1.8
Cells were trypsinized or colonies stained after 6-7 days
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3.3.11 Optimization of media components for growth of RPMI 2650 
in reduced serum conditions
Two final experiments were set up to find the optimum conditions for growth 
of RPMI 2650 cells in reduced serum concentration. Apart from transferrin, 
insulin, EGF and selenium, two other media supplements consistently 
stimulated growth of RPMI 2650 - i.e. MEM non-essential amino acids (NEAA) 
and ascorbic acid (see Tables 3.24 and 3.28, Sec. 3.3.7.). These components 
were tested as individual medium supplements in the presence of 0.25% FCS 
and in conjunction with TIES and each other. DEAE dextran had proven to be 
a very suitable precoating material, hence it was included in the final 
optimization experiment and the action of NEAA and ascorbic acid examined in 
conjunction with DEAE dextran precoating.
Tables 3.46 and 3.47 show the growth recorded under these conditions. NEAA 
and ascorbic acid (AA) both stimulated growth when added to 0.25% FCS or to 
0.25% FCS + TIES. Ascorbic acid worked equally well at both concentrations 
tested (1 pg/ml and 10 pg/ml) , with no significant difference in growth at 
the two concentrations. A significant increase (p<0.05) was observed in 
both the colony number and total colony area when it was added to 0.25% FCS 
and to 0.25% FCS + TIES. NEAA stimulated to a greater extent when added to 
0.25% FCS alone, and showed almost equal stimulatory ability to ascorbic 
acid when added to 0.25% FCS + TIES.
When both NEAA and ascorbic acid (10 pg/ml) were added simultaneously to 
0.25% + TIES, a significant increase in both colony number and colony area 
were recorded, but the stimulation is not additive. When both are added to 
0.5% FCS + TIES, an increase in cell growth is also recorded.
Precoating dishes with DEAE dextran again yielded very good growth of RPMI 
2650 (see also Section 3.3.8.). Growth in the absence of any FCS background 
was very significant, in medium supplemented with TIES NEAA AA. The colony 
number is 74% of the 5% FCS control, while the total colony area is 66%.
The growth observed here is considerably greater than that observed previously 
in the absence of FCS with DEAE dextran precoating (Table 3.37, Section 3.3.8.). 
In this instance NEAA and ascorbic acid are additional medium supplements
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(only TIES were present in previous work). Thus, it seems that NEAA and 
ascorbic acid play a very important role in the absence of FCS.
In the presence of 0.25% FCS and 0.5% FCS, DEAE dextran precoating enhances 
growth significantly. In medium supplemented with 0.25% FCS + TIES, a 
doubling in colony number occurs but a very large increase in total colony 
area occurs. The total colony area recorded is a twenty-fold increase over 
the uncoated control. It is also significantly greater than the total 
colony area in 5% FCS, but microscopic observations show considerable piling 
up of cells in colonies in 5% FCS compared to the cells in colonies in DEAE- 
dextran precoated dishes where cells within a colony are spread out to a 
greater extent over the surface.
Somewhat conflicting results were recorded in medium supplemented with NEAA 
and ascorbic acid. In 0.5% FCS, the addition of these two components to TIES 
causes an increase in colony number and total colony area and DEAE-dextran 
precoated dishes show a very significant increase (p<0 .0 1 ) in total colony 
area over the uncoated control.
In uncoated dishes, growth in 0.25% FCS + TIES NEAA AA was less than that in 
0.25% FCS + TIES (Table 3.47). This must be due to experimental error as there is 
sufficient other data (growth with a 0.5% FCS background in this experiment, 
growth with both 0.5% FCS and 0.25% FCS backgrounds in Table 3.46 and 
results presented in Table 3.28) which shows NEAA and ascorbic acid stimulating 
RPMI 2650 growth.
The results obtained in precoated dishes in the presence of NEAA and 
ascorbic acid also exhibit an unusual characteristic. Under both precoating 
conditions, the addition of NEAA and ascorbic acid to 0.25% FCS + TIES causes 
an increase in the colony number, but a decrease in the colony area, compared 
to precoated dishes with medium supplemented with 0.25% FCS + TIES. This 
decrease in colony area could be due to a decrease in the number of cells per 
colony or a decrease in cell spreading.
When DEAE dextran was added as a medium component, at a concentration of 
1 jjg/ml, a significant increase in both colony number and total colony area 
was recorded. Growth recorded was comparable to that in DEAE dextran 
precoated dishes.
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TABLE 3.46 Optimization of RPMI 2650 medium with reduced FCS 
concentration
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq. mm)
5% FCS 100 100 685 - 72 136.1 - 12.2
0.5% FCS 21 12 141 - 43 16.6 - 6.5
0.5% FCS + TIES 89 35 611 -  36 47.1 - 4.4
0.5% FCS + TIES NEAA AA 93 38 640 - 10 51.3 - 4.1
0.25% FCS 18 3 125 - 64 4.5 - 2.4
0.25% FCS + NEAA 45 11 309 - 4 15.5 - 0.1
0.25% FCS + AA (1 pg/ml) 28 5 192 - 3 7.1 - 0.3
0.25% FCS + AA (10 pg/ml) 31 7 210 - 5 9.2 - 0.4
0.25% FCS + TES 39 10 270 - 41 13.7 - 3.7
0.25% FCS + TIES 59 19 406 - 5 26.5 - 0 . 8
0.25% FCS + TIES NEAA 72 26 496 -  23 36.0 - 3.0
0.25% FCS + TIES AA (1pg/ml) 71 27 488 - 62 37.0 - 3.0
0.25% FCS + TIES AA (lOpg/hl) 72 28 493 - 25 38.7 - 4.3
0.25% FCS + TIES NEAA AA
(1 0pg/ml) 68 
1
26 469 - 21 35.9 -  3.6
*Growth expressed as a percentage of growth in 5% FCS.
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TABLE 3.47 Optimization of growth conditions 
in reduced serum concentrations -
for growth of RPMI 2650 
DEAE dextran precoating
Uncoated Controls
%
Colony
No.*
%
Colony
Area*
Colony No,
Total 
Colony Area 
(sq. mm)
5% FCS
0.5% FCS
0.5% FCS + TIES
0.5% FCS + TIES NEAA AA
0.25% FCS
0.25% FCS + TIES
0.25% FCS + TIES NEAA AA
0.25% FCS + TIES NEAA AA
+ DEAE dextran (ljjg/ml)
- FCS
- FCS + TIES
DEAE DEXTRAN PRECOATING
37°C - 4 hrs
- FCS + TIES NEAA AA 
0.25% FCS + TIES
0.25% FCS + TIES NEAA AA 
0.5% FCS + TIES NEAA AA
Room Temp. - 4 hrs
- FCS + TIES NEAA AA 
0.25% FCS + TIES
0.25% FCS + TIES NEAA AA 
0.5% FCS + TIES NEAA AA
100
44
87
92
11
A l
18
91
0
0
74
90
100
94
66
95
102
90
100
23
53
57
4
17
6
151
0
0
66
311
139
270
43
241
190
270
639 - 59 
279 - 43 
553 - 70 
588 -  28
68  -  20
262 - 29 
116 - 20
580 - 4
0
0
474 - 36 
577 - 66 
639 - 90 
598 -  31
421 - 30 
605 - 48 
653 - 27 
575 - 38
83.6 - 13.5
19.4 - 3.6
44.3 - 10.4
47.6 - 4.0
3.6 - 1.2
14.6 - 2.3
4.6 - 1.6
126.5 - 4.9
0
0
55.3 - 3.5
260.0 - 21.6
116.4 - 29.9
226.0 - 4.0
35.8 - 10.4
201.7 - 19
158.6 - 29.0
226.2 - 18.6
Precoating with DEAE dextran (100 j j g/ml) - details given in key.
Ascorbic acid (AA) concentration - 10 jug/ml. DEAE dextran (1 j x g / m l ) added 
as a medium component (no precoating) in one instance.
*Growth expressed as a percentage of growth in 5% FCS.
3.3.12 Growth of cell lines in TIES-suppleméritéd medium
Experiments were set up to detect the effect of TIES, with a low FCS 
concentration on a number of different cell lines.
A431 cells
A431, a human epidermoid carcinoma cell line, was grown at two clonal 
concentrations in DME:F12 + TIES with both 0.25% FCS and 0.5% FCS. Growth 
occurred in the reduced FCS concentrations but there was no growth 
stimulation due to the presence of TIES. At the higher cell concentration, 
No differences were evident (Table 3.48).
A549 Cells
A549 cells, a human lung carcinoma cell line, was set up at two concentrations,
4 41x10 cells/dish and 5 x 10 cells/dish. This cell line forms very diffuse
colonies and using the image analyser, while the measurement of total colony
area was very accurate, that of colony number was not an accurate reflection
of growth. But interpretation of the values for total colony area gave a
very clear picture (see Table 3.49). Some growth occurs in reduced FCS
concentrations, but there is a total inhibition of growth in the presence of
4TIES. This was found at both concentrations. The results for 5x10 cells/ 
dish are not presented as a complete monolayer had formed, even in 0.25% FCS 
and hence, counting on the image analyser yielded no real results. But, in 
spite of a very high level of growth in 0.25% FCS, no growth at all was 
recorded in the presence of TIES.
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HEP-2 Cells
HEP-2 cells, a human epidermoid cell line, was set up at a clonal 
concentration of 5xl0^cells/dish. Growth occurred in DME:F12 + 0.25% FCS, 
but when TIES was added to this, growth inhibition occurred. Some colonies 
did form but there was a significant decrease in both colony number and 
colony area. (Table 3.50).
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TABLE 3.48 Growth of A431 cells in TIES
% % Total
Colony Colony Colony No. Colony Area
No.* Area* (sq. mm)
2x10^ cells/dish
5% FCS 100 100 428 - 6.2 110.6 - 17.3
0.25% FCS 48 24 204 - 30 26.6 - 5.4
0.25% FCS + TIES 57 19 245 - 37 21.1 - 6.9
0.5% FCS 64 38 275 - 23 41.7 - 0.7
0.5% FCS + TIES 81 34 345 - 37 38.1 - 6.9
5x10^ cells/dish
5% FCS 100 100 615 - 32 276.8 - 41.0
0.25% FCS 93 34 570 - 83 94.2 - 16.5
0.25% FCS + TIES 103 32 635 - 10 87.3 - 10.0
0.5% FCS 98 65 602 - 13 179.3 - 18.4
0.5% FCS + TIES 102 39 630 - 39 108.9 - 7.9
*Growth expressed as a percentage of growth in 5% FCS
TABLE 3.49 Growth of A549 cells in TIES
% % Total
Colony Colony Colony No. Colony Area
No.* Area* ( s q . mm)
1x10^ cells/dish
5% FCS - 100 - 140.0 - 10.0
0.25% FCS - 7 - 10.5 - 1.2
0.25% FCS + TIES - 0 - 0 1 
+
o
0.5% FCS - 65 - 90.4 - 9.4
0.5% FCS + TIES - 0 — o 
+
1o
*Growth expressed as a percentage of growth in 5% FCS
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TABLE 3.50 Growth of HEP-2 cells in TIES
% % Total
Colony Colony Colony No. Colony Area
No. * Area* (sq. mm)
3
5 x 10 cells/dish
5% FCS 100 100 63 - 0.5 5.52 - 0.3
0.25% FCS 43 29 27 - 7 1.6 -  0.5
0.25% FCS + TIES 14 6 9 - 4 0.32 - 0.2
5% FCS 100 100 8 8 - 7 19.7 - 2.0
0.25% FCS 52 25 4 6 - 5 5.0 - 1.4
0.25% FCS + TIES 32 17 28 -  4 3.4 - 1.2
*Growth expressed as a percentage of growth in 5% FCS
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3.3.13 Growth stimulatory activity of milk
There have been some reports in the literature on the growth-promoting 
effects of bovine milk on cells in culture (see Section 1.5). Investigations 
were carried out into growth of a number of cell lines with milk- 
supplemented medium.
3.3.13.1. 3T3
The majority of the analysis of the growth stimulating properties of milk 
was carried out using mouse 3T3 cells as an indicator cell line. Bovine 
milk was prepared by ultrafiltration (see Section 2.10) and sterilised as 
described (see Sec. 2.4). It was tested as a medium supplement (10% v/v 
concentration) in the presence of a low FCS background level and on its own.
Initial work was carried out at monolayer concentrations of 3T3 cells. 3T3
2cells grow normally m  25cm flasks, m  DME + 5% FCS, at concentrations of 
5xl05 cells/flask to 1x10^ cells/flask. Numerous attempts were made to grow 
3T3 cells in this concentration range in 0.25% FCS + 10% milk and in 0.5%
FCS + 10% milk.
Table 3.51 gives a sample of the results obtained by trypsinizing flasks 
after 5-9 days. At a 0.5% FCS background level, a significant increase in 
growth due to milk was observed on occasions, but not consistently. At 
0.25% FCS, stimulation due to milk was recorded on a more regular basis, but 
the extent of stimulation varied greatly. In experiment numbers 1, 4 and 6 
there is approximately a four-fold, a ten-fold and a 19-fold increase in the 
presence of 10% milk + 0.25% FCS over the 0.25% FCS control. Growth in 
medium supplemented with milk only (no FCS) also varies considerably.
These results do suggest that some stimulatory factors are present in milk, 
but the exact extent of their action is not clear. Further work was carried 
out at clonal concentrations of 3T3. These assays were set up in 60mm dishes 
in 5% CO^, at cell concentrations of 50, 100 and 250 cells/dish. 
Investigations were made into choosing a suitable system which would
I l l
consistently yield growth. The initial results looked promising (Table 3.52), 
with stimulation showing consistently due to the addition of milk at a FCS 
background level of 1% and 2Z. Many different batches of milk were tested but 
there was considerable variation within batches and some variation between
batches.
These results led to attempts to identify the stimulating factor. Ultra­
filtration on an Amicon ultrafiltration cell (see Sec. 2.10) yielded filtrates 
and retertates which were tested for growth stimulatory ability. But no 
consistent results were obtained. In some cases, non ultra filtered milk 
(from a batch which had‘been ultrafiltered and had previously shown growth
stimulatory ability), failed to stimulate growth and in other cases, there 
were discrepancies between results obtained from the different ultrafiltration 
fractions. Table 3.53 gives the results from a typical experiment.' No growth 
occurs at 250 cells/dish in the 1% FCS + 10% Milk control but growth occurs 
in retentate containing components between 5,000 and 30,000 molecular weight, 
and in the filtrate after filtration through a 5,000 membrane.
Other treatments were carried out on milk to try to identify what, if any, 
growth stimulating factors were present. Dialysis, heat treatment, trypsin 
treatment, pH treatments and variation of storage conditions (details not 
given) all failed to yield a consistent angwer.
Other milk products were tested on 3T3 cells. Baby food, dried powdered milk 
and colostrum were prepared as described (see Sections 3.12 and 3.13) and 
added into assays similar to those described above, at a 10% concentration. 
Baby food and dried milk failed to show any growth stimulatory ability, and 
while colostrum showed some slight stimulation, it could not be repeatedly 
identified.
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TABLE 3. 51 Growth of 3T3 cells in medium supplemented with milk
Exp. No. Medium , 6* Cells/Flask x 10
1 5% FCS 4.67
0.2% FCS 0.78
0.2% FCS + 10% Milk 2.85
- FCS + 10% Milk 1.65
2 5% FCS 3.21
0.5% FCS 1.40
0.5% FCS + 10% Milk 3.87
3 5% FCS 1.93
0.5% FCS. 1.30
0.5% FCS + 10% Milk 1.40
4 5% FCS 1.93
0.5% FCS 1.30
0.5% FCS + 10% Milk 0.90
5 5% FCS 4.50
0.2% FCS .25
0.2% FCS + 10% Milk 2.43
- FCS + 10% Milk 0.90
6 5% FCS 2.90
0.2% FCS 0.15
0.2% FCS + 10% Milk 2.78
- FCS + 10% Milk 2.64
7 5% FCS 1.87
0.2% FCS 0.65
0.2% fCS + 10% Milk 0.70
*Cells were set up at 5xl05 cells/flask and trypsinized after 5-9 days. 
These results are the average of duplicate flasks.
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TABLE 3.52 Growth of 3T3 at clonal 
supplemented medium
concentrations in milk-
Exp. 1 Exp 2 Ex p  3
Col.
No,
Col.
Area
mm^
Col.
No.
Total 
Col. Area 
mm2
Col.
No.
Total
Col. Area 0mm^
50 cells/dish
5% FCS 26-2 15.0-1.4 63-5 58.0-7.1
- FCS 0 0 0 0
0.5% FCS 0 0 0 0
0.5% FCS + 10% Milk 0 0 8-2* 30.0-1.0*
1% FCS 8-0.5 1.8-0.2 10-1 2.5-0.1
1% FCS + 10% Milk 31-2* 13.5-1.4* 70-3* 12.0-1.2*
2% FCS 21-3 18.0-1.8 54-2 35.0-1.1*
2% FCS + 10% Milk 5 2 - 7 * 33.0-4.0* 83-4* 54.0-2.7*
100 cells/dish
5% FCS 41-3 78.4-1.4 39-4.0 85.0-4.0
- FCS 0 0 0 0
0.5% FCS 5-1 1.2*0.1 * 0 0
0.5% FCS + 10% Milk 5-1 0.8-0.2 0 0
1% FCS 7-2 1.9-0.4 0.5-0.1 0.25-0.1
1% FCS + 10% Milk 8-1 1.7-1.3 6-1* 2.30-1.4*
2% FCS 24-4 13.3-1.9 0 .5*0 .5 1.0-0.5
2% FCS + 10% Milk 39-5 20.4-2.0 39-2* 50.5-4,2*
250 cells/dish
5% FCS 44-1 62.0-14.4 92-4 221.0-4.2
-FCS 0 0 0 0
0.5% FCS 0 0 s±i 1.5*.5
0.5% FCS + 10% Milk 0 0 5-1 1.4*.5
1% FCS 1- .5 1.0-0.5 32-0.5 23.0-6
1% FCS + 10% Milk 61-4* 45.5-0.5* 66-4* 38.5-0.5*
2% FCS 41-12 50.1-3.8 68-10 120.0-10.0
2% FCS + 10% Milk 91-10* 100*1.1* 91-7* |131.4- 8.4*
* Indicates stimulation due to addition of milk
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TABLE 3.5 3 Effect of ultrafiltrated milk on growth of 3T3
Colonies/dish 2Total colony area (mm )
250 cells/dish
5% FCS 4 1 - 3 204.0 - 13.7
1% FCS 4 - 1 30.0 - 2.5
- FCS 0 0
1% FCS + 10% Milk 0 0
1Z FCS + Rn 3 - 1 15 - 1.9-L * + +1% FCS + R„ 1 - 1 1.5 - 2.5z + +1% FCS + R3 2 0 - 3 21.4 - 4.0
1% FCS + F1 0 0i + +1% FCS + F_ 5 0 - 2 56.4 - 5.9-Z + +1% FCS + F3 6 - 2 1.3 - 0.5
- FCS + 10% Milk 0 0
Key: Milk was ultrafiltered on both 30,000 and 5,000 membranes.
Retentate from 30,000 
R2 " " 5,000
R " " 5,000 after ultrafiltering filtrate from
30,000 (F1)
F^ Filtrate from 30,000 
F2 " " 5,000
F_ " " 5,000 after ultrafiltering filtrate from
3 30,000 (Fx)
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3.3.13.2 MDCK
Some experiments were set up to investigate growth of MDCK cells in milk- 
supplemented medium. Assays were done both at monolayer-forming concen­
trations and at clonal concentrations in 35mm dishes. No stimulation due 
to the addition of milk was evident at higher concentrations (Table 3.54) 
but, as in 3T3, some stimulation was evident at clonal concentrations - 
but it was not consistently observed. Table 3.54 shows an increase in the 
colony number, at two cell concentrations, with a 0.2% FCS background. But 
not all assays showed growth stimulation due to milk.
3.3.13.3 RPMI 2650
Growth of RPMI 2650 was examined in milk-supplemented medium. Table 3.55 
shows three sets of typical results recorded. In no instance, with 0.5%
FCS or 0.25% FCS backgrounds, is growth stimulation recorded due to the 
addition of 10% milk. Thus on its own, milk does not appear to stimulate 
RPMI 2650 cells.
However, the effect of milk in conjunction with TIES and a low FCS background 
was observed. With a concentration of 0.5% FCS, no increase in colony number 
or colony area is recorded. But with a 0.25% FCS background, growth recorded 
in 0.25% FCS + TIES + 10% milk is greater than that in 0.25% FCS + TIES.
This stimulation was recorded on a number of occasions which lends support to 
the idea that bovine milk does contain some growth stimulatory ability.
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TABLE 3.54 Growth of MDCK in milk-supplemented medium
Initial cell conc: 37.5 x 10 cells/35mm dish
A
Cells/dish x 10^
5% FCS 1 1 . 0  - 0 . 2
- FCS 0.1 - 0.05
0.25% FCS 6.0 - 0.5
0.25% FCS + 10% Milk 6.1 - 0.4
10% Milk 0 0
These dishes were trypsinized and cell counts done on a haemocytometer.
Initial cell conc: 7.5 x 102 1 . 0  x 103
Colonies/dish Colonies/dish
5% FCS 115 - 5 130 - 10
- FCS 0 0
0.2% FCS 1 - 0.5 10 -  5
0.2% FCS + 10% Milk 2 9 - 2 4 5 - 9
- FCS + 10% Milk 3 - 1 0 - 0
These dishes were stained with Leishmann's and counted on the image analyser
117
TABLE 3.5 5 Growth of RP1MI 2650 in milk-supplemented medium
. . .
%
Colony
No.*
%
Colony
Area*
Colony No.
Total 
Colony Area 
(Sq. mm)
(1)
5% FCS 100 100 1079 + 33 332.0 - 16.0
0.5% FCS 91 44 978 + 40 146.9 - 18.5
0.5% FCS + 10% Milk 88 41 950 + 30 136.9 - 25.5
0.5% FCS + TIES 98 50 1061 + 10 164.6 - 28.5
0.5% FCS + TIES + 10% Milk 99 56 1064 + 43 187.2 - 12
0.25% FCS 53 16 571 + 53 53.8 -  18.2
0.25% FCS + 10% Milk 44 14 471 + 84 47.6 -  15.4
0.25% FCS + TIES 71 21 766 + 54 71.3 - 7.2
0.25% FCS + TIES + 10% Milk 88 47 950 + 34 154.9 - 14.1
(2)
5% FCS 100 100 613 + 42 47.4 - 5.5
0.5% FCS 8 5 50 + 10 2.23 - 0.65
0.5% FCS + TIES 48 '32 296 + 41 15.1 - 2.4
0.5% FCS + 10% Milk 9 4 55 + 22 2.0 - 0.5
0.5% FCS + TIES + 10% Milk 44 35 268 + 40 16.7 -  3.2
0.25% FCS 2 0 . 6 14 + 0.5 0.28 - 0 . 0 2
0.25% FCS + TIES 17 10 104 + 70 4.6 -  3.3
0.25% FCS + 10% Milk 0 0 0 0
0.25% FCS + 10% Milk + TIES 31 20 193 + 44 9.5 - 0.4
(3)
5% FCS 100 100 1015 + 64 108.9 -  19.4
0.5% FCS 33 15 336 + 61 16.0 - 5.3
0.5% + TIES 46 21 469 + 37 23.3 - 2.3
0.5% + TIES + 10% Milk 40 19 410 + 38 21.0 - 3.0
*Growth expressed as a percentage of growth in 5% FCS
118
Fig. 3.3. RPMI 2650 cells growing in medium supplemented with 5% FCS.
Subconfluent monolayer. Notice variety in shape and size 
of colonies.
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Fig. 3.4. Monolayer growth of MDCK (canine kidney) cells in medium
supplemented with 5% FCS. Notice epithelial-like appearance 
of cells.
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4.1
Growth of virtually all types of cells in culture requires the presence of 
serum. Despite numerous attempts in many laboratories, efforts to find a 
universal replacement for serum in the culture medium have met with limited 
success. The complex, but undefined, nature of serum appears to supply the 
cells with a wide range of nutritional and growth requirements, all of 
which must be supplied in the absence of serum. In addition, serum has the 
ability to supply the varying requirements for a wide range of cell types.
The advantages of working with a serum-free system have already been
?discussed (see Sec. 1.2); suffice it to say that the attractions of working 
in a precisely-defined and reproducible environment have provided the 
■stimulus to many laboratories to develop serum-free media.
4.2 Foetal Calf Serum Background
RPMI 2650 is an epithelial cell line, isolated originally from a human nasal 
tumour (Moorhead, 1965) and one that is in continuous use in this laboratory. 
Normally grown in Eagles Minimal Essential ‘Medium (MEM), it is dependent on 
the addition of 5% foetal calf serum for continual growth and subculturing.
Steps were taken to develop a serum-free medium in which RPMI 2650 would 
proliferate. The variable nature of FCS was clearly observed throughout this
work. Initially, the variability between FCS batches was very evident
(see Fig. 3.1), but even after choosing a batch which supported good growth 
of RPMI 2650, major variations were observed within this batch also. It was 
necessary to identify a low level of FCS which would allow limited growth of 
the cells (see Sec. 3.3.2.)., It was established,that FCS concentrations 
of 0.5% or 0.25% were both suitable levels to observe growth stimulation 
by hormones or other media supplements. The results presented throughout 
section 3.3. show the great range of growth recorded at these levels of FCS.
Growth in 0.5% FCS varied from 3% to 81% of that recorded in 5% FCS.
4. DISCUSSION
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This emphasises the variable nature of FCS. It strengthens the argument 
for development of serum-free media, where known concentrations of purified 
components are added to the medium. The varying levels of growth in the 
0.5% or 0.25% FCS controls made it difficult on some occasions to interpret 
results confidently. In some cases, e.g. Table 3.39, where gelatin pre­
coating was under observation, growth in the background FCS level was so 
high that it was more difficult to observe stimulation.
4.3 Identification of growth requirements for RPMI 2650 cells
Much emphasis has been placed by some workers on optimization of the basal 
medium in the development of a serum-free medium (Ham, 1984) . Workers who 
follow this line of approach (see Sec. 1.3) generally develop a chemically- 
defined serum-free medium, e.g. Peehl and Ham (1980) developed a medium 
MCDB 151, Which selectively supports the growth of human keratinocytes in 
the absence of FCS, by qualitative and quantitative adjustments to Ham's F12 
basal medium.
While not strictly following this line of approach, some investigations were 
carried out to choose a suitable basal medium for growth of RPMI 2650. Having 
compared a number of commercially available basal media and one medium 
prepared in this laboratory, Special Liquid Medium (SLM)(Margaret Dooley, 
unpublished), a 1:1 mixture of DME:F12 was chosen (see Sec. 3.3.2.).
This basal medium is the most widely used in serum-free media. DME is one of 
the simpler media, having high nutrient concentrations but fewer constituents 
than F12, but it seems to make a vital contribution when used in conjunction 
with the more complex F12. F12joriginally designed for clonal growth of cells, 
contains a larger number of different amino acids and vitamins although the 
nutrient concentrations are, on the whole, low. Thus, the richness of F12 
and the higher concentrations of basal nutrients in DME have been used in a 
1:1 mixture by many workers, e.g. Taub et al. (1979) grew MDCK epithelial cells, 
Barnes and Sato (1979) report the growth of human mammary tumour epithelial 
cells in basal medium and HeLa cells are also grown in a DME:F12 basal medium 
(Hutchings and Sato, 1978). This medium has also been used with a wide
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variety of cell types other than epithelial^ e.g. with cells of 
mesenchymal origin, NIH/3T3 cells (Chiang at al, 1984) and human and rat 
glial-derived cells (Michler-Stuke and Bottenstein, 1984) . DME:F12 has 
also been used to establish primary cultures, e.g. canine renal 
epithelial cells, (Taub et al„ 1984).
Having chosen the optimum basal medium available, various hormones, growth 
factors and nutrients were added to the medium and changes in the growth 
rate of RPMI 2650 recorded.
Two parameters were used to record cell growth^colony number and total colony 
area. An image-analyser was used to count dishes which had been stained with 
Leishmann's stain (see Sec. 2.15).The colony number, which is directly 
related to the colony forming efficiency (CFE), gives an indication of the 
number of cells that have attached and undergone cell divisions to form 
colonies. The total colony area gives information on the extent of cell 
division, i.e. the area of the individual colonies varies considerably, both 
within a dish and between dishes which have had different treatments.
It is necessary to look at both of these parameters when assessing growth. 
Different factors influence cell attachment and cell growth. Hence, when 
looking at changes in growth levels, it is important to look separately at 
changes in the number of cells attaching and at the number of cell divisions 
occurring. Counting colonies with an image analyser also has some limitations, 
e.g. if two colonies are joined together at one point this is interpreted 
as being a single colony. Hence, in situations where growth is extensive and 
many colonies are touching each other, the number of colonies present is 
underestimated. But by looking also at the second parameter, total colony 
area, misinterpretation of data is less likely.
The total colony area in a given dish is given in square millimetres. A 
conversion factor is fed into the computer memory of the image analyser and 
it converts picture points recorded to the required units. The area of 
individual colonies varies enormously, even within one dish. The average 
colony area can readily be obtained from the data presented throughout Section 
3, but to estimate the number of cells per colony, which indicates how many 
cell divisions take place, is much more difficult.
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TABLE 4.1 Relationship between growth parameter measurements
Dish Colony
No.
Total Colony Area 
(mm )
Av. Colony Area 
(mm )
Av. No. of 
Cells/Col
A 753 70.2 0.093 208
B 543 52.8 0.09 238
C 827 6 6 . 0 0.08 150
D 771 53.97 0.07 94
The colony number and total colony area were recorded from randomly chosen 
dishes using the image analyser, and the average colony area calculated 
from these values. The number of cells per colony are counted microscopically 
and the size distributions recorded.
TABLE 4 .2 Size distribution of coloniee*
Dish Average No. of Number of cells per colony
Cells/Colony 16 32. 64 125 256 512
A 208 0 1 4 2 2 1
B 238 0 0 3 3 2 2
C 150 0 1 1 5 3 0
D 94 0 2 4 4 0 0
* Size of colonies expressed in terms of number of cell divisions which 
have occurred. Microscopic counts carried out on a random selection of 
dishes from typical assays.
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It is clear from Tables 4.1 and 4.2 that by calculating the individual
colony areas, the numbers of cell divisions can be fairly closely
2approximated. A colony area of 0.09 mm (approx.) gives colonies that have 
undergone seven to eight cell divisions, in the examples given in this 
table. However, it is difficult to make broad generalizations about the 
number of cells per colony in all dishes by simply looking at colony area.
This is due to the fact that when growth at high levels is occurring, cells 
tend to pile up on top of each other - this piling of cells is especially 
evident in dishes fed with 5% FCS. Therefore, the two parameters used to 
measure growth, while giving a considerable amount of information on 
changes in growth levels, do not give a totally accurate measure of cell 
growth. Accurate haemocytometer counting of such low cell numbers, however, 
would not be feasible and the method employed here allows rapid assessment 
of growth stimulation.
Using this system to analyse growth, some factors were clearly identified 
as making a significant contribution to growth in reduced serum conditions.
Transferrin was the first component thus identified. It quite clearly plays 
a vital role in supporting growth of RPMI 2650 in low serum conditions. It 
caused significant stimulation when added on its own or in combination with 
other components to 0.25% or 0.5% FCS (see Table 3.12, Sec. 3.3.5.).
Transferrin is used in serum-free media of almost every cell type - canine 
kidney epithelial cells (Taub e£ aL, 1979), human breast carcinoma cell 
lines (Calvo et_ ëlL, 1984) , lung cancer cell lines and primary cultures 
(Carney t^_ aL, 1981) and NÎH/3T3 cells (Chiang, 1984).
The relative importance of transferrin varies in different serum-free media, 
depending on the cell type. Omission of transferrin from a serum-free 
medium (with four other factors) used to grow MCF-7 cells (mammary tumour 
cells) reduces growth of these cells by 20% (Barnes and Sato, 1979), whereas 
omission of transferrin in the serum-free growth of MDCK cells results in a 
dramatic reduction to only 10% of the original growth level (Taub et_ a1* 1979) .
Transferrin is generally used at 5 jjg/ml, which was the concentration chosen 
for use here, but in some cases other levels are used. 25 pg/ml is the
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optimum concentration used for growth of MCF-7 cells, yet growth survives 
at 80% of the original level when transferrin is removed. Transferrin is 
used at a concentration of 10 pg/ml for growth of NCI-H23, a small cell 
lung carcinoma cell line, where it is essential for cell replication - 
cell number is markedly reduced (by 95%) when transferrin is removed 
(Brower et_ al., 1986). Thus there is no correlation between the concentration 
of transferrin and its contribution to.growth relative to other components 
in a serum-free medium.
The results presented here suggest that transferrin is the most important 
factor in this medium. Cell growth occurs in its absence but it is 
significantly reduced (see Table 3.13, Sec. 3.3.5.). Over a concentration 
range of 1 - 1 0 pg/ml, very little change in growth stimulation was observed 
(see Table 3.18, Sec. 3.3.6.)^ Thus it is possible that it is present in 
excess and possibly a lower concentration might be sufficient. Barnes and 
Sato (1979) report that there is approximately 250 pg/ml of transferrin 
present in medium supplemented with 10% FCS* Thus the levels used in serum- 
free media are considerably less than this.
In some cases where transferrin was used routinely at 1-10 Mg/ml 
increasing its concentration led to increased growth stimulation. Simms e^ al., 
(1980) developed a serum-free medium for growth of NC1-H69 cells using 
RPMI ^640 basal medium. Hence, transferrin at 5 pg/ml was used routinely in 
conjunction with four other factors and deletion of it from the medium resulted 
in immediate and dramatic differences in growth. When the concentration of 
transferrin was increased to 100 jjg/ml there was a significant increase in 
cell growth. This high concentration was -used for further work on this cell 
line, but when a different basal medium, F12 was used transferrin at 100jjg/ml 
was inhibitory compared to transferrin at 5 jjg/ml. Medium F12 contains iron, 
whereas RPMI 1640 medium does not. Thus it would appear that if iron is 
available in excess to the cells growth inhibition occurs. Thus, where these 
results show ferrous sulphate (10 5M) to be toxic to the cells, it may be due 
to the presence of excess iron (see Table 331, Section 3.3.7.).
Transferrin functions in iron transport in vivo and it is thought to act 
similarily in vitro. In vivo, iron is transported to the bone marrow and 
other sites bound to plasma transferrin. The plasma transferrin iron pool
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is in equilibrium with the iron in storage forms in the gastrointestinal 
tract and the reticuloendothelial' cells. Both bovine and human transferrin 
are used in serum-free formulations. Transferrin binds to a specific cell 
surface receptor, which functions to transport the iron to intracellular 
compartments for synthesis of heme, which in turn is required for production 
of mature cytochromes, myoglobin and haemoglobin.
Iron is present at a concentration of 0.834 mg/1 in Ham's F12, in the form 
of FeSO^-.^O (ferrous sulphate) , but it is not present in DME. There is a strong 
possibility that iron is removed from the medium as an insoluble ferric 
hydroxide during sterile filtration (Ham, 1984); thus, although a media 
formulation may state that ferrous sulphate is a component, it may no longer 
remain in the medium after filtration. It has been suggested to add a 
solution of freshly prepared sterile ferrous sulphate solution to the 
medium after filtration. Tsao et_ al,, (1982) added ferrous sulphate (10 5M) 
solution to the final medium after it had been sterilised and they found 
that much of the transferrin requirement could be replaced by this. (In 
growing normal epidermal keratinocytes in a chemically-defined basal medium, 
MCDB 152, these workers report the need to add 10 pg/ml of transferrin, in 
conjunction with six other components).
Thus, it seems that transferrin functions primarily to supply iron in a 
usable form to the cells in culture. Transferrin preparations are not 100% 
purified and possibly contain a range of unknown contaminants. It is 
possible that it owes some of its mitogenic ability to the presence of these 
contaminants, particularly when operating in a totally serum-free, chemically- 
defined medium.
Insulin is the second component which has widespread use in serum-free media. 
The requirement for insulin by RPMI 2650 cells is not absolute, yet insulin 
does contribute significantly to growth. These results show that the 
contribution of insulin to growth can be detected in the absence of any 
other factors (see Tables 3.12 and 3.14, Section 3.3.5.), with a 0.5% FCS 
background level. When insulin is in combination with transferrin, the 
growth stimulation which occurs is greater than the sum of the individual 
contributions (see Table 3.12, Section 3.3.5.). . Therefore, insulin and
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transferrin appear to interact in a synergistic manner to increase growth 
of RPMI 2650.
Growth of RPMI 2650 will occur in the absence of insulin, in reduced serum 
conditions. Growth in medium supplemented with 0,5% FCS + TES is compared 
to growth in 0.5% FCS + TIES (see Table 3.15, Sec. 3.3.5.) and it is clear 
that although growth does occur in 0.5% FCS + TES, there is a significant 
increase due to the addition of insulin. This pattern is found in a number 
of other serum-free media formulations, e.g. Simms et aL, (1980), shows 
that, while insulin does lead to a significant increase in growth of a lung 
carcinoma cell line, the removal of insulin totally from the medium results 
in submaximal, but significant growth.
Insulin is found in almost all serum-free media and stimulates a wide range 
of cell types, e.g. a prostatic epithelium cell line (Chaproniere et_ al,, 
1985), a colon carcinoma cell line, HT29, (Zirvi et_ al., 1986), canine kidney 
(Taub ert al., 1979) and monkey kidney cells (Taub, 1984) and Swiss 3T3 
(Shipley and Ham, 1981). As with transferrin, the extent to which cells are 
dependent on insulin varies. As already mentioned, both the RPMI 2650 and 
a carcinoma cell line (Simms et_ al,, 1980) .still exhibit growth in the absence 
of insulin, but with some other cell lines insulin plays a much more 
critical role, e.g. with the MCF-7 mammary tumour cells deletion of insulin 
from the serum-free medium reduces growth by 6 6% (Barnes & Sato, 1979).
Insulin, (a polypeptide of molecular weight circa 5,000), is synthesized 
(in the form of a high molecular-weight precursor) by the # cells in the 
islets of Langerhans in the pancreas. The half life of insulin in the 
blood is only 3 - 4 minutes, which may be of significance to its inclusion 
in serum-free media. Insulin is known to act on a variety of tissues 
(liver, fat, muscle). Insulin preparations are standardized in units by 
measuring their effect on the blood glucose of rabbits. The international 
standard unit contains 24 units per mg recrystallized insulin. The 
insulin content of serum is reported to be 25 pU/ml, which is approximately 
equivalent to 1 ng/ml. Insulin is used at concentrations of 1-10 pg/ml 
in most serum-free media. Therefore, if commercially-available insulin is 
as purified as standard insulin, concentrations used are far above 
physiological levels.
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Insulin plays an important role in metabolism, causing increased carbohydrate 
metabolism, glycogen storage, fatty acid synthesis, amino acid uptake and 
protein synthesis. Insulin receptors are found on the cell surface; these 
are glycoproteins of 300,000 molecular weight, to which insulin binds. It 
is thought that this high affinity binding is vital for insulin action 
in vivo; binding to the plasma membrane of target cells leads to increased 
uptake of amino acids, lipids and ions.
The relationship between the effect of insulin on metabolism and its 
positive effects on growth of cells in culture are at present poorly 
understood. The fact that growth-promoting effects of insulin are visible 
often at supraphysiological levels suggest that insulin may be binding to 
receptors other than its own (Coppack and Straus, 1984).
There is a group of insulin-like growth factors called the somatomedins. 
Human serum contains two classes of somatomedins; they are of M.W. approx. 
7 ,5 0 0kDa and are distinguishable only by their isoelectric points. There 
is considerable evidence to show that the receptors that bind insulin and 
at least one of the somatomedins, insulin-like growth factor I, also 
called Somatomedin C, are imraunologically, structurally and functionally 
related (Perdue, 1984). Some work carried out on adult human fibroblasts 
( Conover et aL, 1985) demonstrate that insulin and IGF-l(SM-C) at 
physiological concentrations are both mitogenic for these cells. These 
workers suggest that when both compounds are present at physiological 
concentration (nanomolar concentrations) they each act through their own 
receptors. When insulin levels are increased to supraphysiological levels 
(10-100 pg/ml) increased stimulation is recorded. It is hypothesized that 
the increased mitogenic action is due to interaction of insulin with IGF-I 
receptor (Rosenfeld & Dollar, 1982).
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Insulin can also modulate various cell functions. Rat pancreatic acinar 
cells are maintained in a serum-free medium supplemented with albumin,
EGF, dexamethasone and hepes. But the addition of insulin at 1 jjg/ml 
concentration significantly increases intracellular and secreted amylase 
activity after 3 days (Brannon et al,, 1985). Thus, insulin may be playing 
a role, when present in medium, that is not detected by looking at 
changing growth levels.
The results presented here show that selenium plays a certain role in growth 
of RPMI 2650 at reduced serum concentrations. The contribution of selenium 
was not evident at higher FCS concentrations (see Table 3.16, Sec. 3.3.5.), 
but at reduced (0.5%) FCS levels selenium consistently increased growth to 
a’relatively small extent. Ham (1984) in a review article on growth of 
human diploid fibroblasts (HDF), reports that selenium is of major 
importance for serum-free growth of HDF but that this requirement is masked 
in most serum-containing systems but becomes very important when the 
concentration of serum is lowered. Thus, our observation of stimulation in 
reduced serum with an epithelial cell line is similar to Ham's report for 
fibroblasts.
Early developmental work on optimized basal media led to the development of 
F10 (Ham, 1963) and F12 (Ham 1965) . Chinese hamster ovary and lung cell 
lines grew in the complete absence of protein supplementation in F12 medium 
but later (Hamilton and Ham, 1977) it was discovered that cellular 
multiplication of these cells in F12 medium without supplementation was 
dependent on the presence in the medium of selenium as a trace element.
Selenium is known to be an antioxidant. This may be important when the cells 
are exposed to an oxygen-rich environment of 95% air and 5% CO^. When 
adrenocortical cells grow in a serum-free defined medium, a-tocopherol 
(Vitamin E) and NaSeO^ have a stimulatory effect on cell proliferation (and 
also affect energy metabolism and differentiated function)- cells did not 
survive in the absence of these antioxidants (Gill et al„ 1934). Selenium is 
known to act as a cofactor for glutathione peroxidase which converts lipid 
hyperoxides to alcohols (Tappel, 1980).
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The importance of selenium in media formulation varies. In growth of 
primary cultures of bronchogenic epidermoid carcinoma cells in serum-free 
conditions selenium is added (with insulin, T„, retinoic acid and glucagon) 
at a concentration of 2.5 x 10 M (Miyazaki et_ al, 1984). Of the four 
factors selenium was the most important when cells were cultivated at low 
density. In the absence of selenium growth was very limited, regardless of 
the addition of the other factors. The precise nutritional and growth 
requirements of individual cell lines is emphasized in work carried out by 
Michler-Stuke & Bottenstein (1984). Here, growth of three different glial 
derived cell-lines in a serum-free medium is recorded. Selenium (sodium 
selenite) is one of the components. Deletion studies show that in the absence 
of selenium growth of one cell line, U-251 (human glioma), is reduced to 
80% of that in selenium-containing medium, growth of the C6 (rat glioma) 
cell line is reduced by more than 50%jwhile growth of the third line, RN-22, 
a rat schwannoma cell line is actually increased in the absence of selenium.
Selenium is not normally included in media originally formulated for use with 
serum and is not in DME or F12. It is postulated that traces of selenium may
be present in FCS (Freshney, 1983), but the only real evidence for this is the 
fact that a selenium requirement has been demonstrated in quite a number of 
cell lines, McKeehan et al, (1976) were one of the earliest to demonstrate 
requirement for selenium when they showed that growth of normal fibroblast 
was stimulated by selenium, a -tocopherol (Vit. E) and selenium have been 
shown to be synergistic in vivo so it is possible that addition of Vit. E 
(not normally a serum-free media component, although there are some reports 
(Bettger et al, 1984), working with human fibroblasts) may enhance the effect 
of selenium in culture.
Our results show selenium having a consistent effect on cell growth (Tables 
3.12 and 3.13, Sec. 3.3.5.). Selenium appears to increase the CFE, but not 
the total colony area, when added on its own or when added in conjunction 
with other components with 0.5% FCS background level. This suggests that 
selenium is acting as an attachment factor, increasing the number of cells 
which attach and form colonies but not affecting the number of cell 
divisions which take place. This is an interesting hypothesis, as the exact 
role of selenium, when present as a trace element in many serum-free media, 
is not known.
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In growth of RPMI 2650 epidermal growth factor plays an important role. 
Although EGF on its own does not cause any significant increase in cell 
growth, when it is added in conjunction with transferrin or selenium 
significant growth stimulation is evident (see Table 3.13, Sec. 3.35).
Again, like insulin, growth occurs in the absence of EGF, but its 
contribution to growth of RPMI is very significant when added at a 
concentration of lOng/ml.
EGF, a polypeptide growth factor (molecular weight 6,000 Da) was first 
described as a peptide which would stimulate precocious eyelid opening 
and tooth eruption in newborn mice. EGF has been used to support serum- 
free growth of a variety of cell types - HeLa cells (Hutchings & Sato,
1978), BHK-kidney cells (Maciag e_t al.. 1980), Wl-38 lung fibroblasts 
(McKeehan e_t aL, 1977) .
The cellular receptor for EGF is the best understood growth factor receptor 
and is present on a large number of cell types. First purified from A431 cells, 
the receptor is a membrane protein (170-kDa) that has an extracellular 
binding region to which EGF binds. The receptor is known to have an 
associated tyrosine kinase activity and it is thought that the inner portion 
of the receptor is involved in this function.
EGF belongs to a diverse family of polypeptide growth factors which share 
common amino acid sequences; these include TGF-a and the insulin-like growth 
factors (IGF-1 and IGF-2) and vaccinia virus protein (VVP). No clear-xiut 
mechanism of action has been identified for these factors but it seems 
certain that, while sharing some characteristics, each has its own'individual 
mechanism of action. EGF is known to require a relatively long exposure 
time (18 hrs) to induce mitogenesis in cells (James, 1984). EGF is 
thought to bind to the surface receptor region and it seems that* internali­
zation of the bound ligand occurs, which may then trigger off the 
biological response.
EGF has widespread applications in serum-free media and in many cases 
interesting interactions with other compounds have been recorded. Lechner 
et al. (1982) show that in a chemically-defined medium, MCDB 151, growth of
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normal epithelial cells is stimulated due to the addition of EGF (5ng/ml). 
Insulin stimulates these cells also, yet the addition of both EGF and 
insulin does not yield an additive effect. EGF displays synergistic action 
with hydrocortisone.
EGF is included in a serum-free medium for growth of MCF-7 cell line, but 
its omission from the medium does not have a very significant effect, if 
cells are counted after 7 days. After a longer incubation period EGF 
deletion had a noticable effect, (Barnes & Sato, 1979).
EGF stimulates the growth of certain cells in primary culture. Rat hepatocyte 
cultures responded greatly to the addition of EGF and the mitogenic response 
was greatly increased due to the addition of insulin and glucagon (Bucher^ 
1984). Although EGF is thought to be present in serum, LaRocca and 
Rheinwald (1985) suggest that, if EGF is present in serum at all^  it is 
present at exceptionally low and non-mitogenic levels (O.lng/ml). EGF may
m -+ +  ' I '  'I*  ,modify Ca and Mg requirements for some cell types (McKeehan, 1984).
Two other additions to the medium caused significant increase in growth of 
RPMI 2650. MEM non-essential amino acids, when added at the concentration 
used in MEM basal medium, led to a significant increase in cell number 
(see Table 3.28, Sec. 3.3.7.). MEM non-essential amino acids (see Table 3.27 
Sec. 3.3.7.) are added to MEM basal medium in which normal growth of RPMI 
2650 occurs in 5% serum. Although not a regular serum-free media supplement, 
the decision to add . NEAA to the medium was taken on the grounds that 
(a) of the amino acids in the mixture, five (L-alanine, L-asparagine, 
L-aspartic acid, L-glutamic acid and L-proline) are not present in DME and 
although present in Ham's Fl2;the final concentration is only half the 
normal concentration and L-asparagine is not present in Ham's F12 at all. 
Hence, as RPMI 2650 are normally supplied with sufficient quantities of these 
amino acids when growing in serum-supplemented medium, it seemed logical to 
supply the cells with at least the same amino acid composition in the more 
stringent, serum-free environment. (b) No optimization of the basal medium 
had been carried out - yet, as optimization generally involved qualitative 
and quantitative alterations in the amino acid composition, the addition of 
this amino acid mixture could be considered a "bulk" optimization procedure.
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The results obtained justified the addition of this mixture of amino acids 
and could justifiably be included in a serum-free media formulation for 
RPMI 2650.
Ascorbic acid was another supplement which yielded a positive response by 
RPMI 2650. Ascorbic acid is very unstable in solution and is not a 
component of either DME or Ham's F12 medium. It has been known to stimulate 
some cells in serum-free conditions, e.g. Gill et al, (1984) report that the 
addition of ascorbic acid (1 0 0 jjg/ml) greatly enhances the growth of adreno- 
corticoid cells. Weinstein et al.(1982) added ascorbate to a DME:F12 mixture 
to enhance human diploid fibroblast growth (in the presence of 6 other 
factors).
Ascorbic acid (Vitamin C) is the least stable of the vitamins, but is 
stable to freezing, which is of great relevance for its potential use as 
a serum-free medium supplement. Ascorbic acid is a reducing agent and 
functions in vivo in some oxidation-reduction reactions. It is present in 
large amounts in the adrenal cortex, (which is interesting^in view of its 
action in culture on adrenocorticoid cells mentioned previously) but its 
function there is not known. It is known to play a role in collagen bio­
synthesis. It is not known how it functions in vitro, but it may stimulate 
cell attachment, due to its stimulation of collagen synthesis.
4.4 Attachment
Many cell types in culture are classed as anchorage-dependent and grow only 
when attached to a suitable surface. Cell attachment to various substrates 
that are in common use (generally negatively-charged polystyrene) is often 
inadequate and this problem is intensified at low cell density and in 
reduced serum/serum-free conditions.
The results presented here (sec. 3.3.8.), show that optimization of 
cellular attachment is a critical step that should be investigated in the 
development of a serum-free medium. Lack of any growth of RPMI 2650 in the 
absence of serum (in medium supplemented with TIES only) suggests that the 
low FCS level may be involved primarily in supplying attachment factors.
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Significant growth stimulation is recorded when dishes are precoated with 
collagen, Vitrogen or DEAE dextran. This, even in the presence of reduced 
FCS, suggests that neither this level of FCS nor the four growth factors 
present (TIES) are supplying sufficient attachment factors to achieve maximum 
cell attachment.
Precoating dishes with collagen stimulated RPMI 2650 growth, over a wide 
range of precoating conditions. Precoating at 37°C (for 30 mins. to over­
night) gave the best results. The precoating procedure used (see Sec. 2.16) 
involved a fairly stringent washing regime, yet cell binding factors must 
obviously bind to the dish surface in such a way that washing does not remove 
them. A collagen gel was not visible on the surface of the dishes, even 
after the longest precoating period (16 hours).
Collagen has been shown to enhance growth of a variety of cell types, when 
used as a precoating material, e.g. T-84, a human colon carcinoma cell line 
(Barnes and Sato, 1980 b) and chicken fibroblasts (Gey et al, 1974) 
showed increased growth on collagen-treated surfaces. Vitrogen, a commercial 
bovine dermis collagen product, which also proved successful as a precoating 
material with RPMI 2650, has been used by other workers instead of collagen 
with considerable success, e.g. Calvo et al»(1984) with human breast cell 
lines.
Collagen is a protein with a very characteristic structure. There are at 
least five isotypes of collagen molecules which are quite similar yet each 
has an identifying characteristic. Type III Collagen was used in our work; 
this acid-soluble collagen is most prominent in blood vessels, skin and 
connective tissue of internal organs. It (and types I and II) is known to be 
synthesised in precursor form, called procollagen, which is modified after 
synthesis. This modification of procollagen requires ascorbic acid and the 
ferrous iron.
Most cells in culture synthesise collagen (Kleinman et^  al., 1981) the amount 
varying with the cell type. The addition of ascorbic acid to the medium is 
known to enhance collagen synthesis. This may explain why ascorbic acid, 
when added to the medium, led to significant proliferation of RPMI 2650 cells 
in culture (Sec. 3.3.7.). Cell-produced collagen can also stimulate attachment.
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It is thought that a collagen-mediated increase in cell growth is likely 
to be due to an interaction between surface glycoproteins on the cells 
and the collagen substratum. Fibronectin is generally accepted as being 
the major protein functioning in this manner; it is present on most cell 
surfaces and also in serum. Thus it is likely that the collagen-mediated 
increase in cell growth is due to the improved binding of cellular 
fibronectin, although fibronectin levels are thought to be greatly reduced 
on the surfaces of malignant cells. The action of ascorbic acid may cause 
increased collagen secretion which stimulates cell proliferation also.
Precoating dishes with fibronectin has also led to increased growth of 
various cell types, e.g. Lechner e_t al_. (1982) showed increased CFE and 
growth rates in bronchial epithelial cells when dishes were precoated with 
Fibronectin (Fn). Fn precoating did not enhance growth of RPMI 2650 when 
added as a precoating substance.
When Fn and collagen were used in a 1:1 precoating mixture growth 
stimulation occurred but it was not significantly greater than growth 
stimulation recorded in other experiments with collagen precoating 
alone. Fn and collagen have been reported to interact to produce 
greater growth stimulation when both are used as precoating agents 
than when either are used alone (Grinnell, 1983) but our results show 
that this does not occur with RPMI 2650 cells.
DEAE (diethyl-amino-ethyl) dextran proved the most successful attachment 
factor tested. The DEAE dextran, in a chloride form with a nitrogen content 
of 3.2%, when used as a precoating substance led to very significant growth 
stimulation. Growth was increased so much that the possibility of 
eliminating the serum background was suggested. Growth in dishes precoated 
with DEAE dextran in medium supplemented with TIES in the absence* of FCS, 
yielded some growth. This was the first recorded growth of RPMI 2650 in the 
absence of serum and it was confirmed in a subsequent experiment by more 
extensive growth in the presence of TIES + non-essential amino acids and 
ascorbic acid (see Table 3-28, Sec. 3.3.7.6 .).
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DEAE dextran is a basic polymer, which, along with many other basic 
polymers, has been tested for its ability to modify the negatively-charged 
polystyrene surfaces to enhance cellular attachment. There have been some 
reports of enhanced cell growth with DEAE dextran-precoating (McKeehan, 1984, 
working with WI-38 fibroblasts), but it has not, as yet, been tested in a 
large number of systems. Some microcarriers are composed of DEAE dextran.
Various other basic polymers have been tested for an effect on cell growth. 
Precoating with poly-D-lysine is one of the most commonly used methods, and 
one of the most successful. Swiss 3T3 cells showed increased colony number 
and colony size in dishes precoated with poly-D-lysine, in the presence of 
low levels of foetal bovine serum-protein, Shipley and Ham, (1983). McKeehan 
(1984) shows a doubling in cell number of WI-38 fibroblast cells with poly-D- 
lysine precoating but precoating with L-Lysine had no effect on cell growth.
As no poly-D-lysine was available, we tried L-lysine and poly-L-lysine but 
no growth stimulation of RPMI 2650 occurred (see Tables 3.40 and 3.41, Sec. 
3.3.8.). McKeehan (1984) states that, while either the D- or L- isomers of 
polylysine are effective, monomeric lysine or dilysine shows no stimulatory 
effect. McKeehan suggest that a minimum polymer length of 10 amino acids is 
necessary in the case of polylysine to stimulate cell growth. Our results 
show L-lysine inhibiting growt^ while poly-L-lysine has no effect on this 
epithelial cell line.
Various other polymers were tested with RPMI 2650 (see Sec. 3.3.8 .4.), 
but none showed any great growth stimulatory activity. Gelatin (denatured 
collagen) is a substance that has stimulated growth in numerous systems - 
e.g. Richler and Yaffe, (1970) used it to culture myoblasts and Haas et al. , 
(1984) grew fibroblasts on gelatin-coated dishes. Gelatin has, however, 
been used more by workers studying cellular attachment (e.g. Haas et al. , 1984), 
than for continuous culture of a cell line. Gelatin provides a simple, 
uniform and well-defined model collagenous substratum and it binds more 
fibronectin than does undenatured collagen, thus explaining its use in 
cellular attachment studies.
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The manner in which any basic polymer-coated surface enhances cell growth 
is not known. In some cases the effect of this treatment is more apparent 
at low cell densities and low serum concentrations (Michler-Stuke and 
Bottenstein, 1984). This has led to suggestions that the coated substrate 
is substituting for serum-proteins or cell-derived factors but no studies 
have been reported which identify exactly what is happening. Cell spreading 
has been recorded as being much more extensive on coated substrates (McKeehan 
and Ham, 1976 with fibroblasts) and this may serve to increase the cell 
surface area to affect transport and receptor sites for nutrients and hormones 
in the culture medium. It is not clear why, for example, RPMI 2650
should grow better in dishes precoated with DEAE dextran, or why growth occurs 
in these dishes in the absence of serum, while a low level of serum is vital 
for growth in dishes which have a sulphonated polystyrene surface only.
In some cases attachment factors are included as medium components in 
solution. The addition of collagen to medium supplemented with TIES and a 
reduced FCS level stimulated growth of RPMI 2650 significantly. When 
fibronectin was added to the medium growth stimulation occurred (where 
precoating had no effect) and when DEAE dextran was added to the medium 
extensive growth stimulation was recorded.
4.5 Other developmental work
Cells are known to produce autostimulatory growth factors and these factors
can act in conjunction with any growth factors which are present as medium
supplements to stimulate increased cell growth. There are also some
instances where the nutritional requirements of cells at high densities
differ from those of cells at lower densities, e.g. transferrin at 100 Mg/ml
increases growth of lung cells at high density but not at low density (Simms
et al., 1980). Therefore, growth was observed over a range of cell concen- 
=""""= 2trations from 1x10 cells/dish to 1x10 cells/dish. The lowest concentration
of cells at which growth occurred in medium supplemented with1 5% FCS was
2 . . .  .5x10 cells/dish and this may indicate an involvement of autostimulatory
growth factors. At this concentration^as well as at 1x10^ cells/dish,
growth in 0.5% FCS + TIES was significantly greater than in 0.5% FCS alone.
I
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Many problems arose when attempting to culture cells in flasks in medium 
with a low serum concentration and supplemented with TIES (see Sec. 3.3.10.).
It would appear that growing cells in ap-.npen dish, allowing gaseous exchange 
to occur with the 5% atmosphere, is a superior manner of culturing cells 
in low serum conditions or in the absence of serum. Most workers who report 
long-term subculturing of cells in serum-free media carry out subculturing 
in open petri dishes (30 mm or 60 mm), e.g. Taub et al.,(1979),
This method appeared very inaccurate for use with RPMI 2650, as cell counts
were low from small dishes - almost too low to detect using a haemocytometer.
2Therefore, considerable time was spent trying to grow RPMI 2650 m  25 cm 
flasks. The fact that growth was eventually achieved only when partially- 
open flasks were used in a 5% CO^ atmosphere suggests that there was 
insufficient buffer present in the medium or alternatively relates to O^/CO^ 
exchange. This suggests that not only the nutritional but also the gaseous 
requirements of cells should be taken into account when subjecting the cells 
to suboptimum conditions.
Many compounds, apart from transferrin, insulin, EGF and selenium were 
examined for ability to stimulate RPMI 2650 growth. None of them consistently 
stimulated growth although some, e.g. bombesin and hydrocortisone did stimulate 
under particular conditions. It is common‘in developing a serum-free medium 
to examine a large number of compounds and to eliminate those that are 
definitely inhibitory or having no effect. To a large extent, if a compound 
appears to be contributing anything at all to growth of the cell line in 
question, workers retain this compound in their serum-free medium formulation. 
There is always the possibility that a slight stimulatory action will be 
potentiated by the random addition at a later date of another compound.
This mode of action can be seen in many of the deletion studies (some examples 
given in Sec. 4.3.)^ where omission of a component from a serum-free 
formulation makes little difference. Brower et_ al»(1986) , for example, 
describe a serum-free medium,ACL-3^which contains TIES, hydrocortisone, T^ 
and sodium pyruvate, in which a lung carcinoma cell line grows in the absence 
of serum. But deletion studies show that, in the absence of either T^ or 
sodium pyruvate^growth continues at 90% of the original value. Yet, in spite 
of the small contribution these factors are making, they are included in the 
serum-free formulation.
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4.6 Optimal conditions for growth of RPMI 2650 in reduced 
serum conditions and in the absence of serum
The results of a final experiment carried out to detect the best 
combination of factors for growth of RPMI 2650 show that DEAE dextran 
precoating of dishes greatly enhances growth of RPMI 2650, supporting growth 
in the absence of FCS when the medium is supplemented with TIES, MEM, 
non-essential amino acids and ascorbic acid. The CFE in the precoated dishes 
was an average of 70% of that in the 5% FCS control while the total colony 
area was over 50% of that in 5% FCS. These results represent a major break­
through in the development of a serum-free medium for RPMI 2650.
Once growth has been achieved in the total absence of FCS, increasing the
extent of this growth is a relatively easy matter. An adequate set of 
attachment^nutritional and growth requirements of this cell line have now 
been identified and optimization of these factors, with the addition of 
possibly a few more compounds, should yield consistently high levels of 
growth, comparable to that in 5% FCS. It is possible that some of the
compounds rejected previously as having no consistent growth stimulatory
ability for RPMI 2650 (particularly bombesin and hydrocortisone) may now, 
in the absence of FCS, perform some function that was previously masked by 
the low level of FCS present.
The inclusion of DEAE dextran as a medium component, in the absence of
precoating, in medium supplemented with 0.25% FCS + TIES, non-essential 
amino acids and ascorbic acid, yielded growth comparable to that in DEAE 
dextran precoated dishes (see Table 3.47, Sec. 3.3.11.). The inclusion of 
an attachment factor as a medium component is obviously more advantageous 
for use in a routine system. Hence, investigation into growth in the absence 
of FCS with DEAE dextran as a medium component would certainly be of 
interest.
The growth obtained in the presence of 0.25% FCS and 0.5% FCS backgrounds, 
in DEAE dextran coated dishes was excellent (see Table 3.47, Sec. 3.3.11.). 
The total colony area in these dishes not only exceeded that in the non­
coated controls but also that in the 5% FCS controls. Microscopic
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observation of the colony morphologies showed a distinct difference in the 
number of cells per colony between the coated and uncoated dishes. Colonies 
in 5% FCS are more densely packed than in the precoated dishes and thus the 
difference in total colony area is not an accurate reflection of the 
difference in cell number . F.urther analysis involving cell counts would 
be needed to obtain more information. However, microscopic observations 
suggest that there is a real increase in cell number between precoated and 
non-precoated ,dishes fed with TIES - supplemented medium.
Thus it appears that growth equivalent to that in 5% ECS can be achieved in
dishes precoated with DEAE dextran (100 ug/ml) in DME:F12 medium supplemented
with 0.25% ECS and transferrin (5 pg/ml), insulin (5 pg/ml), EGF (10 ng/ml),
“8selenium (1x10 M) , ascorbic acid (10 pg/ml) and MEM non-essential amino acids 
(1 :1 0 0 dilution).
A rough estimate of the cost of 100 mis of medium (and DEAE dextran coating 
of 50 dishes) shows no marked reduction in costs compared to using medium 
supplemented with 5% FCS. At current prices, transferrin (£23.62/100 mg), 
insulin (£22.50/100 mg), EGF (£94.60/100 ^g) selenium (£10.54/1 mg), 
ascorbic acid (£10.54/100 mg), MEM non-essential amino acids (£5.21/100 mis) 
and DEAE dextran (£7.81/10g), supplemented with 0.25% FCS>costs approximately 
£2, (including V.A.T.), for 100 mis of this medium. 100 mis of medium 
supplemented with 5% FCS and MEM non-essential amino acids costs approximately 
£1.60. But the composition of this medium is much more precisely defined and 
hence is a better system to work with.
Development of a serum-free medium is not complete until continuous growth of 
the cells is examined in this environment. The nutritional requirements 
for short-term survival of cells may be inadequate for continual cultivation 
of cells in this environment. It is always advisable to maintain stocks in 
serum-supplemented medium while long-term growth in a newly-developed serum- 
free medium is being tested, as the nutritional and growth requirements may 
change with subculturing. Simms et al.(1980) showed that, when growing NCI-M69 
lung carcinoma cells in serum-free conditions, omission of insulin does not 
reduce growth greatly, when cells have been freshly subcultured from serum- 
containing medium. But after the cells have been maintained for six months 
in this serum-free medium^ deletion of insulin from the medium led to a cessation 
of growth.
i
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The growth achieved here in reduced serum conditions with RPMI 2650 cells 
has been tested only over a single growth period (7 days). No subculturing 
has been carried out. This is an area that would have to be thoroughly 
investigated before claiming to have identified reduced serum growth 
conditions for this cell line. Apart from changing growth and nutritional 
requirements, there is also the problem of trypsinization. Serum contains 
a trypsin inhibitor which protects the cells from further trypsin action 
once serum-containing medium is added to the cells. In the absence of 
serum, the cells must be protected from destructive trypsin action. Soya­
bean trypsin inhibitor may afford sufficient protection - this was used 
routinely in setting up cell assays. This would have to be checked over a 
number of trypsinizations, to define the optimum conditions for continuous 
growth of RPMI 2650 in the absence of serum.
Investigations are currently being carried out in this laboratory into the 
production of autocrine growth factors by RPMI 2650. Medium which has been 
conditioned by the cells is collected and examined for the presence of 
growth factors. This work may benefit from the development of a serum-free 
medium, as a more accurate knowledge of the cellular environment would be 
available in which to test the activity of these factors.
4.7 Growth of other cell lines in TIES-sapplenrented medium
The results presented in Sec. 3.3.12. emphasize the problem of development 
of a universal serum-free substitute. The complex nature of serum provides 
the growth requirements for a very extensive range of cell types and it is 
proving very difficult to mimic this action with serum-free formulations.
Many workers report a serum-free formulation which will stimulate a number 
of cell types of similar nature, e.g. Calvo £t^  al^ .(1984) developed a serum- 
free medium for one human mammary cell line and found that this medium also 
supported the continuous growth of four other human breast cancer cell lines. 
But little success has been reported in development of serum-free formulation^ 
with widespread applications.
Growth of A431 cells was unchanged in the presence of TIES. A431 cells, in 
spite of having an increased number of EGF receptors, is actually inhibited 
by EGF at nanogram concentrations (Barnes, 1984). Thus although transferrin
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and insulin are both stimulatory to A431 cells (Barnes, 1984), the TIES 
combination yields no significant growth stimulation. One possibility is 
that the EGF is negating any positive stimulation of transferrin and 
insulin but time did not permit testing of this hypothesis.
The growth inhibition recorded in the HEP-2 cell line is somewhat surprising.
It is generally accepted that this cell line is contaminated with HeLa cells. 
Hutchings and Sato (1978) developed a serum-free medium for HeLa cells which 
consisted of Ham's F12 basal medium, supplemented with transferrin, insulin, 
EGF, hydrocortisone and a trace element mixture which included selenium. The 
growth requirements of the HEP-2 cells must obviously differ somewhat from 
those of HeLa cells, in spite of supposed contamination.
Total inhibition of growth in A 549 cells occurred in the presence of TIES.
Carney (1984) reports the growth of A549 in medium supplemented with TIES, 
hydrocortisone and albumin and involving serum precoating: this is the LA 
medium developed by Barnes (1981) . Carney also reports growth of A549 in
TIES and hydrocortisone (HITES) - supplemented medium but stats that it is the 
only non-small cell lung cancer cell line that grows in HITES. No details 
are given on the importance of hydrocortisone in this latter medium. The 
total inhibition of growth in 0.5% FCS + TIES or 0.25% FCS + TIES must be 
due either to the presence of the low level of FCS or the absence of 
hydrocortisone.
Thus, none of these lines tested showed a similar response to the TIES- 
supplemented medium. While, the developmental work carried out with the RPMI 
2650 cells identified the growth requirements of this cell line, these 
clearly are not the growth requirements of A431, A549 or HEP-2 cell lines.
4 . 8  Milk as a medium supplement
Milk or milk products have been used as a medium supplement by a small number 
of workers. Sereni and Baserga (1981) report growth of several cell lines, 
including mouse 3T3, in both dairy farm milk and pasteurised skim milk. They 
added a low level of serum, 0.5% calf serum, to help cellular attachment. 
Fassolitis et^  al.(1981) used 5% powdered milk to support the growth of a 
number of epithelial cell lines in the absence of serum. They reported that
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cell growth was slower than in serum-supplemented medium but the same 
saturation densities were obtained. They also claimed that two fibroblast 
cell lines failed to grow in milk-supplemented medium, which opened up the 
possibility of a selective medium supplement.
Steimer and Klagsbrun (1981) reported the growth of certain fibroblastic 
cells in medium supplemented with milk in dishes precoated with fibronectin. 
Previously, Klagsbrun (1980) stated that MDCK cells grew in medium 
supplemented with colostrum over a period of five months with continuous 
subculturing, but failed to grow in milk obtained one week after the birth 
of the calf.
We attempted to test milk-supplemented medium on some of the cell lines in 
our laboratory. The first problem we encountered was sterilization of the 
milk. Milk from commercial sources was used and attempts to repeat the work 
of Sereni and Baserga failed completely. They claimed that, after centrifuging 
milk to remove fat and cellulose debris and diluting it to 10% in DME, 
sterility was achieved by passing it through a 0.44 pm and a 0.22 urn Millipore 
filter. In our experience, milk failed to pass through a 0.22 pm filter even 
after having been passed through a stack of membranes of larger pore size.
This is probably due to the presence of micelles. Milk filtered through 0.45pni 
only was usually contaminated.
We then used a Pellicon ultrafiltration unit, with a 1x10^ molecular weight 
membrane (see Section 2.10) which retained the micelles without clogging the 
filter, due to the tangential flow in the apparatus. Filtrate from here was 
passed through a 0 . 2 2  pm filter under ^  pressure but this did not consistently 
produce sterile milk. A membrane stack, while increasing the volume of milk 
filtrate that could be sterilised, did not increase the sterility of the milk. 
The membrane stack repeatedly failed an integrity test.
The addition of a 0.22 Millipore-GV filter (presealed)to the end of the 
membrane stack resulted in sterile milk being consistently obtained. Having 
overcome the technological problem of achieving a sterile milk solution, we 
then tested it on a number of cell lines (see Section 3.3.13.).
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As reported in Section 3.3.13, great inconsistencies were recorded in the 
growth-stimulatory ability of milk-supplemented medium. Out of a total of 
41 attempts to grow mouse 3T3 cells in milk-supplemented medium in the 
presence of a low FCS level, 21 positive results were obtained and 20 
negative results. it was obvious that milk has some growth-stimulating 
property, but the manner in which it operates remains a mystery. Similar 
results were obtained with MDCK cells and RPMI 2650 cells. With the latter, 
no stimulation was ever recorded when milk was added on its own to medium 
with 0.5% FCS. But when milk was added to medium with 0.5% FCS + TIES 
growth recorded on a few occasions was greater than in 0.5% FCS + TIES.; 
again this stimulatory action of milk was not consistently observed.
Growth in colostrum, dried milk or baby food showed no stimulatory action. 
The results we obtained using milk as a medium supplement need to be 
compared with those published in the literature. We found that the 
sterilization methods used by Sereni and Baserga were not sufficient to 
produce a sterile milk solution, thus raising some questions relating to 
their results. Steimer and Klagsbrun (1981) reported that milk failed to 
support growth of fibroblastic cells, and Klagsbrun (1980) showed growth in 
milk-supplemented medium only in the presence of fibronectin. Therefore, 
our lack of convincing positive growth-stimulation due to the addition of 
milk is not in total conflict with other literature reports.
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ABBREVIATIONS USED THROUGHOUT THESIS
BSA - Bovine serum albumin
CFE - Colony forming efficiency
DEAE - Diethylaminoethyl
DMEM/DME - Dulbecco's Modified Eagles Medium
EDTA - Ethylene diamine tetra acetic acid
EGF - Epidermal growth factor
FCS - Foetal calf serum
Fn - Fibronectin
Hepes - 4-(2-hydroxyethyl-l-piperazine ethane sulphonic acid)
I - Insulin
ITS - Insulin, transferrin, selenium
MEM - Minimal Essential Medium
MDCK - Mandin Darby Canine Kidney Cells
PBS - Phosphate buffered saline
PDGF - Platelet-derived growth factor
PGE^ Prostaglandin E^
RPMI 2650 - Roswell Park Memorial Institute - cell line
S - Selenium
T ' - Transferrin
TV - Trypsin versene
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